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Chapter 1
Introduction
Computed tomography (CT) is a common and widespread diagnostic tool in medical imag-
ing. The benefits are the good availability, a high diagnostic efficiency and the compar-
atively low costs. But until now molecular imaging cannot be performed with computed
tomography. The main reason for this is the lack of targeted and molecularly specific con-
trast agents [89]. Especially for cancer diagnosis and therapy monitoring, CT is of high
importance as it provides valuable anatomical information regarding tumor location, size
and spread. Several materials have been suggested as new contrast agents for computed
tomography. Materials containing elements such as bismuth [65,90], lanthanoids [86] and
gold with a K-edge at high energies are very promising for improving medical imaging.
The advantage of these materials is their high atomic number (high-Z), which leads to a
higher contrast at equal mass density. This effect is beneficial, since on the one hand it
provides an increased contrast-to-noise ratio at a certain dose or on the other hand the
dose can be reduced without detriment for the contrast-to-noise ratio [84].
Newly developed spectral CTs with a photon-counting and energy-selective detector pro-
vide the possibility to obtain additional information about an object’s absorption proper-
ties, the footprint of which can be found in the energy spectrum of the detected photons.
These new CT systems are capable of yielding valuable insight into the elemental com-
position of the tissue and open up the way for new CT contrast agents by detecting
element-specific K-edge patterns. In a conventional energy-integrating detector, photons
are weighted according to their energy (i.e. low-energy photons are weighted less); for
spectral CT, a weighting factor of one is assigned to each photon.
The goal of this thesis is to analyze the potential of gold-nanoparticles as a CT contrast
agent to improve medical spectral CT imaging. Challenging questions in medical ap-
plication of gold-nanoparticles concern the required gold concentration and the specific
targeting of malignant tissue.
The presented work is subdivided into three subtasks. For the first subtask, Monte Carlo
simulations with the software tool EGSnrc are performed to model medical spectral CT
imaging with gold in humans. The simulation results are then analyzed and different
2
3material-decomposition algorithms are applied to enable a specific detection of gold. For
the evaluation of the images the signal-to-noise ratio, the contrast-to-noise ratio and the
contrast is calculated. The minimum concentration of gold required to provide sufficient
contrast in spectral CT in-vivo can be estimated with these simulations. In the second
subtask, the dose enhancement effect in the vicinity of gold is examined with EGSnrc
simulations to better assess potential side effects of gold-nanoparticles. Different X-ray
tube voltages and different gold concentrations are implemented to determine the impact
on the dose enhancement effect. In the last subtask, cell culture experiments with tumor
cells and gold-nanoparticles are performed. The gold-nanoparticles are functionalized with
a tumor-specific antibody enabling the realization of targeted nanoparticle-based tumor
imaging. The results of the different experiments help to address the question if the des-
ignated concentration of gold can be targeted to malignant cells.
This thesis is organized as follows: After the introduction there is a section concerning
the theoretical background (Chapter 2), followed by an overview of the methodology and
techniques used (Chapter 3). In the results section all outcomes are presented, analyzed
and discussed (Chapter 4). The conclusions are drawn in Chapter 5. Applied algorithms
and additional investigations are provided in the annex.
Chapter 2
Theoretical background
This chapter summarizes the background and the current state of the art of the main topics
covered by this thesis: computed tomography (section 2.1), gold-nanoparticles (section 2.2)
and heat shock proteins (section 2.3).
2.1 X-rays and computed tomography
Computed tomography (CT) is an imaging technique, which is based on X-ray attenua-
tion. As opposed to X-ray projection data, CT provides superposition-free tomographic
data, generated by rotating the X-ray tube and the detector around the patient. In the
following sections, first the X-ray generation (X-ray tube) and detection are described, the
interaction of photons with matter and the K-edge effect are summarized, and then the
basic principals of CT and the differences between conventional CT and spectral CT are
outlined.
2.1.1 X-ray generation and detection
The main parts of an X-ray tube are the cathode (usually made of tungsten), the anode
and a glass cylinder with high vacuum. The applied voltage Ua between the heated
cathode (to overcome the binding energy of the electrons) and the anode leads to an
acceleration of the thermionic emitted electrons towards the anode. The X-ray spectrum
(Fig. 2.1) consists of the continuous bremsstrahlung and a superimposed characteristic
line spectrum. When the electrons hit the anode they interact with orbital electrons
and the atomic nucleus and are decelerated. This deceleration produces electromagnetic
waves with a continuous distribution of energies, the continuous bremsstrahlung. The
interaction of incoming electrons with inner shell electrons of the anode material lead
to the characteristic line spectrum. The characteristic line spectrum is specific for the
material of the cathode. The maximum energy of the spectrum is determined by the
acceleration voltage Ua and is attained if the entire energy of an electron is transferred to
4
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a single photon eUa = Emax. The anode current specifies the intensity of the spectrum.
Only about 1% of the energy is converted to X-rays, the remaining energy generates
heat [21].
Figure 2.1: Polychromatic X-ray spectrum (tube voltage 120 kV, tungsten anode) dis-
tributed over 6 energy bins. This spectrum was obtained with the calculator by the
Institute of Physics and Engineering in Medicine (IPEM) [35] and was used for the Monte
Carlo simulations.
After penetrating an object, X-rays are not detected directly, but most frequently nowa-
days by scintillator detectors, consisting of a scintillator medium and a photon detector.
Inside the scintillator medium, the impinging photons are converted to light, which is
then detected by the photon detector and converted to an electric signal [21]. Such an
energy-integrating detector converts the number of incident photons to a single intensity
value. This contributes to the problem that CT is not always able to distinguish between
different materials. For example, calcified cortical bone and tissue with a high amount of
iodine-based contrast agent may have similar attenuation values. A possible solution for
this problem would be the use of energy-resolving detectors [9,109], compare section 2.1.4.
2.1.2 Interaction of photons with matter
X-rays have the ability to highly penetrate tissue. While passing through tissue, X-rays
undergo an exponential reduction of radiation intensity, i.e., of the number of photons.
Absorption and scattering processes are the reason for this attenuation.
The intensity of X-rays I(s, E), with energy E passing a distance s through an object with
linear attenuation coefficient µ(E, x) is given by Lambert-Beer’s law
I(s, E) = I0(E) exp
(
−
∫ s
0
µ(E, x)dx
)
. (2.1)
The space dependence of the linear attenuation coefficient is described by x.
6 CHAPTER 2. THEORETICAL BACKGROUND
2.1.2.1 Photoelectric effect and Compton scattering
While penetrating matter, photons may interact with the nucleus or the electrons of the
material. These interactions with matter either lead to a complete absorption of the pho-
ton (its energy is transferred to electrons or positrons) or the photon is scattered and part
of its energy is transferred to an electron. These secondary electrons usually have a short
path length and deposit their energy in the material.
Several factors influence the attenuation of photons. The atomic number of the element,
(or the effective atomic number for chemical compounds), the concentrations of the dif-
ferent components of mixtures and the density have a big influence on the attenuation.
For photons with an energy in the diagnostic range, the total linear attenuation comprises
mainly two different physical effects, the Compton scattering (photon interacts with a
loosely bound electron) and the photoelectric effect (photon interacts with a tightly bound
electron) (Figure 2.2). The total linear attenuation can be written as a linear combination
of these two effects (Eq. 2.2) [97]
µtotal(E, x) = µphoto(E, x) + µCompton(E, x). (2.2)
Figure 2.2: Mass attenuation coefficients2 of liver tissue (left) and pure gold (right). The
energy dependent mass attenuation coefficients were calculated with XCOM [55].
The probability of a specific interaction with a single atom is defined by its cross section
σ. The linear attenuation coefficient is defined by [21]
µtotal = n σtotal (2.3)
σtotal = σphoto + σCompton
where n is the number of target atoms per unit volume. The linear attenuation coefficient
2The mass attenuation coefficient is defined by µ/ρ, where ρ is the density of the material.
2.1. X-RAYS AND COMPUTED TOMOGRAPHY 7
for the photoelectric effect and Compton scattering can be approximated by [7]
µphoto(E, x) = Cphoto(x)
1
E3
(2.4)
µCompton(E, x) = CCompton(x)fKN
(
E
Ee
)
(2.5)
where fKN(E/Ee) is the Klein-Nishina-function [66], Ee is the rest mass energy of the
electron (Ee ≈ 511 keV) and re is the classical electron radius
fKN(α) = 2πr
2
e
1 + α
α2
[
2(1 + α)
1 + 2α
− ln(1 + 2α)
α
]
+
ln(1 + 2α)
2α
− 1 + 3α
(1 + 2α)2
. (2.6)
The position-depending coefficients Cphoto(x) and CCompton(x) are defined as [7]
Cphoto(x) ∝ ρ(x)Z(x)3 (2.7)
CCompton(x) ∝ ρ(x) (2.8)
with the mass density ρ(x) and the atomic number Z(x). Compton scattering is indepen-
dent of the atomic number Z, whereas the photoelectric absorption is proportional to Z3.
The mass attenuation coefficient µ/ρ for mixtures and compounds is defined by [3](
µ(E, x)
ρ(x)
)
total
=
∑
i
wi(x)
(
µ(E)
ρ
)
i
(2.9)
wi denotes the weight fraction and (µ(E)/ρ)i is the mass attenuation coefficient of material
i. Rearranging this equation and substitution of equation 2.2 yields the following
µtotal(E, x) =
∑
i
ρtotal(x)wi(x)
(
µ(E)
ρ
)
i
=
∑
i
w˜i(x)
(
µ(E)
ρ
)
i
=
∑
i
w˜i(x)
(
µphoto(E) + µCompton(E)
ρ
)
i
(2.10)
with w˜i(x) = ρtotal(x)wi(x)
Since the energy dependence of either the photoelectric absorption or the Compton scat-
tering is the same for all elements of a mixture or compound, Eq. 2.10 remains valid
independent of the elemental composition as long as no absorption edges occur. For CT
examinations where elements (contrast agents) with a high atomic number (and absorption
edges) are present, Eq. 2.10 needs to be modified [97,100].
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2.1.2.2 K-edge effect
For materials with a high atomic number, K-edge discontinuities of the mass attenuation
coefficient have a big influence on the attenuation. The K-edge effect describes a sudden
increase of the attenuation coefficient (Figure 2.3), if the photon energy is equal or just
above the binding energy of the K-shell electrons. The energy at which the K-edge effect
occurs, is specific for each material and can be used to identify and quantify high-atomic-
number contrast agents in a tissue. To use the K-edge discontinuity for medical imaging,
one needs to be aware of photon starvation as a result of beam hardening in the low-
energy part of the X-ray spectrum, which can result in the imperceptibility of the K-edge
effect [21].
Figure 2.3: Mass attenuation coefficients of gold, iodine, bone and soft tissue. The energy
dependent mass attenuation coefficients were calculated with XCOM [55].
2.1.3 Computed tomography
Computed tomography was developed during the 1960s and 1970s by Sir Godfrey Hounsfield,
who received the Nobel Prize in Medicine for his invention.
CT imaging is an X-ray technology, where the X-ray tube and the detector rotate around
the patient. The measured attenuation values from one angular position define one pro-
jection. The scan data of all projections form the raw data set, which is also called a
sinogram. The raw data set represents the Radon transformation of the scanned object
structure. To reconstruct cross-sectional images, the inverse Radon transformation needs
to be calculated, which can be done, e.g. with a filtered back projection or other more
elaborate reconstruction techniques. The reconstructed CT images provide the spatial
distribution of the linear attenuation coefficients µ. For medical imaging (e.g. mammog-
raphy, projection radiography, CT) the X-ray tube voltage is typically in the range of 25
to 150 kV. The main advantage of CT images as compared to other imaging techniques
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is the high spatial and temporal resolution. In contrast to conventional X-ray projection
images, reconstructed CT images provide sectional views, which are free from superimpo-
sition [21].
The linear attenuation values µ in each voxel of the reconstructed CT image are converted
to Hounsfield Units (HU), to obtain values which are approximately independent of the
used spectrum, [21]
HU =
µ− µwater
µwater
1000. (2.11)
The HU value of water is equal to 0 and air has the HU value of -1000. The Hounsfield
scale used in medical imaging ranges from -1024 to +3071, but the human visual system
cannot distinguish between 4096 gray values. To overcome this visualization problem, a
process called “windowing” is applied. Voxels with values below a certain threshold are
displayed as black and voxel values above another threshold are displayed as white. Voxel
values within this window are then mapped to appropriate gray-scale intervals [21].
2.1.4 Conventional CT and spectral CT
A disadvantage of conventional CT systems is that the commonly used energy-integrating
detectors do not provide any information about the polychromatic energy spectrum of
the detected photons. This disadvantage can be potentially overcome by newly developed
so-called spectral CT systems (e.g. by Philips Healthcare Deutschland GmbH, Hamburg3,
Fig. 2.4). This new CT system has a photon-counting and energy-selective detector. In
a conventional energy-integrating detector, photons are weighted according to their en-
ergy (therefore low-energy photons are weighted less). In contrast to conventional CT, a
photon-counting detector assigns a weighting factor equal to one to all incoming photons.
Energy-depending weighting schemes can be applied to increase the contrast (and/or the
contrast-to-noise ratio). This could be especially interesting for soft tissue contrast, which
is higher for low-energy photons. Furthermore, the energy spectrum of the X-ray tube can
be divided into sub-energy-ranges, so-called energy bins. An energy-selective detector pro-
vides the possibility to assign the incoming photons, depending on their energy, to different
energy bins. The energy-selective detector developed by Philips has 6 energy bins with
freely selectable energy thresholds. This new detector technology provides the possibility
to differentiate between tissues based on their different energy-depending attenuations and
is by this capable of yielding valuable insight into the elemental composition of the tissue.
A further potential of spectral CT devices is the possibility to detect element-specific K-
edge patters, opening up the way for new high-atomic number CT contrast agents. The
system is able to detect K-edge patterns of several high-atomic-number contrast agents
enabling the simultaneous use of more than one contrast agent [40]. It can furthermore
reduce the X-ray radiation dose, as no contrast free reference examination is necessary,
3Philips medical systems is involved in the m4 cluster, in which framework this study was conducted.
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since virtual non-contrast images can be calculated based on the information in the differ-
ent energy bins. This information can also be used for a better material characterization,
which is particularly useful for kidney stone differentiation, lesion and plaque character-
ization. Furthermore cupping artifacts can be reduced. Cupping artifacts, also called
beam-hardening artifacts, are a result of the non-linear relation between projection data
and the attenuation coefficients. While passing through tissue, photons with low energy
are strongly attenuated in contrast to photons with higher energy. The polychromatic
X-ray beam thus becomes harder4 while passing through tissue [21]. Furthermore, elec-
tronic noise can be reduced and even molecular imaging might be possible with spectral
CT [40,68,101,109].
The small-animal spectral CT by Philips Healthcare has a single-line, energy-sensitive
detector (Gamma Medica-Ideas, Northridge, CA, USA) with a 3-mm-thick cadmium tel-
luride sensor. This photon-counting detector is able to separate the incoming photons
according to their energy into six energy-bins. The energy thresholds between the indi-
vidual bins can be freely set. The field-of-view is 6 to 23 cm and the spatial resolution is
100 to 250 ➭m. The voltage of the X-ray tube is 40 to 130 kV and the rotation speed is
1/3 s [78].
Figure 2.4: Philips prototype small-animal spectral CT [109].
The formula describing the intensity of X-rays after penetrating an object (Eq. 2.1) can
be modified, to obtain the integrated intensity in bin i of a spectral CT:
Ii(s) =
∫ Ei
Ei−1
Ii0 exp
(
−
∫ s
0
µ(E, x)dx
)
dE for i = 1, ...,K (2.12)
Ii0 =
∫ Ei
Ei−1
I0(E)dE
4Beam hardening describes the removal of low-energy photons from the X-ray beam and by this increases
the average energy of the beam.
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where K is the number of energy bins. Ei are the energy-thresholds of the bins and Ii0 is
the polychromatic X-ray photon fluence in bin i.
Eq. 2.12 can be rewritten
ln
(
Ii0
Ii(s)
)
=
∫ Ei
Ei−1
∫ s
0
µ(E, x)dxdE. (2.13)
The main drawback of a photon-counting detector is the long scanning time, which makes it
impossible to use this new technique for clinical applications at the moment. Furthermore,
the Philips Healthcare prototype can only be used for small animals and phantoms [109].
The long scanning time is due to the reduction of the CT rotation speed and the X-
ray tube current, which is necessary to ensure a low count rate and a short dead time.
The high count rates are especially a problem for the unattenuated primary beam (beam
which does not penetrate tissue); filters could be used to eliminate that problem. Smaller
detector pixels could help to overcome the high count rates, but Compton-crosstalk, K-
escape radiation and charge sharing effects need to be considered [97]; in addition the
noise in each energy bin is increased, as a consequence of the decreased number of photons
per bin [46].
2.2 Gold-nanoparticles
Nanotechnology opens up a wide field for scientific research. It is therefore not surprising,
that there has been a continuously rapid growth in nano-science during the last years.
Nano-technology is used in many different research areas and relies on the interaction of
several scientific fields, including chemistry, biology, physics, informatics and medicine.
2.2.1 Nanoparticles in medicine
In medicine, nanoparticles have found numerous applications including drug delivery, ther-
apy and diagnostics. Nanoparticles are very promising in in-vivo cancer imaging and
therapy. They can be used as minimal-invasive diagnostic tools and at the same time
as drug delivery systems. Functional groups, such as antibodies, imaging labels and
therapeutic drugs, can be conjugated to nanoparticles. This multifunctional character-
istic of nanoparticles provides the possibility to combine targeted-therapy and molecular
imaging, also called theranostics (therapy+diagnostics). Nano-technology is a promis-
ing approach for personalized oncology [13, 22, 48]. However, a number of conditions for
applying nanoparticles as diagnostic and therapeutic tools must be taken into considera-
tion. Particular attention is given to the short and long term toxicity, the biodistribution,
the nonspecific uptake, routes of elimination, routes of delivery and bioavailability of the
nanoparticles [48]. It is important to realize that the properties of nanoparticles often
differ substantially from the properties of macro materials. Since nanoparticles are much
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smaller than human cells, they can interact with biomolecules on the surface and inside
the cell [22]. Taking all that into consideration, nanoparticles for the intravascular applica-
tion should have the following properties: The nanoparticles should be easily dispersable
and stable. Nanoparticles should have a long circulation time, which implies no uptake
by the reticuloendothelial system. Nevertheless; there should be programmed clearance
mechanisms, which guarantee a safe excretion. They should have a high sensitivity and
specificity for the target, and hardly any unspecific binding should occur [48].
2.2.2 Gold-nanoparticles: Physical properties, uptake and toxicology
A specific class of nanoparticles with potential applications in medicine are gold-nano-
particles. Considering their relatively simple synthesis with defined size, shape and surface
chemical compositions, make gold-nanoparticles attractive candidates for medical appli-
cation. Furthermore, they can be easily coupled with biological targeting molecules (e.g.
tumor-specific antibodies), enabling targeted tumor imaging.
Gold-nanoparticles appear red, blue, green or brown depending on their size and shape.
Interactions of conduction band electrons with the incident light lead to these different
colors, this effect is called localized surface plasmon resonance [91]. The diameter of gold-
nanoparticles is typically in the range of 2 to 100 nm [22]. To enhance the (tumor) target-
ing efficacy gold-nanoparticles can be functionalized with different chemical compounds
such as bovine serum albumin (BSA) [27], PEG5 [31, 70, 119], high-density lipoprotein
(HDL) [34], anti-EGFR6 antibody [93], trastuzumab7 [23, 50], 2-deoxy-D-glucose [12, 72],
gadolinium chelate [6], 18FDG-anti-MTDH8 [116] and radioactive iodine-labeled, cyclic
RGD-PEG9 [64].
One common method to synthesize gold-nanoparticles is described by Turkevich [115]
and Frens [41]. For this method, chloroauric acid (HAuCl4) solution is brought to boil,
sodium citrate solution (Na3C6H5O7) is added and then gold-nanoparticles will form.
Sodium citrate ions serve as reducing agent and as coating and stabilizing agent of the
gold-nanoparticles. The citrate anions attach to the gold-nanoparticle surface leading to
an electrostatic repulsion and by this prevent agglomeration of the gold-nanoparticles.
The diameter of gold-nanoparticles can be adjusted by changing the citrate/gold ratio.
The mechanism of gold-nanoparticle uptake and cytotoxic effects depend on various fac-
tors, such as surface properties (e.g. charge), coating or functionalization, shape, size,
concentration and incubation time [4, 25, 29, 63, 122]. The physiochemical properties of
functionalized and coated gold-nanoparticles correspond to the properties of the adsorbed
protein layer [122]. This protein layer can reduce the internalization of gold-nanoparticles
5polyethylene glycol
6epidermal growth factor receptor
7Her2 specific monoclonal antibody, trade name Herceptin
8[18F]2-fluoro-2-deoxy-D-glucose and anti-metadherin antibody
9RGD-arginine-glycine-aspartic acid
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by immune cells, which would lead to a rapid clearance of the gold-nanoparticles from the
bloodstream. The uptake mechanism of gold-nanoparticles has not been fully explained
yet. Direct penetration, receptor-mediated endocytosis and macropinocytosis are possible
uptake mechanisms leading to gold-nanoparticles, that are localized in the cell in vesicles
or vacuoles [4, 26, 63,122].
Several studies investigated the toxic effects of gold-nanoparticles in vitro and in vivo.
The applied amounts of gold-nanoparticles, the size and coating/functionalization of gold-
nanoparticles differed a lot. Hainfeld et al. [51] estimate the median lethal dose (LD50)
at 3.2mg gold/g (for 1.9 nm gold-nanoparticles). Khlebtsov et al. [63] specified a con-
centration limit of 1012 gold-nanoparticles/ml (approximately 0.02mg/g (0.002w%)) for
gold-nanoparticles with a diameter of 10 nm, below that, no cytotoxic effects should oc-
cur.
Several studies with 50 nm gold-nanoparticles indicated no toxic effects [24, 26]10. They
had a smaller organ distribution than smaller gold-nanoparticles [36].
For this thesis, gold-nanoparticles with a diameter of 50 nm and 15 nm were chosen.
2.2.3 Gold-nanoparticles as CT contrast agents
The application of contrast agents in medical imaging is a common procedure to im-
prove the contrast and highlight different structures in the body. Nowadays iodine-based
materials are the only contrast agents, which are clinically used for intravascular contrast-
enhanced computed tomography11. Iodine-based contrast agents are generally well toler-
ated [118]. A benefit of iodine-based contrast agents is their high solubility in water and
their relatively high mass attenuation coefficient [84]. The main drawback of iodine is its
short blood half-life, which is less than 10 minutes [48]. Furthermore, side effects, such
as thyroid or renal dysfunction or anaphylactoid symptoms, may occur. Literature data
concerning side effects vary from 1:10000 to 1:100000 [118]. Unfortunately, conjugates of
iodine and targeting moieties or antibodies has failed to deliver detectable concentrations
to the desired location, preventing its use for molecular imaging [51]. To overcome these
problems, gold-nanoparticles have been suggested as new contrast agents for computed
tomography. A new contrast agent should fulfill the following requirements [18]:
1) The contrast agent leads to an increase in the localized signal.
2) Little or no undesirable side effects to the patient occur.
3) It leads to a high specific uptake by the targeted tissue and
4) a low background uptake.
10The applied gold-nanoparticle concentration was not specified in [26]. Mice were injected with 8mg
gold-nanoparticles per kg body weight per week (approximately 8×10−4w%) in [24].
11Another commonly applied X-ray contrast agent is barium sulfate, which is only used for the alimentary
tract.
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To item 1) several groups have shown that gold-nanoparticles are a promising new CT
contrast agent. The localized signal was over 5-times higher, compared to the tissue
without gold-nanoparticles [89, 93]. It was also shown that coated/functionalized gold-
nanoparticles enable longer imaging times [51]. Another beneficial aspect is the possibility
to detect small tumors with a diameter of 0.4-1 cm, which could lead to better prog-
noses [50,51,93]. It was furthermore shown that the contrast enhancement is independent
of size and shape of the nanoparticles. Only the concentration of the gold in the tissue
affects the attenuation of the X-rays [57].
To item 2) gold-nanoparticles have shown to be nontoxic in the concentration applied here.
To items 3) and 4) a high specific uptake of gold-nanoparticles can be achieved by func-
tionalization of the gold-nanoparticles with specific antibodies, such as 2-deoxy-D-glucose
labeled gold-nanoparticles [12, 72], by trastuzumab (Her2 specific monoclonal antibody,
trade name Herceptin) labeled gold-nanoparticles [50], high-density lipoprotein (HDL)
gold-nanoparticles [34] and by anti-EGFR antibody labeled gold-nanoparticles [93].
Several investigations with conventional CT, dual-energy CT and spectral CT were al-
ready performed with gold-based contrast agents. Hainfeld et al. [51] were one of the
first using gold-nanoparticles as contrast agent. X-ray imaging of mice was performed
2 minutes after intravenous injection of 0.2ml gold-nanoparticle solution (concentration
270mg/ml). The amount of gold in the tumor was determined by graphite furnace atomic
absorption spectrometry. 15minutes after injection the tumor contained 2.268mg/g gold
(4.3% of the injected dose, approximately 0.23w%12). However, the gold concentration
rapidly decreased in the first hour. In the X-ray image, the blood vessels could be clearly
distinguished due to the higher absorption of gold and the increased vascularity in the
tumor. One should remember that for the precise identification of gold-based contrast
agent in a conventional CT an additional contrast-free scan is required, which increases
the X-ray dose applied to the patient.
In 2011 Hainfeld published new results with gold as micro-CT contrast agent in mice [50].
The gold-nanoparticles (15 nm) were conjugated to trastuzumab. The tumors showed a
mean uptake of 8.3% of the injected dose (conversion into w% yields 0.05w% up to 0.18w%
for the applied doses). On the micro-CT images, the tumors were identifiable by their ra-
diodense peripheries. Boote et al. [18] investigated gold-nanoparticles as a CT contrast
agent in juvenile swine. The results are not clearcut. They stated that a few hundred
➭g gold per g wet tissue were sufficient to achieve a good contrast, but in the presented
figures and tables higher values are given. For example, it was stated that the gold amount
in the liver was 380 ➭g/g, but own recalculations of the amount of gold in the liver with
the values given in Table 1 result in 3.94mg/g. The presented results should therefore be
interpreted with caution.
Ducote et al. [38] and Clark et al. [96] used gold for dual-energy CT imaging. To obtain
12The term w% stands for weight% and means mass of gold [g] per mass of tissue [g]×100%.
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a SNR of 5 in the projection data of the dual-energy CT, the required amount of gold
was determined to be 58.5mg gold per ml (approximately 5.85w%) [38]. For the measure-
ments done by Roessl et al. [96], similar gold concentrations (0.2mol/L and 0.25mol/L,
approximately 4 to 5w% gold) were used; this amount of gold was clearly recognizable
in the dual-energy CT. Another investigation in dual-energy micro-CT showed that the
detectability limit of gold ranged from 4mg/ml down to 1mg/ml (approximately 0.4 down
to 0.1w%) for different filter algorithms. The phantom had a diameter of 3 cm. The de-
tectability limit of gold in an in-vivo mouse experiment was 1.5mg/ml (approximately
0.15w%) [33].
As described in section 2.1.4 the K-edge discontinuity of high-atomic number materials can
be used to improve medical imaging. However, photon starvation in the low-energy part
of the X-ray spectrum, can lead to the imperceptibility of the K-edge effect. Considering
this, gold would be better suited for K-edge imaging than iodine, as the K-edge of iodine
is in the low-energy part of the X-ray spectrum (33.2 keV), while the K-edge of gold is at
80.7 keV, which lies well inside the X-ray energy spectrum relevant for medical imaging
and is only little influenced by photon starvation.
Several factors should be taken into consideration for the application of gold-nanoparticles
K-edge imaging. The capability to detect K-edge patterns depends strongly on the concen-
tration of gold in tissue. As the gold concentration decreases, the step size of the K-edge
gets smaller (Figure 2.5).
Figure 2.5: Impact of the concentration of gold in liver tissue on the size of the K-edge.
The energy dependent mass attenuation coefficients were calculated with XCOM [55].
In case of an energy-selective detector, the bin thresholds have also a significant impact on
the ability to detect K-edge patterns. To use the K-edge discontinuity in the average mass
attenuation curve, the average mass attenuation coefficient in the bin below the K-edge
needs to be smaller than the average mass attenuation coefficient in the bin above the K-
edge. In Figure 2.6, the average mass attenuation coefficient in the bin below the K-edge
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of gold (A) is higher than the mass attenuation coefficient in the bin above the K-edge
(B). Reducing the bin size of the bin below the K-edge can overcome this problem. As
already mentioned above, one also needs to take into account that the number of photons
per bin decreases with decreasing bin size, inducing higher noise in that bin.
Figure 2.6: Mass attenuation curve for 0.2w% gold in liver tissue (blue curve). The dashed
red lines mark the bin thresholds for the bin below and above the K-edge of gold. The
points A and B mark the energy, where the attenuation is equal to the average attenuation
in the two bins. The energy dependent mass attenuation coefficients were calculated with
XCOM [55].
As the tissue concentration of gold decreases, the bin size, for which the above mentioned
criteria holds, becomes smaller. Figure 2.7 shows the possible bin sizes below and above
the K-edge with respect to the concentration of gold in the tissue. The mass attenuation
coefficient below the K-edge of gold is smaller than the coefficient above the K-edge only
in the uncolored region, i.e. above the shown surface. The purpose of this figure is to
illustrate that the possible bin sizes rapidly decrease with a decreasing gold concentration.
Figure 2.7: Relationship between gold concentration and bin size. The energy-dependent
mass attenuation coefficients for different gold concentrations and different bin sizes were
calculated with XCOM [55], without taking account of image noise.
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Several examinations were performed with spectral-CT and gold as a contrast agent [15,47,
105]. Cormode et al. [34] performed spectral CT measurements in combination with gold-
HDL nanoparticles enabling a specific targeting of atherosclerosis. In a concentration series
with gold-HDL (concentrations from 0 to 100mM, i.e., approximately 0.39 to 1.97w%),
iodine and calcium phosphate powder, the gold containing regions in the phantom could
be clearly identified. They furthermore performed in-vivo mouse experiments. Mice were
injected with 500mg gold per kg body weight. Gold-HDL accumulated in atherosclerotic
plaques and could be clearly detected in the images.
2.2.4 Dose enhancement in the presence of gold
Ionizing radiation is attenuated while traveling through tissue and radiation energy is ab-
sorbed by the tissue. The dose enhancement effect of gold (or other high-atomic-number
materials) is a purely physical effect, which depends on the concentration of gold and the
photon energy, i.e. the used X-ray spectrum. A substance which leads to a localized dose
enhancement is called a radiosensitizer. The dose enhancement factor can be defined as
the ratio of absorbed dose in the tissue with a radiosensitizer divided by the absorbed dose
without this radiosensitizer. The absorbed dose in the tissue is defined as the absorbed
energy divided by the mass of the absorbing material.
The basic principle, which leads to the dose enhancement effect of gold is the higher mass
attenuation coefficient/cross section compared to biological tissues. This effect leads to an
increased absorption followed by secondary electron production when the incoming pho-
tons interact with gold-nanoparticles. These secondary electrons can reach the DNA and
lead to single and double strand breaks. The radiolysis of the cellular water produces hy-
drogen radicals and hydroxyl radicals. These radicals can further interact with biological
molecules and are responsible for the indirect ionization effects [71, 123]. The produced
secondary electrons have a short penetration range in tissue (e.g. 2.711 ➭m for 50 kV [71]).
As a result of this short penetration range, the dose enhancement effect strongly depends
on the location of gold-nanoparticles in the cell. Possible side effects on healthy cells when
using gold-nanoparticles as X-ray contrast agent should therefore be examined.
The dose enhancing effect of high-atomic-number materials has been known for many
years. Matsudaira et al. showed the dose enhancement effect of iodine already in 1980 [76].
The idea to use gold as radiosensitizer was proposed by Regulla et al. [92]. The predicted
dose enhancement factor close to a gold foil ranged from 55 (120 kV) up to 114 (60 kV).
The influence of different beam energies, the concentration of gold and the size of gold-
nanoparticles on the dose enhancement effect has been investigated with different Monte
Carlo simulations [30,37,59,69–71,75,77,114]. In-vivo and in-vitro experiments have also
been carried out [23, 29, 49, 52, 70]. The simulations and the in-vivo and in-vitro studies
showed that beam energies in the keV range lead to a higher dose enhancement than
MeV beam energies [29, 30, 59, 69, 71, 77]. The reason for this seems to be the decreased
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interaction probability of high energy photons with the gold-nanoparticles. The size of
the gold-nanoparticles has a minor influence on the dose enhancement. The self-absorbed
energy by the gold-nanoparticles is very small compared to the deposited total energy.
The crucial parameter is the amount of gold inside the cells [29, 69, 71].
The dose enhancement effect in the environment of a single gold-nanoparticle was also
investigated with Monte Carlo simulations [59, 71]. Simulations with NOREC13 demon-
strated a microscopic dose enhancement factor for a 50 kV spectrum of approximately
130 at 0.1 ➭m away from a gold-nanoparticle and approximately 14 at 10 ➭m away from
a gold-nanoparticle. For distances larger than 13 ➭m, the dose enhancement effect van-
ished (this corresponds to the maximum range of secondary electrons) [59]. Leung et
al. [71] performed GEANT414 simulations. They simulated single gold-nanoparticles with
a diameter of 2, 50 and 100 nm. The results demonstrated an interaction enhancement
ratio15 up to 2000 for a 50 kV beam. The observed maximum range of the secondary
electrons was 13 ➭m for the 50 kV spectrum (independent of the nanoparticle size). For
50 nm gold-nanoparticles and the 50 kV spectrum the mean effective range of the electrons
was 2.711±0.003 ➭m.
Further simulations were performed with tissue mixtures containing a specific gold amount
instead of single gold-nanoparticles. The results of these simulations are summarized in
Table 2.1.
Table 2.1: Summary of dose enhancement factors (DEF) in the literature.
Simulation
code spectrum DEF gold amount Reference
DOSXYZnrc 140 kV 2.114 7mg/g (≈ 0.7w%) [30]
DOSXYZnrc 140 kV 3.811 18mg/g (≈ 1.8w%) [30]
DOSXYZnrc 140 kV 5.601 30mg/g (≈ 3w%) [30]
GEANT4 150 kV 1.7 10mg/g (≈ 1w%) [77]
Penelope 600 kV 1.304 5mg/g (≈ 0.5w%) [75]
Penelope 600 kV 1.597 10mg/g (≈ 1w%) [75]
Calculations based on Penelope simulations16 (with a 300 kV source) predicted that the
required amount of gold for doubling the prescribed dose is 15.4 up to 20.2mg gold per
gram (approximately 1.5 up to 2.0w%) [69]. Detappe et al. [37] and Berbeco et al. [16]
performed analytical calculations to investigate the dose enhancement factor of gold in
blood vessels with a 6MV spectrum and 30mg gold per ml (approximately 3w%). The
predicted dose enhancement factors were 2.1 and 1.7.
Alqathami et al. [5] developed a novel multicompartment phantom radiochromic radia-
13Monte Carlo code for simulating electron tracks in liquid water.
14Monte Carlo simulation package to simulate the passage of particles through matter
15The interaction enhancement ratio is calculated by taking the ratio of the total number of produced
secondary electrons within the gold-nanoparticle and within water [71].
16Monte Carlo simulation of electron and photon transport.
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tion dosimeter. The phantom contained a small compartment with a concentration of
0.5mM (approximately 0.01w%) gold-nanoparticles (diameter 50 nm). The obtained dose
enhancement factors were 1.77 for a 100 kV spectrum and 1.11 for a 6MV spectrum.
Chithrani et al. [29] showed that gold-nanoparticles with a size of 50 nm provided the
highest dose enhancement compared to other sizes; this effect is due to the higher uptake
of these gold-nanoparticles into the cell.
2.3 Heat shock proteins
After introducing the physical aspects of CT and gold-nanoparticles as possible agents for
imaging and therapy, the next sections will concentrate on possibilities of a specific binding
of the gold-nanoparticles to the target cells. For this thesis, Hsp70 in combination with the
monoclonal antibody cmHsp70.1 is of special interest as it might serve as a tumor-specific
target and ligand, that can be used for the functionalization of gold-nanoparticles. Thus,
the following section will give a short overview on heat shock proteins.
In 1962 the young scientist Ferruccio Ritossa described the puffing of the chromosomes17
of Drosophila after heat exposure. A prominent journal editor initially rejected this dis-
covery, because “it was irrelevant to the scientific community”. The products of the genes,
associated with the puffing of the chromosomes, were called heat shock proteins, as they
were produced after heat exposure [94]. It was shown later that many different chemical
and physical cellular stress factors, like virus transformation, hypoxia and arsenite lead to
an increased synthesis of Hsps, for this reason heat shock proteins are also called stress
proteins [81]. Hsps seem to be present in every organism (plants, animals, archaebacteria,
eubacteria) [73]. They form a large group of physiologically essential, phylogenetically
conserved proteins, which can be divided into discrete families according to their molec-
ular weight: Hsp100, Hsp90, Hsp70, Hsp60 and small Hsps (also called Hsp20) [80, 102].
Hsps perform several functions in the body. They play a pivotal role as molecular chap-
erones18, and are important in cancer and virus immunogenicity [53,111], apoptosis [102],
stimulation of macrophages [14], antigen processing and presentation [103,117].
2.3.1 Localization of heat shock proteins in-vivo
Hsps are classically found intracellular, where they perform their pivotal role as intracel-
lular chaperones and prevent unfolded proteins from aggregation during cellular differen-
tiation. Transport of proteins across membranes, protein repair and protein degradation
are further functions of Hsps. In order to protect cells from lethal damage, the synthesis
of Hsps is increased in normal and in tumor cells after environmental stress [73]. Welch et
17Puffing of chromosomes describes specific gene activity.
18Chaperones are proteins. They play a key roll in the folding or assembly of newly synthesized proteins.
After this process is finished the chaperones do not occur in these structures anymore and are available
for folding or assembly processes of other proteins.
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al. [120] discovered that Hsps are located in the cytoplasm, Golgi apparatus, endoplasmic
reticulum, nuclei or the nucleoli.
Hsps can also be present in the extracellular milieu, where they are important for the
stimulation of the immune system. They especially affect the activity of natural killer
cells [19, 42]. It was shown that Hsps in the serum are associated with stress conditions,
such as inflammation, bacterial and viral infections and oncological diseases [80]. The
transport mechanisms to the plasma membrane, the membrane anchorage, and the export
of the Hsps are not fully identified. Increased amounts of Hsp70 and Hsp90 in the serum
of cancer patients and in the medium of tumor cell lines, might be due to tumor necrosis
and apoptosis, but also an active release from viable tumor cells is possible [80]. Asea
et al. [11] could demonstrate that extracellular Hsps act as cytokines, influencing human
monocytes, which leads to a pro-inflammatory immune response.
The transport of the Hsps to the cell membrane and the membrane anchorage is not com-
pletely clear yet. It is assumed that viable tumor cells secret the extracellular Hsps by an
active release. The Hsps on the cell membrane are also very important for the stimulation
of the immune system [80]. Hsps on the cell membrane might bind peptides, which could
lead to an immune response [53].
2.3.2 Heat shock protein 70 and the monoclonal antibody cmHsp70.1
Heat shock protein 70 (Hsp70)19 is the major stress-inducible member of the Hsp family.
As already described above, the function of Hsp70 depends on its localization. Intracellular
Hsp70 mainly performs chaperone functions. In tumors, the basal Hsp70 level is increased
and will be further increased after environmental stress such as nutrient deficiency, hy-
poxia, heavy metals, irradiation, and/or chemotherapeutic agents [82]. In cancer cells,
Hsp70 can lead to a suppression of various anticancer mechanisms and to tumor rejection
by the immune system [103]. On the other hand, extracellular Hsp70 can bind to antigen-
presenting cells (monocytes/macrophages, dendritic cells). This leads to a non-specific
stimulation of the innate immune system, initiated by secretion of pro-inflammatory cy-
tokines (e.g. IL-1β, IL-6, TNF-α) [11].
The membrane-bound Hsp70 seems to be highly tumor-specific, making it a promising tar-
get structure for cancer therapeutics, diagnostic and/or prognostic markers [44,103]. The
work of Gehrmann et al. [43] indicates that membrane-bound Hsp70 acts as a protector
against radiation/chemotherapy-induced apoptosis and as a target structure for natural
killer cell-mediated cytolysis. It is not clear yet, what causes the difference of the Hsp70
expression on the cell membrane of normal and tumor cells. Gehrmann et al. [44] assumed
that differences in the composition of the membrane lipids are a causative factor. Investi-
gations lead to the presumption that the expression of Hsp70 on the membrane of tumor
19Old nomenclatures for Hsp70 are Hsp72, Hsp70i, Hsp70-1 and HspA. In order to resolve this multiple
designations a new nomenclature for the Hsps was introduced, according to this the new term for Hsp70
is HspA1A [61]. Still the old nomenclature is most common and will therefore be used for this thesis.
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cells is a negative prognostic marker for the overall survival of tumor patients [85, 110].
These results make Hsp70 a very promising target for cancer therapy.
Several groups have investigated the occurrence of Hsp70 on the membrane of tumor cells.
Ferrarini et al. [39] was one of the first, who described the occurrence of Hsp70 on the
plasma membrane of the GLC1 cell line (microcitoma). It was shown that Hsp70 is ex-
pressed on the cell membrane of HTLV-I infected rabbit cell lines [32], various sarcoma cells
and larynx carcinoma cells [81]. Furthermore, Hsp70 is expressed on the cell membrane of
colorectal, gastric, lung, neuronal, pancreas carcinomas, liver metastases (primary tumor:
colorectal cancer) and leukemic blasts (cells generated from tumor biopsy material) [53,85].
Multhoff et al. [80] screened more than 1000 different tumor biopsies (lung, colon, gastric,
pancreatic, mammary cancer), blasts of hematological diseases (acute myeloid leukemia,
acute lymphoblastic leukemia, chronic myeloid leukemia, chronic lymphoid leukemia) and
the corresponding healthy tissues for the surface expression of Hsp70. None of the normal
tissues expressed Hsp70 on the membrane surface, but 50 to 70% of the tumor tissue were
Hsp70 membrane positive.
Antibodies are proteins, which can detect and bind to a specific target (a so-called anti-
gen). For this thesis, the monoclonal antibody cmHsp70.1 was used. It was shown that
this antibody conjugates to the tumor-specific membrane-bound Hsp70. Other commer-
cially available mouse anti-Hsp70 antibodies fail to conjugate to the membrane-bound
Hsp70 of viable tumor cells [82]. Stangl et al. [108] demonstrated the internalization of
the monoclonal antibody cmHsp70.1 into tumor cells.
Chapter 3
Methods
3.1 Spectral CT imaging with gold-nanoparticles - Monte
Carlo simulations
To investigate the effect of gold as a new CT contrast agent, Monte Carlo simulations
with EGSnrc were performed [62]. EGS is an abbreviation for Electron-Gamma-Shower.
The code is owned by the National Research Council (nrc) of Canada. EGSnrc is free of
charge for research and other non-commercial purposes.
EGSnrc simulates the coupled transport of electrons and photons with energies ranging
from 1 keV to 10GeV. Transport of charged particles is simulated with the condensed
history technique. Cross sections for the photoelectric effect, Rayleigh scattering and pair
production are in agreement with the XCOM/NIST database. For the imaging simula-
tions, the cutoff energy for photons was 1 keV and for electrons 60 keV. The particle’s
energy is locally deposited, if it is below the cutoff energy. For a detailed description of
EGSnrc the reader is referred to [62].
EGSnrc has a flexible user-interface, in which the geometry of the X-ray detector and the
source is specified. A few changes in these subroutines, written by Helmut Schlattl, were
necessary for the simulation of the spectral CT (i.e. the photon-counting detector). The
changes are described in detail in the following sections.
3.1.1 Phantom setup, simulations and general evaluation
3.1.1.1 Phantom setup
Simple voxel phantom
As part of this dissertation, a simple cylindrical voxel phantom was implemented. The
purpose of this voxel phantom was to determine the minimum gold concentration required
to provide sufficient contrast in spectral CT in-vivo and to investigate the influence of
different sizes of regions of interest (ROI).
The diameter of the phantom was 30 cm and each voxel had a size of 1.765×1.765×4.84mm3.
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The voxel phantom consisted of simulated liver parenchyma (ρ = 1.06 g/cm3) and five
sets of 4 ROIs, referred to as metastases. The metastases had a size of 1.4×1.4 cm2,
1.05×1.05 cm2, 0.7×0.7 cm2 and 0.35×0.35 cm2. It was assumed that the elemental com-
position of the metastases is the same as the liver parenchyma, but the density was de-
creased to ρ = 1.02 g/cm3, since metastases are usually visible as hypodense lesions in
CT. For each set of 4 ROIs, a different concentration of gold was added to the metastases.
The gold-nanoparticles were not explicitly modeled in these simulations, instead a homo-
geneous distribution of gold in the tissue was implemented. This approach can be justified
with the assumption of a rather homogeneous distribution of the gold-nanoparticles and
the detector resolution. The elemental composition and the densities are summarized in
Table 3.1 and the voxel phantom is shown in Figure 3.1(a).
Table 3.1: Chemical composition of different tissues.
Liver [56] Metastasis with and without gold
0w% 0.7w% 0.4w% 0.3w% 0.2w% 0.1w%
ρ [ g
cm3
] 1.06 1.02 1.154 1.0931 1.0748 1.0566 1.0383
H [w%] 10.2 10.2 10.13 10.16 10.17 10.18 10.19
C [w%] 13.9 13.9 13.80 13.84 13.86 13.87 13.89
N [w%] 3.0 3.0 2.98 2.99 2.99 2.99 3.00
O [w%] 71.6 71.6 71.10 71.31 71.39 71.46 71.53
Na [w%] 0.2 0.2 0.2 0.2 0.2 0.2 0.2
P [w%] 0.3 0.3 0.3 0.3 0.3 0.3 0.3
S [w%] 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Cl [w%] 0.2 0.2 0.2 0.2 0.2 0.2 0.2
K [w%] 0.3 0.3 0.3 0.3 0.3 0.3 0.3
Au [w%] 0 0 0.7 0.4 0.3 0.2 0.1
Human voxel phantom
The human voxel phantom was based on CT data of a real female [112]. The dimen-
sions of one voxel were 1.765×1.765×4.84mm3. The size of the whole phantom was 244
voxels (430.66mm) in x-direction, 142 voxels (250.63mm) in y-direction and 346 voxels
(1674.64mm) in z-direction. The chemical composition of the organs was based on the
ICRU report 44 [17].
To investigate the effect of gold as a contrast agent in small tumors or metastases in the
liver, three ROIs with a size of 1.24×1.24 cm2, 0.88×0.88 cm2 and 0.35×0.35 cm2 were
implemented in the voxel phantom as part of this thesis. The CT slice which was used for
the simulations is shown in Figure 3.1(b). The elemental composition and the densities of
the ROIs were the same as in (Table 3.1).
The applied dose was estimated for the human voxel phantom. The variable EDEP in
EGSnrc provides the deposited energy during a particular step and can be summed up
to get the total deposited energy. The simulations here are only performed for one slice.
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The slice thickness at the detector is 1.6mm, giving a slice thickness of 0.877mm at the
isocenter. The scan length for a liver-spleen scan is assumed to be 18.4 cm. The total
number of rotations for that scan length is 210 (scan length divided by slice thickness at
the isocenter). The mass of the whole phantom is 58.92 kg. The whole body dose20 can
then be calculated as the product of the deposited energy in one slice and the number
of rotations divided by the mass of the whole phantom. This result is then multiplied
with a weighting factor to get the effective dose. The weighting factor for this scan is
approximately 1.865 (Helmut Schlattl, private communication).
(a) Simple voxel phantom used for the Monte
Carlo simulations.
(b) Slice of the human voxel phantom
used for the Monte Carlo simulations
(slice number 250, height from the ground
1.21m).
Figure 3.1: The two voxel phantoms used for the Monte Carlo simulations.
3.1.1.2 Simulation setup
All simulations were performed on a high performance computing - high availability -
cluster (IBM x3950 X5, 2×Intel Xeon 8C X7560 130W 2.26GHz/24MB, 32GB RAM).
Detector
For the simulations an ideal photon-counting detector was implemented, i.e. all incident
photons were detected, the count rate was unlimited and the energy resolution was perfect.
Scattered photons were stored in a separate array and were not used for the evaluation, i.e.
20The whole body dose is defined as the fraction of the total amount of ionizing radiation absorbed by
the body and the body’s mass.
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the raw data sets did not contain signals from scattered photons. The original detector
implementation was modified, by adding a further array dimension (with size 97), which
is used to store the number of incoming photons depending on their energy. Each element
of the new array dimension stores the number of photons with energies in the interval
[x keV,(x+1) keV) (x ∈ 25, 26, ..., 120), referred to as 1-keV-bins. All incoming photons
with an energy below 25 keV were stored in one element of the array [0 keV,25 keV).
For all the simulations, the focus-detector distance (FDD) in the simulations was 104 cm
and the focus-object distance (FOD) was 57 cm. 1160 views were performed and the num-
ber of histories per view was 109. For the simple voxel phantom, the detector had 580
detector elements, each with a size of 1.5mm. For the human voxel phantom, the detector
had 640 detector elements, each with a size of 1.6mm. The slice thickness was 1.6mm.
Spectrum
The spectrum used for the imaging simulations had a peak energy of 120 keV and a mean
energy of 64.5 keV. X-rays were filtered with 1.2mm titanium and 1.5mm aluminum. The
anode material was tungsten. To calculate the spectrum, the calculator by the Institute
of Physics and Engineering in Medicine (IPEM) [35] was used. The spectrum is shown in
Figure 2.1.
CT image reconstruction and filtering
All CT images were reconstructed with the OPED algorithm (orthogonal polynomial ex-
pansion on disc) [121]. Each pixel in the reconstructed images had a size of 0.84×0.84mm2
and the reconstruction size was 512×512 pixel. If explicitly stated a bilateral filter algo-
rithm [113] was used to filter the reconstructed images. Bilateral filtering merges range
and domain filtering. Both filters calculate weighted averaged image values. The range
filter applies weights, that decrease with decreasing similarity of the regarded image val-
ues. Domain filtering uses weights, that decline with increasing distance. The CT image
reconstruction and the image processing algorithms were performed on an Intel 64-bit,
3.2GHz, Core 2 Duo cluster.
3.1.1.3 Image analysis and image quality quantities
CT image quality deals with two different approaches, the spatial resolution also called
high-contrast resolution and the contrast detectability also called low-contrast resolution.
Spatial resolution can be defined as the capability to resolve small items, which are very
close together. The modulation transfer function (MTF) is the common method to char-
acterize the spatial resolution. Many factors in the image acquisition process can impair
the spatial resolution, e.g. the focal spot size, image reconstruction, detector characteris-
tics [98].
The contrast detectability is of major interest for this thesis. Contrast detectability de-
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fines the capability of a system to discriminate items with similar densities. Three factors
mainly influence the detectability of an object with respect to its size. The first one is
the level of contrast, i.e. the difference in density between the object and the background.
Image noise is the second factor and the third factor is the window setting, which is ap-
plied to display the image [98].
To judge and compare the quality of the reconstructed and processed images, the signal-to-
noise ratio (SNR), the contrast-to-noise ratio (CNR) and the contrast (C) were calculated
in the image domain. These quality measurements give an indication which image pro-
cessing algorithm described below is most suitable for the detection of gold. One should
keep in mind that the objects shape, size and sharpness of edges do not affect these qual-
ity measurements. The perceptibility of objects in different images can differ despite of
similar quality measurements.
The mean energy Ei of bin i was approximated by
Ei =
∫
Ei
EN0(E)dE∫
Ei
N0(E)dE
(3.1)
where N0 is the photon fluence in photons/keV for the X-ray spectrum described above.
These values were used as input information for XCOM [55], to calculate the energy
dependent average mass attenuation coefficients for each bin. The weight percentage of
all elemental components is shown in Table 3.1. The mean energy and the average mass
attenuation coefficients for each bin are required input parameters for some of the material-
decomposition algorithms.
For the simple voxel phantom only the biggest metastases for each gold concentration were
selected as ROIs, each ROI had a size of 20×20 pixels. The ROIs for the human voxel
phantom consisted of all three metastases. The three ROIs had sizes of 11×11, 7×7 and
4×4 pixels. To be able to compare all results, the images were normalized to [0, 1] before
the evaluation. The SNR, CNR and the contrast were calculated for each individual ROI
and then the mean was calculated. The ROIs and the corresponding background regions
are shown in Figure 3.2.
The signal-to-noise ratio is defined as the ratio of the mean value in the region of interest
µROI and the standard deviation
√
σ2ROI [104]
SNR =
µROI√
σ2ROI
. (3.2)
The SNR does not give any information about the perceptibility of an object. This is
represented by the contrast-to-noise ratio (CNR), which takes into account the signal and
noise features of the reconstructed images.
The CNR is defined as the attenuation difference between the ROI µROI and the back-
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ground µB divided by the noise, [104].
CNR =
|µROI − µB|√
σ2ROI + σ
2
B
(3.3)
where σ2ROI, σ
2
B are the variances respectively.
The effective CNR (CNReff) is defined as the CNR multiplied by the square root of the
number of pixels (N) in the ROI. According to the Rose criterion [79] the effective CNR
in CT images should be greater than 5 to be able to differentiate between the background
and the metastases.
CNReff =
√
NCNR (3.4)
The contrast (C) is defined as [105]
C =
|µROI − µB|
µROI + µB
. (3.5)
Figure 3.2: ROIs for the two voxel phantoms and the corresponding background (B)
regions. In the simple voxel phantom for the ROI with 0.2w% and 0.1w% gold the same
background region is used.
3.1.2 Energy-integrating and Photon-counting detectors
For the first examinations, a photon-counting and an energy-integrating detector (con-
ventional X-ray detector) without energy resolution were simulated and the reconstructed
images were compared. Photon-counting detectors weight all impinging photons with
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a weighting factor equal to one, whereas energy-integrating detectors apply an energy-
depending weighting factor to the each photon. The used weighting function was 1/E3, as
this weighting function provides the highest signal-to-noise ratio [45]. The photon-counting
and energy-integrating detectors were calculated as
photon-counting =
119 keV∑
E=25 keV
1-keV-binE (3.6)
energy-integrating =
1-keV-bin25 keV
(23.3 keV)3
119 keV∑
E=26 keV
1-keV-binE
E3
. (3.7)
The 1-keV-binE is the array, which contains the number of photons with energies in the
interval [E,E + 1keV). All photons with an energy in the range of [0 keV,25 keV) were
stored in one bin, the mean energy of this bin was 23.3 keV.
Photon-counting detectors have advantages over energy-integrating detectors, e.g. rejec-
tion of electronics noise, low noise imaging and smaller cupping artifacts [106].
The cupping artifacts in the reconstructed images were quantified by the the image value
at the edge and the center of the phantom.
cupping =
µedge − µcenter
µedge
· 100% (3.8)
The results are furthermore used as comparison to the performance of the energy-resolved
photon-counting detector.
3.1.3 Optimization of detector bin thresholds
Roessl et al. [95] have shown that for optimal material detection one bin threshold should
be at the K-edge of the high-Z material. The bins just below this threshold and just
above this threshold are very important for the efficient detection of the high-Z material.
As described before the incoming photons were stored in 1-keV-bins corresponding to the
photon energy. To show the effect of different bin sizes above and below the K-edge of gold
(80.7 keV), the 1-keV-bins were summed up and the CT images were then reconstructed
with OPED. The bins above the K-edge ranged from [81,82) keV up to [81,120] keV and
the bins below the K-edge ranged from [80,81) up to [40,81) in steps of 1 keV. The recon-
structed images were then analyzed with the assessment criteria described above.
The SDNR criterion
To investigate the optimal width of the two energy bins just below and above the K-edge
of gold, the signal-difference-to-noise ratio (SDNR) criterion was used [54].
SDNR =
µCTabove − µCTbelow√
σ2CTabove + σ
2
CTbelow
(3.9)
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with µCTabove and µCTbelow being the linear attenuation coefficients in the ROIs in the
reconstructed CT images in the bin above and below the K-edge and σ2CTabove and σ
2
CTbelow
describe the corresponding variance. In order to use the sudden increase in the linear
attenuation coefficient of gold21, Eq. 3.9 needs to be maximized under the constraint
µXCOMabove > µXCOMbelow (3.10)
µXCOMabove and µXCOMbelow are the theoretical linear attenuation coefficients in the bin
below and above the K-edge of gold calculated with XCOM. This constraint ensures that
the theoretical linear attenuation coefficient in the bin below the K-edge of gold is bigger
than in the bin above the K-edge of gold.
Figure 3.3: Structure of the performed steps and the used additional information.
21This sudden increase, inside the relevant diagnostic energy range, is unique for high-Z materials and
does not occur in biological tissues.
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3.1.4 Material-decomposition techniques
In the following sections the implemented material-decomposition techniques will be de-
scribed. The main aim of all these algorithms is to enhance the images and improve the
detectability and ideally the quantification of gold by a human observer.
The evaluated algorithms are an eigenvector decomposition, the K-edge decomposition
and a least-squares parameter estimation. Only the K-edge decomposition algorithm is
applied to the raw data sets, all other techniques utilize the reconstructed CT images. All
algorithms are applied to the bin data pixel by pixel, i.e. are working on a vector of length
K (K - number of energy bins).
The sequence of the steps is illustrated in Fig. 3.3.
3.1.4.1 Eigenvector decomposition
The idea for the eigenvector decomposition algorithm for energy resolved CT images is
based on the principal component analysis (PCA) (also known as Karhunen-Loe´ve the-
orem). PCA is a method in multivariate statistical analysis. The basic principle of the
method is the transformation of the multivariate data set with respect to the covariance
matrix [58]. The main purpose of this algorithm is the noise reduction in the reconstructed
energy dependent images. The algorithm is applied along the energy axis and not in the
spatial dimensions, therefore no loss in spatial resolution or blurring occurs. A similar
approach was introduced by Gonzales and Lalush [46,47].
The X-ray projection data of the K = 6 energy bins were reconstructed with OPED.
For the eigenvector decomposition, the reconstructed images and the mass attenuation
(µ(E)/ρ) values in each energy bin of M known materials are required. The mass atten-
uation values were calculated for each bin with XCOM [55] and are summarized in Table
3.2.
Each energy dependent linear attenuation vector µ(E, x) ∈ RK can be described with a
basis V = [v1, ..., vK ] ∈ RK×K (all basis vectors vi ∈ RK are linearly independent) and
z(x) ∈ RK
µ(E, x) =
K∑
i=1
vizi(x) = V z(x) . (3.11)
x describes the spatial dependence. This linear attenuation vector µ(E, x) can now be
approximated by using a subset of the basis vectors vi with i = 1, ...,K
′ and K ′ < K
µ˜(E, x) =
K′∑
i=1
vizi(x) = V˜ z˜(x) . (3.12)
According to the principal component analysis the error µ(E, x)−µ˜(E, x) is minimal, if the
basis V consists of the eigenvectors of the covariance (or correlation) matrix of µ(E, x) [58].
The primary idea of the algorithm is now to implement the covariance matrix based on
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the mass-attenuation curves of the P known materials instead of estimating it from the
reconstructed images. It is assumed that the attenuation curve at each pixel contains
a mixture of these basis functions (Equation 2.9). For this thesis the mass-attenuation
curves of gold, hard bone mixture, and liver tissue were used (Table 3.2),
µ(E, x) =
P∑
i=1
ρtotal(x)wi(x)
(
µ(E)
ρ
)
i
= ρtotal(x)Mw(x)
Cov(µ(E, x)) = MCov(ρtotal(x)w(x))M
T (3.13)
with M ∈ RK×P being the matrix containing the mass-attenuation curves of the P known
materials and MT is the transposed matrix.
Table 3.2: Mass attenuation vectors used as input for the eigenvector decomposition.
Bin 1 Bin 2 Bin 3 Bin 4 Bin 5 Bin 6
non-optimized bin thresholds
mean Energy [keV] 30.9 43.3 63.2 84.8 98.5 113.0
(µ/ρ)gold [cm
2/g] 25.470 10.490 3.9630 7.8490 5.3600 3.7850
(µ/ρ)bone [cm
2/g] 0.9313 0.5245 0.3256 0.2573 0.1994 0.1766
(µ/ρ)liver [cm
2/g] 0.3302 0.2526 0.2112 0.1944 0.1762 0.1664
optimized bin thresholds
mean Energy [keV] 39.9 54.1 66.5 77.5 83.0 97.1
(µ/ρ)gold [cm
2/g] 13.070 5.9140 3.4790 2.3650 8.2920 5.5590
(µ/ρ)bone [cm
2/g] 0.6125 0.3479 0.2623 0.2232 0.2100 0.1865
(µ/ρ)liver [cm
2/g] 0.2698 0.2162 0.1957 0.1844 0.1800 0.1709
For this thesis the following estimation of the covariance matrix Cov(ρtotal(x)w(x)) was
used
n1︷ ︸︸ ︷ n2︷ ︸︸ ︷ n3︷ ︸︸ ︷ n4︷ ︸︸ ︷
= Cov
 0.0032 0.0 0.0 0.0· · · 0.0 · · · · · · 1.782 · · · · · · 0.0 · · · · · · 0.0 · · ·
1.0716 0.0 1.06 0.0
(3.14)
=
 2.29× 10
−6 −2.45× 10−6 5.30× 10−6
−2.45× 10−6 0.49 −0.11
5.30× 10−6 −0.11 0.24
 = Cov(ρtotal(x)w(x)) (3.15)
To obtain this covariance matrix the number of pixels containing gold (n1 = 582), bone
(n2 = 50190), the remaining pixels in the phantom (n3 = 79792) and air (n4 = 131580)
were approximated. The columns in the matrix 3.14 are the product of the total den-
sity multiplied by the weight fraction. For the first n1 columns this is equal to 1.0748 ·
32 CHAPTER 3. METHODS
[0.003, 0.0, 0.997] (i.e. 0.3w% gold and 99.7w% liver tissue). For the next n2 columns it
is equal to 1.782 · [0.0, 1.0, 0.0], for the next n3 columns it is equal to 1.06 · [0.0, 0.0, 1.0]
and for the last n4 columns refer to the pixels containing only air and therefore w(x) =
[0.0, 0.0, 0.0].
According to the principal component analysis the covariance matrix in Equation 3.13 can
be written as
MCov(ρtotal(x)w(x))M
T = V ΛV T (3.16)
V contains the orthonormal eigenvectors of the covariance matrix and Λ the corresponding
eigenvalues. The eigenvalues and the corresponding eigenvectors are arranged in decreasing
order (with respect to the absolute value of the eigenvalues). So the first eigenvector is
related to the direction with maximal variance and the last eigenvector to the direction
with minimal variance. As already described above the linear attenuation vector µ(E, x)
can now be estimated by using only a subset of the eigenvectors (Equation 3.12). With
equation 3.11 and 3.12 it follows, that the noise suppressed images µ˜(E, x) can be obtained
as follows
z(x) = V Tµ(E, x)
z˜(x) = V˜ Tµ(E, x)
µ˜(E, x) = V˜ V˜ Tµ(E, x) . (3.17)
With some further transformations, the concentration w˜(x) = ρtotal(x)w(x) ∈ R3 of gold,
bone and liver (multiplied by the total density) can be calculated. The total density can
be approximated as ρtotal(x) =
∑3
i=1 w˜i(x).
6×1︷ ︸︸ ︷
µ˜(E, x) =
6×3︷︸︸︷
V˜
3×6︷︸︸︷
V˜ T
6×1︷ ︸︸ ︷
µ(E, x)
!
= ρtotal(x)
6×3︷︸︸︷
M
3×1︷ ︸︸ ︷
w(x)
V˜ T µ˜(E, x) = V˜ Tµ(E, x) = ρtotal(x)V˜
TMw(x)
(V˜ TM)−1V˜ T µ˜(E, x) = (V˜ TM)−1V˜ Tµ(E, x) = ρtotal(x)w(x) (3.18)
The matrix V˜ TM is invertible. With the eigenvector decomposition also so called basis
images B(x) ∈ RK can be calculated as the scalar product
B(x) = V Tµ(E, x) (3.19)
The first basis image contains the information due to the maximal variance, the second
basis image the information due to the second highest variance and so on. PCA is often
used to reduce dimensionality, without a serious information loss. The first basis image
should therefore be similar to a CT image of a conventional CT detector (i.e. without
energy resolution). The basis images are shown in the annex.
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3.1.4.2 K-edge decomposition algorithm
One of the first approaches to use the spectral information was the K-edge decomposition
technique, also called K-edge imaging, which was first described in 1976 by Alvarez and
Macovski [7,74]. This method uses the energy-dependent attenuation information in each
energy bin to convert it into two components, the photoelectric effect and the Compton
scattering. The basic idea of the algorithm is described below.
The raw data sets from each energy bin are used as input data for the algorithm and the
algorithm is applied to each pixel.
For CT examinations where elements (contrast agents) with a high-atomic-number are
present, a modification of Eq. 2.2 is necessary [97, 100]. According to Equation 2.10
the total attenuation of a mixture can be presented as a sum of the individual elements.
Instead of using all individual elements, the total attenuation can be split up into the low-
atomic-number elements (i.e. the biological tissues) and the high-atomic-number element.
For the low-atomic-number elements Eq. 2.10 holds, yielding the following equation:
µtotal(E, x) = w˜lowZ(x)
(
µ(E, x)
ρ(x)
)
lowZ
+ w˜highZ(x)
(
µ(E, x)
ρ(x)
)
highZ
µtotal(E, x) = w˜lowZ(x)
(
µphoto(E, x) + µCompton(E, x)
ρ(x)
)
lowZ
+w˜highZ(x)
(
µ(E, x)
ρ(x)
)
highZ
(3.20)
Substituting Eqs. 2.4 and 2.5 into 3.20 leads to 22
µ(E, x) = C˜photo(x)
1
E3
+ C˜Compton(x)fKN
(
E
Ee
)
+ w˜highZ(x)
(
µ(E)
ρ
)
highZ
. (3.21)
with
C˜photo(x) =
(
w˜(x)
ρ(x)
)
lowZ
Cphoto(x) = ρtotal
(
w(x)
ρ(x)
)
lowZ
Cphoto(x) (3.22)
C˜Compton(x) =
(
w˜(x)
ρ(x)
)
lowZ
2πr2eCCompton(x) = ρtotal
(
w(x)
ρ(x)
)
lowZ
2πr2eCCompton(x) .(3.23)
In order to increase numerical stability the factor 2πr2e was eliminated from fKN. 1/E
3,
fKN(E/Ee) and (µ(E)/ρ)highZ should be linearly independent (i.e. form a basis in R
K),
in order to provide a clear separation of the three effects. The linear independence of
these three vectors can be easily checked (e.g. with Wolfram Mathematica). It might
be beneficial to multiply each vector with a constant factor to increase the numerical
tolerance.
22The constant term 2πr2e in the Klein-Nishina-function fKN (Equation 2.6) is shifted to C˜Compton(x).
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Integrating Eq. 3.21 leads to∫ s
0
µ(E, x)dx =
∫ s
0
C˜photo(x)
1
E3
+ C˜Compton(x)fKN
(
E
Ee
)
+ ρhighZ(x)
(
µ(E)
ρ
)
highZ
dx
= Aphoto
1
E3
+AComptonfKN
(
E
Ee
)
+AhighZfhighZ(E) (3.24)
with
Aphoto =
∫ s
0
C˜photo(x)dx
ACompton =
∫ s
0
C˜Compton(x)dx
AhighZ =
∫ s
0
w˜highZ(x)dx = δhighZ
fhighZ(E) is the mass attenuation coefficient, which includes Compton scattering, the
photoelectric effect and hence the K-edge contributions of the high-atomic-number element
(for this thesis the mass attenuation coefficient of gold). ρhighZ(x) is the local density
[g/cm3] and δhighZ represents the area density [g/cm
2] of the high-atomic-number material.
Substitution of Eq. 3.24 in 2.12 results in
Ii(Ak) = Ii0
∫ Ei
Ei−1
exp
(
−
K∑
k=1
Akfk
)
dE (3.25a)
ln
(
Ii0
Ii(Ak)
)
=
∫ Ei
Ei−1
3∑
k=1
AkfkdE (3.25b)
with Ak =

Aphoto k = 1
ACompton k = 2
AhighZ k = 3
and fk =

1
E3
k = 1
fKN k = 2
fhighZ k = 3.
To solve Eq. 3.25a for the unknown coefficients Ak at least three energy bins are needed.
If the measurements provide data of more than three energy bins the system is over-
determined, so generally no solution exists. To be still able to solve the system a maximum-
likelihood approach is used to find the coefficients Ak. Equation 3.25a describes the
expected number of incident photons Ii(Ak) for each bin i. The number of actually
detected photons per bin is denoted as mi. It is assumed that the detected photons form a
set of independent Poisson random variables. The likelihood function for each component
k is then
P (m1, ...,mK |I1(Ak), ..., IK(Ak)) =
K∏
i=1
[Ii(Ak)]
mi
mi!
exp(−Ii(Ak)) . (3.26)
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To calculate the unknown coefficients Ak equation 3.26 needs to be maximized, but instead
it is recommended to minimize the negative log-likelihood function L:
L(m1, ...,mK |Ak) =
K∑
i=1
[Ii(Ak) + lnmi!−mi ln Ii(Ak)]
≈
K∑
i=1
[Ii(Ak)−mi ln Ii(Ak)] → min . (3.27)
The Ii are calculated according to Eq. 3.25a. Terms which are not relevant for the
minimization problem are neglected in the last approximation. Solving the minimization
problem reveals the coefficients Ak. The solution of the maximum-likelihood approach are
three raw data sets, which represent the fractional contribution to the total attenuation
of the photoelectric effect, Compton scattering and the high-Z material.
Due to the identity
AhighZ =
∫ s
0
w˜highZ(x)dx = δhighZ
the reconstructed image of the high-Z material (w˜highZ(x)) contains the weight fraction of
the high-Z material multiplied by the total density (in units of mass per volume). The unit
of the reconstructed photoelectric effect image is keV3/cm and the Compton scattering
image unit is cm−1 23.
Compton scattering is independent of the atomic number Z of the material (according
to Equation 2.8). The soft tissues (i.e. small-atomic-number) are most prominent in
the Compton images. Since the photoelectric absorption is proportional to Z3 (Equation
2.7), the photoelectric image will mainly provide information about materials with a high-
atomic-number (except the contrast agent, since that information is in the third image),
e.g. bones.
A more detailed description of the algorithm can be found in [7, 74, 97, 100]. The IDL
source code of the algorithm and further analysis of the K-edge decomposition are set out
in the Annex. To solve the minimization problem the constrained min procedure was
used, which uses the generalized reduced gradient method.
3.1.4.3 Least-squares parameter estimation
Density image decomposition
The idea for the least-squares parameter estimation method is based on the work by Le and
Molloi [68]. The underlying method of the algorithm is the least-squares fitting method
working on the OPED-reconstructed projection data of the six energy bins. As for the
eigenvector decomposition algorithm, the mass attenuation values (µ(E)/ρ) in each energy
23The raw data sets Ak were used for the reconstruction. It is also possible to reconstruct Akfk, with
fk calculated at the mean energy of the used spectrum. All three reconstructed images would then have
the same unit cm−1
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bin and of P different materials of interest are required input data. For this thesis the
mass attenuation values of hard bone mixture, liver and gold are used (Table 3.2).
Assuming that the mass attenuation vector (µ(E, x)/ρ(x))total ∈ RK in each pixel is a
sum of these three materials, leads to the following formulas(
µ(E, x)
ρ(x)
)
total
= wliver(x)
(
µ(E)
ρ
)
liver
+ wbone(x)
(
µ(E)
ρ
)
bone
+ wgold(x)
(
µ(E)
ρ
)
gold
µtotal(E, x) =
3∑
i=1
w˜i(x)
(
µ(E)
ρ
)
i
(3.28)
w˜i(x) = ρtotal(x)wi(x)
with 1 =
3∑
i=1
wi(x)
with i = {liver, bone, gold}
with wi being the concentration (i.e. fraction by weight) of material i. The mass at-
tenuation vectors (µ(E)/ρ)i in each bin are calculated with XCOM [55] and the linear
attenuation values µtotal(E, x) are obtained from the reconstructed images. The idea is
now to minimize the distance between the linear attenuation values and the given mass
attenuation coefficients over all bins:
∑
K
(
µtotal(E, x)−
3∑
i=1
w˜i(x)
(
µ(E)
ρ
)
i
)2
→ min
w˜i(x)
(3.29)
with w˜i(x) ≥ 0 .
The algorithm calculates material density images w˜i(x) for all three materials. To get
the concentration wi(x), the density images need to be divided by ρtotal(x), which can
simply be calculated as ρtotal(x) =
∑3
i=1 w˜i(x). The least-squares parameter estimation
therefore provides the possible to determine the concentration of gold, and not only the
weight fraction multiplied by the total density as the K-edge decomposition algorithm.
The IDL source code of the least-squares parameter estimation is set out in the Annex.
To solve the minimization problem the constrained min procedure was used, which uses
the generalized reduced gradient method.
Density filter
The basic idea of this algorithm was introduced by Kalender et al. [60]. This algorithm
is called the density filter, as it can only be applied to material density images, obtained
by the least-squares parameter estimation algorithm described above. The algorithm is
applied to each pixel individually.
The algorithm was originally intended for two material density images, which were cal-
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culated from dual-energy CT measurements. However the least-squares parameter esti-
mation generates three material density images w˜i(x), with i = {liver, bone, gold}. In
contrast to the other algorithms, the linear attenuation values (µ(Emean)/ρ)i ∈ R at the
mean energy of the used X-ray spectrum are required as input. The attenuation at the
mean energy of the used X-ray spectrum (µmean(x) ∈ R) can then be expressed as a sum
of the density images
µmean(x) =
3∑
i=1
w˜i(x)
(
µ(Emean)
ρ
)
i
. (3.30)
The original algorithm can be easily adapted to three material density images (generated
with the least-squares parameter estimation algorithm), if the pixel value in one image is
zero or close to zero. A threshold of t = 10−8 was used for thesis, yielding w˜i3(x) < t and
w˜i1/2(x) > t. The third term in equation 3.30 can then be neglected. The algorithm is
only applied to pixels where that criterion holds, the remaining pixel values in the density
images are not changed.
The first step is now to calculate high-pass filtered versions of the two density images
w˜i1(x) and w˜i2(x).
∆w˜i1/2(x) = w˜i1/2(x)− ̂˜wi1/2(x) (3.31)̂˜wi1/2(x) is the median over an n×n mask (for this thesis n = 7). Kalender et al. [60] have
demonstrated that ∆w˜i1(x) and ∆w˜i2(x) must have opposite sign, if they are induced
by noise. The goal of the algorithm is now to calculate filtered density images w˜′i1(x)
and w˜′i2(x), which should minimize pixel deviations weighted by the corresponding mass
attenuation values (µ(Emean)/ρ)i1/2 .[(
µ(Emean)
ρ
)
i1
(w˜′i1(x)− ̂˜wi1(x))
]2
+
[(
µ(Emean)
ρ
)
i2
(w˜′i2(x)− ̂˜wi2(x))
]2
→ min (3.32)
Under the constraint that the mean linear attenuation value µmean(x) as described in
Equation 3.30 should not change in the filtered images, the following condition is obtained.(
µ(Emean)
ρ
)
i1
w˜i1(x) +
(
µ(Emean)
ρ
)
i2
w˜i2(x)
!
=(
µ(Emean)
ρ
)
i1
w˜′i1(x) +
(
µ(Emean)
ρ
)
i2
w˜′i2(x) (3.33)
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Rearranging equation 3.33 for w˜i1(x) respectively w˜i2(x), substituting in equation 3.32
and differentiating with respect to w˜i2(x) respectively w˜i1(x) gives
w˜′i1(x) = w˜i1(x)− C(x)/
(
µ(Emean)
ρ
)
i1
(3.34a)
w˜′i2(x) = w˜i2(x) + C(x)/
(
µ(Emean)
ρ
)
i2
(3.34b)
with the correction term
C(x) =
1
2
[(
µ(Emean)
ρ
)
i1
∆w˜i1(x)−
(
µ(Emean)
ρ
)
i2
∆w˜i2(x)
]
(3.35)
To minimize edge artifacts, which arise when sharp density transitions are present in the
images, the correction term C will be adjusted [60]. To do that it is presumed that a
standard CT image can also be generated with a spectral CT, just by summing up the
number of photons in each bin and then reconstructing that image µref(x). The advantage
of the standard CT image is the lower noise level. If that assumption is not valid then
equation 3.30 can be used to calculate µref(x). Now a high-pass filtered version ∆µref(x)
of µref(x) is calculated
∆µref(x) = µref(x)− µ̂ref(x) (3.36)
with µ̂ref(x) being again the median over an n × n mask. Filter strength is adapted by
introducing a parameter ǫ to modify the correction term C(x)
C ′(x) = (1− ǫ2)C(x) (3.37)
with
ǫ(x) = min
|∆µref(x)/η|1 (3.38)
The parameter η should be much bigger than the pixel noise in the monoenergetic image,
for this work η is set to 0.05. In comparatively homogeneous regions the pixel noise
corresponds to ∆µref(x), and ǫ(x) approaches zero. In areas with sharp density transitions
∆µref(x) increases and therefore ǫ(x) increases. The filtered density images can than be
calculated according to equations 3.39a and 3.39b:
w˜′′i1(x) = w˜i1(x)− C ′(x)/
(
µ(Emean)
ρ
)
i1
(3.39a)
w˜′′i2(x) = w˜i2(x) + C
′(x)/
(
µ(Emean)
ρ
)
i2
. (3.39b)
For image areas, which are almost homogeneous, ǫ(x) approaches zero and equations 3.39a
and 3.39b converge to equations 3.34a and 3.34b.
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The IDL source code of the density filter is set out in the Annex.
3.2 Dose enhancement effects - Monte Carlo simulations
The second subtask of this thesis deals with the dose enhancement effects in the vicinity of
gold-nanoparticles. This effect should be considered when using gold-nanoparticles as X-
ray contrast agent, as it could lead to adverse effects. However, the dose enhancement effect
could also be of particular interest for the application of gold-nanoparticles in radiotherapy.
3.2.1 Phantom setup
For the dose enhancement simulations a new voxel phantom was set up. The voxel phan-
tom simulated a cell culture flask, typically used for the cell irradiation experiments (Figure
3.4). The voxel phantom had a size of 2.4×5.1185×5.1185 cm3 (800×29×29 voxel). Each
voxel had a size of 0.03×1.765×1.765mm3 (Figure 3.4). For the material of the flask,
PMMA (polymethyl methacrylate) was used and the cell monolayer was represented by
liver tissue with different concentrations of gold (0w%, 0.1w%, 0.2w%, 0.3w% and 0.4w%);
the composition was the same as for the imaging simulations (Table 3.1). The gold-
nanoparticles were not explicitly modeled in these simulations, instead a homogeneous
distribution of gold in the tissue was modeled. The material composition of PMMA is
8.05w% hydrogen, 59.98w% carbon and 31.96w% oxygen, the density is 1.19 g/cm3 and
the volume is 14692mm3. The simulated cell monolayer had a thickness of 30 ➭m and a
volume of 70.653mm3. For simplicity, cell culture medium was replaced by water in the
simulations, the volume was 48115mm3.
Figure 3.4: Voxel phantom of the cell culture flask used for the dose enhancement Monte
Carlo simulations.
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3.2.2 Spectra
The spectra used for the simulations were generated with SpekCalc [87,88]. The required
inputs were:
❼ energy bin width: 0.5 keV
❼ anode take off angle θ: 20 degree
❼ air thickness: 470mm
❼ beryllium thickness: 0.8mm
❼ aluminum thickness: 3.9mm
The energy bin defines the interval between the calculated intensity values of the X-ray
spectrum. The anode take off angle defines the angle under which X-rays are emitted.
For the simulations five different polyenergetic X-ray spectra with a peak energy of 60,
80, 100, 120 and 140 kV were used (Figure 3.5).
Figure 3.5: X-ray Spectra used for the dose enhancement simulations.
3.2.3 Simulation setup
Dose enhancement simulations were also performed with EGSnrc. The following code
adjustments were required. To use the single-step mode in EGSnrc the skindepth for bca
parameter is set to 1020 and bca algorithm was set to 0. For each simulation 109 histories
were used. The cutoff energy for photons and electrons was 1 keV. One simulation for each
X-ray spectrum and each gold concentration was performed.
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3.2.4 Evaluation
The EGSnrc user code was modified such that the output included the number and energy
of produced secondary Compton, photo- and Auger-electrons and the deposited energy in
each material. With these results the secondary electron spectra for all X-ray spectra and
the different materials were determined.
The dose in each material can be calculated as the deposited energy in each material
divided by its mass. The dose enhancement factor was defined as the ratio of absorbed
dose in the tissue with gold divided by the absorbed dose without gold:
DEF =
absorbed dose with gold
absorbed dose without gold
. (3.40)
3.3 Internalization of gold-nanoparticles into cells - biolog-
ical experiments
The main goal of these experiments was to address the question, whether the predicted
concentration of gold can be specifically targeted to malignant cells. For this purpose,
biological experiments with Hsp70 membrane positive cells, the cmHsp70.1 antibody and
gold-nanoparticles were performed. The intended conjugation of the gold-nanoparticles
and the antibody cmHsp70.1 is illustrated in Figure 3.6.
Figure 3.6: Illustration of the conjugation and binding of the gold-cmHsp70.1.
Specification of the used materials
4T1 cells
For this thesis, the tumorigenic 4T1 mouse mammary gland tumor cell line was used [8].
The 4T1 cells were kindly donated to use by the group of Prof. G. Multhoff, Klinik
fu¨r Strahlentherapie, Klinikum rechts der Isar, Technische Universita¨t Mu¨nchen. After
injection into BALB/c mice, 4T1 cells spontaneously produce highly metastatic tumors.
The tumor metastasizes into the lung, liver, lymph nodes and the brain. 4T1 cells express
Hsp70 on the cell membrane (personal conversation with Prof. G. Multhoff).
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Figure 3.7: Light microscopy of 4T1 cells. The scale bar is equivalent to 20 ➭m.
Cultivation:
The 4T1 cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium
supplemented with 10%volume/volume (v/v) fetal calf serum (FCS), 2mMol L-glutamine,
50Units/ml penicillin, 50 ➭g/ml streptomycin, and 1mMol sodium pyruvate at 37➦C in 5%
v/v CO2, 95% humidity. Cells were maintained in the exponential growth phase by regular
cell passage twice a week. They were seeded in T-75 culture flasks at constant cell densities
of 2.1×106 cells in 20ml conditioned medium. An optical microscope image of the cells is
shown in Figure 3.7.
Subcultivation:
Remaining medium was removed and cells were washed with 10ml phosphate buffered
saline (PBS). Then the adherent growing cells were detached with 3ml Trypsin-Ethylen-
ediaminetetraacetic acid (Trypsin-EDTA) and were incubated for 2min. Afterwards, 7ml
medium was added and cells were counted and subcultured into new T-75 culture flasks.
Further medium was added to make up the volume to 15ml.
Freezing:
Cells were detached from the culture flask and counted. Cells were then centrifuged at
300×g for 5min. The supernatant was discarded without disturbing the cell pellet. Cells
were then resuspended in cold freezing medium (40% medium, 50% FCS, 10% dimethyl
sulfoxide (DMSO)), such that the concentration was 1×106 cells/ml. Aliquots of 2ml were
pipetted into cryo tubes, which were placed in a deep freeze vial filled with isopropanol
and frozen at -80➦C. After one day the cells were removed from the deep freeze vial and
further stored at -80➦C.
Thawing:
The cryo tube, containing the frozen cells, was put into a 37➦C water bath until only
a small piece of ice was left. Cells were then pipetted into a centrifuge tube and 10ml
medium was added dropwise (approximately 5ml/min). Then further 10ml medium was
added and the suspension was transferred into a T-75 cell culture flask. After incubation
of the cells at 37➦C for 2 hours medium was removed and 15ml fresh medium was added.
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Counting:
Cell counting was performed with the FastRead-102 counting chambers (Immune Systems
Ltd.); each counting chamber had ten 4×4 grids. Cell suspension was dropped near the
counting chamber and capillary action drew the suspension into the chamber. Cells in
three 4×4 grids were counted and the concentration was then calculated according to
Cells/ml =
total number of counted cells
number of complete 4× 4 grids counted × 10
4
Gold-nanoparticles
Due to their characteristic optical and physical properties, gold-nanoparticles are widely
used.
The gold solution, used for this thesis, was obtained from BBI Solutions (Cardiff, UK).
According to BBI Solutions, their gold-nanoparticles have a superior stability, a stan-
dardized size and uniform spherical shape (>95% spherical, <5% uneven shapes). Gold-
nanoparticles were suspended in water and had a red color (Figure 3.8).
50 nm gold-nanoparticles:
The particle mean diameter was 50.7 nm (coefficient of variation <8%). The concentra-
tion of the gold-nanoparticles was 1.0 × 1012 nanoparticles/ml and they had a mass of
4.77×10−5 g gold/ml [1]. One gold-nanoparticle consists of approximately 3.86×106 gold
atoms and has a weight of 1.26×10−15 g.
15 nm gold-nanoparticles:
The particle mean diameter was 14.6 nm (coefficient of variation <8%). The concentra-
tion of the gold-nanoparticles was 4.5 × 1010 nanoparticles/ml and they had a mass of
5.68×10−5 g gold/ml [1]. One gold-nanoparticle consists of approximately 1.04×105 gold
atoms and has a weight of 3.41×10−17 g.
The official website of BBI Solutions did not provide any information about their gold-
nanoparticle synthesis and the used stabilizers.
Figure 3.8: Gold solution from BBI Solutions (image from www.bbisolutions.com).
The monoclonal antibody cmHsp70.1
Multimmune GmbH (Munich, Germany) generated the cmHsp70.1 antibody. It is an
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IgG1 mouse monoclonal antibody, which specifically detects cell membrane-bound Hsp70
on viable tumor cells. Western blot, flow cytometry, and dot blot analysis revealed that
this particular antibody does not cross with Hsc70 (Heat shock cognate protein 70). Hsc70
is the constitutive form, which performs physiological cellular processes, whereas Hsp70
is the stress-inducible form. Hsc70 and Hsp70 are highly homologous (84% sequence
homology) [80].
3.3.1 Optimization of antibody concentration for gold-antibody conju-
gation
For the conjugation of the cmHsp70.1 antibody to the gold-nanoparticles, a titration se-
ries was performed to determine the minimum amount of antibody needed to stabilize
the gold-nanoparticles (i.e., prevent aggregation). Addition of a sufficient amount of pro-
tein (e.g. antibodies) to the gold-solution induces a complete displacement of the citrate
anions. Electrostatic and hydrophobic interaction between gold-nanoparticles and anti-
bodies lead to a passive adsorption of the antibody to the gold-nanoparticles and by this
stabilizes the gold-nanoparticles (steric stabilization). If the amount of applied protein
is too small, citrate anions still coat the gold-nanoparticles. Addition of sodium chloride
(NaCl) solution will then interfere with the citrate anions and the gold-nanoparticles are
not stable anymore and agglomerate. This reaction induces a color change from red to
blue [91].
Table 3.3: Concentrations for the titration series
Amount of Amount of Amount of Concentration of
gold solution antibody purified water the antibody
1ml 0 ➭l 150 ➭l 0 ➭g/ml
1ml 10 ➭l 140 ➭l 1 ➭g/ml
1ml 20 ➭l 130 ➭l 2 ➭g/ml
1ml 30 ➭l 120 ➭l 3 ➭g/ml
1ml 40 ➭l 110 ➭l 4 ➭g/ml
1ml 50 ➭l 100 ➭l 5 ➭g/ml
1ml 60 ➭l 90 ➭l 6 ➭g/ml
1ml 70 ➭l 80 ➭l 7 ➭g/ml
1ml 80 ➭l 70 ➭l 8 ➭g/ml
1ml 90 ➭l 60 ➭l 9 ➭g/ml
1ml 100 ➭l 50 ➭l 10 ➭g/ml
1ml 110 ➭l 40 ➭l 11 ➭g/ml
1ml 120 ➭l 30 ➭l 12 ➭g/ml
1ml 130 ➭l 20 ➭l 13 ➭g/ml
1ml 140 ➭l 10 ➭l 14 ➭g/ml
1ml 150 ➭l 0 ➭l 15 ➭g/ml
The titration series involves the following steps [2]. First the gold solution was adjusted to
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approximately pH 9 (with NaOH or HCl). 16 clean plastic tubes were prepared and 1 ml of
the gold solution was added to each tube. Afterwards the monoclonal antibody cmHsp70.1
(concentration 0.1 ➭g/➭l) was added to each tube in a series from 0 to 150 ➭l and each tube
was filled up to 1.15ml with purified water (Table 3.3). After gently shaking each tube for
5minutes, 100 ➭l 10% NaCl was added to each tube and shaken again for 1minute. The
tube that showed no color change from red to blue after the addition of NaCl contained the
minimum amount of antibody, needed to stabilize the gold-nanoparticles. The titration
series was performed for the gold-nanoparticles with a diameter of 15 and 50 nm.
3.3.2 Conjugation of gold-nanoparticles and antibody
The conjugation of the antibody cmHsp70.1 to gold-nanoparticles enables specific targeting
of tumor cells. The conjugation was performed according to the protocol, which was pro-
vided by BBI Solutions [2]. With this method, antibodies conjugate to the nanoparticles
surface simply by electrostatic interactions (noncovalent binding). It would be beneficial
to perform the conjugation at a pH value close to the isoelectric point24 of the antibody.
Unfortunately, the isoelectric point of cmHsp70.1 was not known. After a personal con-
versation with group members of Prof. G. Multhoff the pH value for the conjugation was
adjusted to 7.2 (with NaOH or HCl).
Three clean plastic tubes were prepared and 1ml of the gold solution (15 and 50 nm) was
put in each tube. The minimal amount of antibody, determined by the titration series,
plus an additional amount of 10% was added to the gold solution. After rapidly shaking
the solution for 10minutes, 10% BSA (adjusted to pH 7.2) was added to each tube, so
that the total concentration of BSA is 0.25%, 0.5% and 1%. The solution was shaken for
10minutes. BSA covered remaining uncoated gold-nanoparticle surface areas and acted as
a so called secondary stabilizer. To remove the remaining non-adsorbed antibody and BSA
the tubes were centrifuged at 4➦C, at 3000×g for 60minutes (50 nm gold-nanoparticles) or
at 15000×g for 60minutes (15 nm gold-nanoparticles). The supernatant (containing the
non-adsorbed antibody and BSA) was removed and resuspended with 1ml 0.25% BSA
(adjusted to pH 7.2). In the following sections the cmHsp70.1 antibody conjugated to
gold-nanoparticles is referred to as gold-cmHsp70.1. The conjugation was performed for
the gold-nanoparticles with a diameter of 15 and 50 nm.
In order to demonstrate the effect of the antibody, gold-nanoparticles were coated only
with BSA as a reference. The method was exactly the same as described above, only the
addition of the antibody was left out. Gold-nanoparticles coated with BSA are referred
to as gold-BSA in the following sections.
To verify the conjugation of the monoclonal antibody cmHsp70.1 and the gold-nanoparticles
a dot blot was performed. A dot blot is a method for the detection, analysis, and identifi-
24The isoelectric point denotes the pH of a protein where the positive and negative charges are equal,
the protein has therefore no electrical net charge.
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cation of proteins. For this technique, protein samples “dots” are directly applied onto a
membrane. For the specific detection of that protein dot an antibody against that protein
is added. This antibody can then be visualized with different techniques.
The dot blot was performed with the gold-nanoparticles with a diameter of 50 nm. Six
pieces of the dot blot Hybond Hybond polyvinylidene difluoride (PVDF) membrane were
activated as described above. On three pieces 2 ➭l of the Hsp70 protein and on the other
three pieces 2 ➭l of the Hsc70 protein were applied and left to air dry. Blocking of the
membrane was done by placing the membrane into PBS + 1% BSA for half an hour.
The blocking solution was removed and each membrane piece was put into a small petri
dish, containing 3ml PBS + 1%, 0.5% or 0.25% BSA and 60 ➭l gold-cmHsp70.1. Different
amounts of BSA were used to find out if that influences the conjugation. The membrane
pieces were carefully wheeled for 2h and were then allowed to air dry. The method is
illustrated in Figure 3.9.
Figure 3.9: Illustration of the dot blot with the cmHsp70.1 antibody.
3.3.3 Verification of gold-antibody conjugation with UV-visible spec-
troscopy
UV-visible spectroscopy uses electromagnetic waves within the wavelength range of ul-
traviolet (UV) and visible light. For the method, electromagnetic waves of a specific
wavelength penetrate the sample, get absorbed and the non-absorbed part is then de-
tected. The location of the maximum transmittance and the intensity are characteristic
properties of the sample.
If the conjugation of gold-nanoparticles and cmHsp70.1 respectively BSA was successful,
the location of the maximum transmittance for the gold solution, gold-BSA and gold-
cmHsp70.1 should be different. The absorption of the different gold-solutions depends on
different factors such as geometry, size and the protein layer on the surface of the nanopar-
ticles. The protein layer for this thesis was BSA or the antibody cmHsp70.1, this protein
layer leads to a change of the refraction index and therefore to a change in the absorption.
This change can be used as an indicator for the conjugation of the gold-nanoparticles and
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a protein.
For the UV-visible spectroscopy, absorption spectra were measured using a Cary 1 Bio
UV-Visible (Varian, Palo Alto, USA), scanning spectrophotometer, operated at a spectral
resolution of 1 nm. The UV-visible spectrophotometer provides wavelength in the range
of 250 to 900 nm with a spectral bandwidth of 0.1 to 3 nm. Each sample was measured
three times and the mean absorbance was then calculated.
Gold-BSA and gold-cmHsp70.1 were prepared as described above, but the supernatant
was removed after the centrifugation and the gold-nanoparticles were resuspended in mil-
lipore water instead of 0.25% BSA. The UV-visible spectroscopy was only performed for
the gold-nanoparticles with a diameter of 50 nm.
3.3.4 Determination of the amount of gold per cell with ICP-OES
With inductively coupled plasma optical emission spectrometry (ICP-OES), also called
inductively coupled plasma atomic emission spectroscopy (ICP-AES), trace metals can be
detected. For this technique, an inductively coupled plasma is used to generate excited
atoms. With the intensity of the element specific optical emission, the concentration of
the trace metal in the sample can be calculated.
The amount of gold-nanoparticles in the cell or attached to the cell membrane was deter-
mined with this technique.
4T1 cells were seeded in T-75 flasks until they were about 80% confluent. Medium was
removed and 7ml fresh medium was added. Cells were then incubated with 2.24ml gold-
BSA or 2.24ml gold-cmHsp70.1 for 6, 12 and 24 hours. After the incubation with gold-
BSA/gold-cmHsp70.1 medium was removed and the cells were washed three times with
PBS to remove unbound gold-nanoparticles. Cells were detached (as described above) and
counted. The cell suspension was then transferred to silica glass tubes and centrifuged at
300×g for 10min, and the supernatant was removed.
The further sample preparation for the ICP-OES measurements was done by the group
of Prof. Dr. Bernhard Michalke (Research Unit Analytical BioGeoChemistry, Helmholtz
Zentrum Mu¨nchen). To each tube, 1 ml aqua regia was added and a pressure digestion
at 170➦C was performed. Then water ad 10ml was added. Each sample was measured at
two different wavelengths with the ICP-OES. The limit of detection was approximately
2-3 ➭g/L in the undiluted samples, i.e. approximately 30 ➭g/L for the diluted samples.
The ICP-OES measurements were performed for the gold-nanoparticles with a diameter
of 15 and 50 nm.
3.3.5 Investigation of the spatial distribution of gold-nanoparticles in
the cell with TEM
The gold-cmHsp70.1 should bind to the 4T1 cell membrane and might lead to an inter-
nalization of the gold-nanoparticles into the cell. To analyze the actual location of the
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gold-nanoparticles (50 nm) transmission electron microscopy (TEM) was used.
4T1 cells were seeded in a 6-well plate and were incubated over night. Old medium was
removed and 3ml fresh medium and 0.48ml gold-BSA (7.2×109 gold-nanoparticles per
ml medium) was added to three wells and 3ml fresh medium and 0.48ml gold-cmHsp70.1
(7.2×109 gold-nanoparticles per ml medium) was added to the remaining three wells.
Each of the 3 wells with gold-BSA/gold-cmHsp70.1 was incubated for 2, 4 and 6 hours
respectively. After that time, medium was removed and cells were washed with 1ml PBS
three times. Then cells were detached, transferred to embedding capsules and centrifuged
for 5minutes at 500×g. The supernatant was removed and the capsules were filled with
fixation solution (2.5% glutaraldehyde in 0.1M sodium cacodylate).
Further preparation steps required to obtain the TEM images were performed by the In-
stitute of Pathology at the Helmholtz Zentrum Munich (Prof. Dr. A. Walch and Dr. M.
Aichler). No further information about the sample preparation was provided.
Chapter 4
Results and Discussion
4.1 Spectral CT imaging with gold-nanoparticles - Monte
Carlo simulations
The major goal of this study is to determine the minimum concentration of gold required
to provide sufficient contrast in spectral CT imaging in humans. To reach this goal, Monte
Carlo simulations with EGSnrc were performed.
A few preliminary considerations and investigations of photon-counting and energy-inte-
grating detectors (without energy resolution) are presented at the beginning of this chap-
ter. In order to solve the key problem, the influence of the energy thresholds on the
detectability of gold was analyzed. In a next step the performance of the delineated
algorithms were evaluated with respect to the SNR, CNR and the contrast.
4.1.1 Simulations and radiation dose
To be able to compare all simulations, the number of histories, i.e., the administered dose,
for all simulations was the same. The whole body dose is calculated for the human voxel
phantom. For the simulations the deposited energy in one slice is approximately 1.95mJ25.
The whole-body dose for a liver-spleen scan (scan length approximately 18.4 cm, yielding
210 slices) is then 7.0mGy and the effective dose 13.0mSv. This effective dose is compa-
rable to a real liver-spleen scan [107]. The presented images and the calculated SNRs and
CNRs in the following sections should therefore be similar to clinical CT images.
The computing time on the high performance computing - high availability - cluster is
approximately four weeks (with 32 processors in parallel) for one simulation with 1160
views and 109 histories per view.
Hainfeld et al. [50] already tried to predict the concentration of gold required to provide
sufficient contrast in spectral CT imaging in humans. Those calculations will be further
analyzed in order to better assess the presented results in this thesis. With the assump-
25The deposited energy was simulated by Helmut Schlattl.
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tion that CT scanners can detect lesions with a difference of at least 8 Hounsfield units
(HU), Hainfeld et al. calculated the required concentration of gold to be 0.05w%. For
their calculations they used a simplified formula and they started from the assumption
of a 140 kV CT spectrum (mean energy 70 keV). This calculation is repeated with an
extended formula for the 120 kV spectrum (mean energy 64.5 keV). At the mean energy
the linear attenuation coefficient µ of gold is 72.59 cm−1, of water 0.1994 cm−1, of the liver
0.2102 cm−1 and of the metastasis 0.2023 cm−1. The HU change can then be calculated
with the following formula. The metastasis with gold is referred to as ROI.
∆HU = HUROI −HUliver
∆HU = 1000
µROI − µliver
µwater
(4.1)
The linear attenuation coefficient of the metastasis with gold is calculated as follows. w
is the fractional weight of gold.
µROI =
(
w
(
µ
ρ
)
gold
+ (1− w)
(
µ
ρ
)
metastasis
)
ρROI
ρROI = wρgold + (1− w)ρmetastasis
µROI = aw
2 + bw + µmetastasis (4.2)
with a = µmetastasis + µgold −
(
µ
ρ
)
gold
ρmetastasis −
(
µ
ρ
)
metastasis
ρgold
b =
(
µ
ρ
)
metastasis
ρgold +
(
µ
ρ
)
gold
ρmetastasis − 2µmetastasis
Plugging Eq. 4.2 into Eq. 4.1 and solving for the fractional weight w gives
w1/2 =
−b±√b2 − 4ac
2a
(4.3)
with c = µmetastasis − µliver − ∆HUµwater
1000
Using the linear attenuation coefficients above and the densities given in Table 3.1 and
demanding ∆HU is equal to 8, the fractional weight of gold is then w = 0.13w%. The
same calculation with the 140 kV spectrum of Hainfeld and ∆HU=8 gives w = 0.14w%,
which is almost three times the predicted concentration of Hainfeld.
4.1.2 Energy-integrating and photon-counting detectors
The first result should elucidate the performance differences of a conventional CT with a
photon-counting or an energy-integrating detector. No beam shaping filter (Bowtie filter)
was used to correct for cupping artifacts.
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(a) photon-counting (b) energy-integrating
Figure 4.1: Summed image of the simple voxel phantom for a photon-counting and an
energy-integrating detector (images are equally scaled and windowed).
(a) photon-
counting
(b) energy-
integrating
Figure 4.2: Summed images of the human voxel phantom with 0.3w% gold for a photon-
counting and an energy-integrating detector (images are equally scaled and windowed).
(a) photon-
counting
(b) energy-
integrating
Figure 4.3: Summed images of the human voxel phantom with 0.2w% gold for a photon-
counting and an energy-integrating detector (images are equally scaled and windowed).
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The cupping artifacts in the simple voxel phantom are smaller for the photon-counting
detector than for the energy-integrating detector (Figure 4.1). Calculating the percentage
of cupping (Eq. 3.8) for the photon-counting detector gives 0.16% and for the energy-
integrating detector 3.14%. All metastases with 0.7 down to 0.2w% gold are identifiable
for both detector types. The metastases with 0.1w% gold are not visible at all. The
first results indicate that at least 0.2w% gold are required to provide sufficient contrast in
spectral CT imaging in humans.
The cupping artifacts in the human voxel phantom are not as pronounced as in the sim-
ple voxel phantom (Figure 4.2 and 4.3). All metastases with 0.3w% and 0.2w% gold are
recognizable for both detector types.
The SNR, the (effective) CNR and the contrast were analyzed only for the biggest metas-
tasis in the simple voxel phantom. For the human voxel phantom, the mean of all three
metastases was calculated. The image quality quantities slightly favor different detectors
for various combinations of phantom and gold concentration (Tables 4.1 and 4.2). How-
ever, the absence of a clear trend with gold concentration and the small differences between
the two detector models do not allow the conclusion that one of the detectors is benefi-
cial. Further investigations could be done to determine optimal weighting factors for each
bin, as already described in the literature [101, 104]. As presented above all metastases
with 0.2w% up to 0.7w% gold are clearly visible in all phantoms, but the metastases with
0.1w% gold are not detectable. As already mentioned in section 3.1.1.3, the effective CNR
must be higher than 5 (Rose criterion). The effective CNR for the metastases with 0.1w%
gold is approximately 5, but the standard deviation is very high, leading to the conclu-
sion that the required minimum concentration of gold is approximately 0.2w%, which is
close to the calculated value in section 4.1.1. The standard deviation in the liver of the
human voxel phantom is 0.42HU for the photon-counting detector and 0.67HU for the
energy-integrating detector. With these standard deviations the demanded difference of
∆HU=8, in section 4.1.1, appears to be reasonable. Micro-CT investigations by Clark et
al. [33] revealed a detectability limit of approximately 0.15w% gold which is in accordance
with the presented results in this thesis and the calculations in section 4.1.1.
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Table 4.1: Performance results for the photon-counting and the energy-integrating detector for the simple voxel phantom.
photon-counting energy-integrating
SNR CNR CNReff C SNR CNR CNReff C
0.7w% gold 26.7±1.0 5.32±0.97 106±19.7 0.115±0.021 27.7±1.0 5.33±0.99 107±19.7 0.111±0.020
0.4w% gold 60.7±1.0 5.77±1.01 115±20.2 0.0595±0.010 64.0±1.0 5.83±1.02 117±20.3 0.0571±0.010
0.3w% gold 90.2±1.0 5.43±1.06 109±21.2 0.0420±0.008 95.4±1.0 5.48±1.05 110±21.1 0.0402±0.008
0.2w% gold 116±1.0 3.73±1.04 74.7±20.9 0.0232±0.006 113±1.0 3.41±0.97 68.1±19.3 0.0218±0.006
0.1w% gold 106±1.0 0.275±0.64 5.51±12.8 0.00180±0.004 106±1.0 0.229±0.59 4.59±11.8 0.00152±0.004
Table 4.2: Performance results for the photon-counting and the energy-integrating detector for the human voxel phantom.
photon-counting energy-integrating
SNR CNR CNReff C SNR CNR CNReff C
0.3w% gold 89.3±1.0 5.02±1.07 46.1±10.0 0.0374±0.008 91.3±1.0 5.05±1.07 46.3±10.0 0.0366±0.008
0.2w% gold 90.8±1.0 2.55±1.03 22.7±9.69 0.0184±0.007 93.0±1.0 2.57±1.04 22.9±9.71 0.0181±0.008
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4.1.3 Optimization of detector bin thresholds
Prior to the detailed analysis of the spectral simulation results, a closer look at the re-
lationship between the gold concentration and the bin sizes of the bin below and above
the K-edge of gold is taken. The bin size below the K-edge ranged from [40,81) keV to
[79,81) keV and the bin size above the K-edge from [81,83) keV to [81,120] keV.
The number of detected photons increases with increasing bin size resulting in a higher
signal and reduced noise. Above the K-edge of gold, the mass attenuation values of gold
decline faster than the mass attenuation values of the liver. Below the K-edge the mass
attenuation values of gold increase faster than the mass attenuation values of the liver (Fig-
ure 4.4). The highest differences between the mass attenuation values of gold and liver
are slightly above the K-edge and at low energies. This fact will influence the (effective)
CNR and the contrast.
Figure 4.4: Mass attenuation curves for liver tissue and 0.2w% gold.
Simple voxel phantom
The SNR, the (effective) CNR and the contrast were analyzed only for the biggest metas-
tasis in the simple voxel phantom.
The SNR below the K-edge increases with increasing bin size as one might expect. The
SNR is lower for higher gold concentrations. The reason for this is the higher attenuation
for increasing concentrations of gold, i.e., less photons are able to penetrate the object
leading to lower count rates in the detector. Due to the K-edge effect the attenuation is
higher in the bins above the K-edge yielding a smaller SNR (Figure 4.5). In contrast to
the SNR, the effective CNR is higher for higher gold concentrations (Figure 4.6). The
effective CNR increases with increasing bin size. Above the K-edge of gold the effective
CNR increases rapidly for small bin sizes, but above a certain bin size, which depends on
the concentration of gold, the effective CNR remains almost constant. An increase in the
effective CNR is due to an increased contrast or to decreased noise (decreased variance)
or both. As the bin size increases the noise decreases, but the contrast first increases up
to a maximum and then decreases again (Figure 4.7). This leads to the almost constant
effective CNR. For the ROI with 0.1w% gold the effective CNR below the K-edge of gold
is smaller than 5, above the K-edge the effective CNR is approximately 10, however the
4.1. SPECTRAL CT IMAGING WITH GOLD 55
standard deviation is high. These results indicate that a concentration of 0.1w% gold is
not detectable.
Figure 4.5: SNR in the simple voxel phantom below (left) and above (right) the K-edge
for different bin sizes.
Figure 4.6: Effective CNR in the simple voxel phantom below (left) and above (right) the
K-edge for different bin sizes. The dotted line represents an effective CNR of 5.
Figure 4.7: Contrast in the simple voxel phantom below (left) and above (right) the K-edge
for different bin sizes.
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The contrast is higher for higher gold concentrations (Figure 4.7). To derive a maximum
benefit from the K-edge effect, the difference between the contrast below and above the
K-edge of gold should be maximal. Below the K-edge the contrast shows a minimum for
bins [70,81) keV (0.7w%), [68,81) keV (0.4w%), [66,81) keV (0.3w%), [69,81) keV (0.2w%)
and [75,81) keV (0.1w%). The contrast above the K-edge shows a maximum for bins
[81,91) keV (0.7w%), [81,89) keV (0.4w%), [81,91) keV (0.3w%), [81,89) keV (0.2w%) and
[81,87) keV (0.1w%).
These results already indicate that smaller bin sizes seem to be beneficial.
Human voxel phantom
The same evaluations as for the simple voxel phantom were performed for the human voxel
phantom with 0.3 and 0.2w% gold. The SNR, the effective CNR and the contrast were
calculated as the mean of all three metastases.
Figure 4.8: SNR in the human voxel phantom below (left) and above (right) the K-edge
for different bin sizes.
As already observed in the simple voxel phantom, the SNR increases with increasing
bin size for 0.3 and 0.2w% gold. The higher attenuation due to the K-edge of gold is
represented by the smaller SNR above the K-edge (Figure 4.8). The SNR below the K-
edge of gold is slightly higher for 0.3w% gold and above the K-edge of gold the SNR is
slightly higher for the 0.2w% gold. The effective CNR in the human voxel phantom with
0.2w% gold is smaller than for the human voxel phantom with 0.3w% gold. In the human
voxel phantom with 0.3w% gold the effective CNR is always higher than 5, whereas for
the 0.2w% gold the effective CNR is smaller than 5 for bins [76,81), ... , [80,81), indicating
that gold is not visible for those small bins. The values of the effective CNR closely match
the values in the simple voxel phantom (Figure 4.9). The contrast values in the human
voxel phantom are similar to the simple voxel phantom (Figure 4.10). In the human voxel
phantom with 0.2w% and 0.3w% gold the contrast below the K-edge shows a minimum
for bin [71,81) keV and above the K-edge the maximum is at bin [81,89) keV (Figure 4.10).
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Figure 4.9: Effective CNR in the human voxel phantom below (left) and above (right) the
K-edge for different bin sizes. The dotted line represents an effective CNR of 5.
Figure 4.10: Contrast in the human voxel phantom below (left) and above (right) the
K-edge for different bin sizes.
The SDNR criterion
In a next step the optimal bin thresholds for the bin below and above the K-edge of gold
were calculated with respect to the maximum signal-difference-to-noise ratio (SDNR) (Eq.
3.9). The curve progression of the SDNR for the simple voxel phantom and for the human
voxel phantom are shown in Figure 4.11. The results are summarized in Table 4.3 for the
simple voxel phantom and Table 4.4 for the human voxel phantom.
In theory, the difference between the linear attenuation values in the bin above and below
the K-edge increases with decreasing bin sizes, but noise also increases with decreasing
bin sizes. The SDNR represents a compromise between a high difference and relatively
small noise. Furthermore the constraint µXCOMabove > µXCOMbelow must be fulfilled. As
already shown in section 2.2.3 (Figure 2.5 and 2.7) the bin sizes for which that criteria
holds rapidly decrease with decreasing concentrations of gold.
For the following investigations, the bin thresholds below the K-edge were set to [75,81) keV
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and the bin thresholds above the K-edge were set to [81,86) keV, based on the results
summarized in Table 4.4.
(a) Simple voxel phantom 0.7w%
gold
(b) Human voxel phantom 0.3w%
gold
(c) Human voxel phantom 0.2w% gold
Figure 4.11: Curve progression of the SDNR.
Table 4.3: Comparison of the maximum SDNR for the simple voxel phantom.
0.7w% Gold 0.4w% Gold 0.3w% Gold 0.2w% Gold 0.1w% Gold
below K-edge [74,81) keV [73,81) keV [77,81) keV [77,81) keV [78,81) keV
above K-edge [81,84) keV [81,86) keV [81,86) keV [81,85) keV [81,83) keV
maximum SDNR 2.230 1.758 1.478 0.9868 0.3969
Table 4.4: Comparison of the maximum SDNR for the human voxel phantom.
0.3w% gold 0.2w%gold
below K-edge [75,81) keV [75,81) keV
above K-edge [81,86) keV [81,85) keV
maximum SDNR 1.295 1.297
.
The intensity of the X-ray spectrum above 86 keV is low, that means only a small number
of photons is generated. In order to produce as little noise as possible in this bin, the bin
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thresholds were set to [86,120] keV. For the remaining three bins, the intensity
Ii(Ei−1, Ei) =
∫ Ei
Ei−1
I0(E) exp(−µBone(E)x1 − µLiver(E)x2)dE for i = 1, 2, 3 (4.4)
was calculated for different bin thresholds Ei−1, Ei. It was assumed that X-rays are passing
through 5 cm of bone (x1) and 25 cm of liver tissue (x2). The total distance of 30 cm is
approximately the mean diameter of the human voxel phantom. The linear attenuation
coefficients µBone(E) and µLiver(E) were calculated with XCOM. The goal was to have
a high difference in these intensities for each of the three bins. The first bin was set to
[25,47) keV, as I1(25 keV,47 keV) is almost equal to zero, if the upper threshold, E1, is
below 47 keV (Figure 4.12(a)). For the second bin the lower threshold E1 is 47 keV and
for the third bin the upper threshold E3 is 75 keV. The intensity function for the second
bin I2(47 keV,E2) and for the third bin I3(E2,75 keV) is shown in Figure 4.12(b). In order
to have a maximal difference between all three intensities, E2 was chosen such that
I3(E2, 75keV)− I2(47keV, E2) ≈ I2(47keV, E2)− I1(25keV, 47keV)
i.e.
I3(E2, 75keV) + I1(25keV, 47keV)
2
≈ I2(47keV, E2) (4.5)
(a) Intensity function I1(25, E1) (b) Intensity function I2(47, E2) (green line),
I3(E2, 75) (blue line) and (I3(E2, 75)+I1(25, 47))/2
(dotted blue line)
Figure 4.12: Evaluation of the intensity function Ii(Ei−1, Ei) to determine the bin thresh-
olds for the first three bins.
Equation 4.5 is represented by the dotted line in Figure 4.12(b), yielding E2 =60 keV
as a bin threshold. The bin thresholds for the third bin were set to [60,75) keV and for
the second bin to [47,60) keV. (These new bin thresholds are referred to as optimized
bin thresholds). For a comparison the bin thresholds were chosen according to [34], the
bins were [25,34), [34,51), [51,80), [80,91), [91,110) and [110,120] keV (referred to as non-
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optimized bin thresholds). The energy thresholds for the optimized and non-optimized
case are shown in Figure 4.13. For the energy ranges with a low number of incident
photons the bins are bigger in the optimized case and the bins just below and above the
K-edge of gold are much smaller than in the non-optimized case.
It was stated that the non-optimized energy thresholds, provide the highest sensitivity
with regard to simultaneous imaging of iodine and gold [34]. But the above results already
indicate that the non-optimized energy thresholds are not optimal for imaging of gold in
humans.
For this thesis, the SDNR was only used to calculate the optimized bin thresholds for
the bin just below and just above the K-edge of gold. The remaining bin thresholds were
selected considering the higher absorption of X-rays at lower energies. Therefore the bin
thresholds were chosen such that the number of incident photons per bin was higher for
lower energies. Further investigations could be done to improve these bin thresholds.
(a) Non-optimized bin thresholds (b) Optimized bin thresholds
Figure 4.13: Different bin thresholds related to the mass attenuation curve of the mixture
of 0.3w% gold and liver tissue.
The purpose of the presented figures (4.14, 4.15 and 4.16) is to illustrate the big impact
of the energy thresholds on the reconstructed CT images.
Especially the images in the first and the last bin show big differences. The proportion
of incident photons in the first and the last bin were small for the non-optimized case.
Furthermore the attenuated amount of photons is higher for lower energies. These effects
are especially visible in the non-optimized [25,34) keV and [110,120] keV images, which
show strong noise.
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Non-optimized bin thresholds
(a) [25,34) keV (b) [34,51) keV (c) [51,80) keV (d) [80,91) keV (e) [91,110) keV (f) [110,120] keV
Optimized bin thresholds
(g) [25,47) keV (h) [47,60) keV (i) [60,75) keV (j) [75,81) keV (k) [81,86) keV (l) [86,120] keV
Figure 4.14: Reconstructed images for the simple voxel phantom (corresponding images are equally scaled and windowed).
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Non-optimized bin thresholds
(a) [25,34) keV (b) [34,51) keV (c) [51,80) keV (d) [80,91) keV (e) [91,110) keV (f) [110,120] keV
Optimized bin thresholds
(g) [25,47) keV (h) [47,60) keV (i) [60,75) keV (j) [75,81) keV (k) [81,86) keV (l) [86,120] keV
Figure 4.15: Reconstructed images for the human voxel phantom with 0.3w% gold (corresponding images are equally scaled and
windowed).
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Non-optimized bin thresholds
(a) [25,34) keV (b) [34,51) keV (c) [51,80) keV (d) [80,91) keV (e) [91,110) keV (f) [110,120] keV
Optimized bin thresholds
(g) [25,47) keV (h) [47,60) keV (i) [60,75) keV (j) [75,81) keV (k) [81,86) keV (l) [86,120] keV
Figure 4.16: Reconstructed images for the human voxel phantom with 0.2w% gold (corresponding images are equally scaled and
windowed).
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4.1.4 Material-decomposition techniques
4.1.4.1 Eigenvector decomposition
The eigenvector decomposition is basically a filter algorithm leading to a noise suppression
in the energy domain. The required input data are the mass attenuation values for each
bin of the basis materials (i.e. gold, hard bone mixture and liver tissue). The algorithm
provides two distinct results. The first one are the noise suppressed images of each bin
and the second one are images corresponding to the concentration of gold, bone and liver.
The eigenvalues λ of the defined covariance matrix MCov(ρtotalw)M
T are summarized in
Table 4.5. The eigenvalues relate to the whole image, not only to the metastases with
gold.
Table 4.5: Eigenvalues of the covariance matrix MCov(ρtotalw)M
T .
non-optimized optimized
bin thresholds bin thresholds
3.0799×10−1 7.4316×10−1
4.6819×10−3 1.0432×10−2
6.5803×10−7 4.1400×10−7
-1.8730×10−9 1.2804×10−9
-3.2922×10−9 -3.6009×10−9
-5.1772×10−10 5.8947×10−9
For this thesis only the three eigenvectors corresponding to the three largest eigenval-
ues will be used (i.e. K ′ = 3) to calculate the noise suppressed images. The results for
the noise suppression performance of the algorithm is examined for the optimized bin
thresholds in the human voxel phantom with 0.3w% gold. The difference between the
unprocessed images and after the eigenvector decomposition are illustrated in Figure 4.17.
The differences before and after the eigenvector decomposition are small. The images indi-
cate that bins with a low number of photons benefit from the algorithm, this is particularly
visible for bins four and five (Figure 4.17(d) and (e)). The noise suppression along the
energy axis is illustrated in Figure 4.18. The linear attenuation value in the unprocessed
images (blue squares) in bin 4 is too big and too small in bin 5. The K-edge effect is not
correctly reflected, i.e. higher attenuation in bin 5 compared to bin 4. After applying the
eigenvector decomposition algorithm the curve progression of the linear attenuation val-
ues (red dots) is very similar to the exact linear attenuation values (green triangles). The
mean percentage deviation of the linear attenuation values decreases from 2.35% before
the eigenvector decomposition to 1.49% after the eigenvector decomposition. The K-edge
effect is correctly displayed after the eigenvector decomposition.
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Before the eigenvector decomposition
After the eigenvector decomposition
(a) [25,47) keV (b) [47,60) keV (c) [60,75) keV (d) [75,81) keV (e) [81,86) keV (f) [86,120] keV
Figure 4.17: Close-ups of the human voxel phantom with 0.3w% gold before and after the
eigenvector decomposition.
Figure 4.18: Demonstration of the noise suppression along the energy axis of the eigenvec-
tor decomposition algorithm for a single pixel inside the biggest metastasis in the human
voxel phantom with 0.3w% gold (optimized bin thresholds). The blue squares correspond
to the linear attenuation values in each bin in the unprocessed images. The red dots
correspond to the linear attenuation values in each bin after applying the eigenvector de-
composition algorithm. The green triangles show the exact linear attenuation values for
each bin.
The graphs (Figure 4.19) show a clear increase of the SNR and CNR for bin 1 to 5
after the eigenvector decomposition. For bin 6 the SNR and the CNR decreases after the
eigenvector decomposition. The contrast only increases for bins 2 and 5. The eigenvector
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decomposition induces a SNR increase by 14.7% and a CNR increase by 12.3%. Only the
contrast slightly decreases by -1.3%. In conclusion, it can be said that the eigenvector
decomposition leads to a noise reduction in the images.
(a) SNR (b) CNR (c) Contrast
Figure 4.19: Comparing the SNR, CNR and the contrast for the human voxel phantom
with 0.3w% gold (optimized case), before and after the eigenvector decomposition.
Non-optimized bin thresholds
(a) Liver (b) Gold
Optimized bin thresholds
(c) Liver (d) Gold (e) Gold after bilateral
filtering
Figure 4.20: Images corresponding to the concentration of gold, liver and bone of the
eigenvector decomposition of the simple voxel phantom.
The images, corresponding to the concentration of the three materials (Figure 4.20), show
a better result for the optimized bin thresholds than for the non-optimized bin thresholds.
In Figure 4.20(d) and (e), all metastases with 0.7w% down to 0.2w% gold are identifiable.
Even the metastases with 0.1w% gold are slightly visible. In the liver image (Figure 4.20(a)
and (c)) a positive contribution from gold is still visible.
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Non-optimized bin thresholds
(a) Liver (b) Bone (c) Gold
Optimized bin thresholds
(d) Liver (e) Bone (f) Gold (g) Gold after bilat-
eral filtering
Figure 4.21: Images corresponding to the concentration of gold, liver and bone of the
eigenvector decomposition of the human voxel phantom with 0.3w% gold.
The results for the human voxel phantom with 0.3w% gold (Figure 4.21) and with 0.2w%
gold (Figure 4.22) are very similar. The eigenvector decomposition achieved better results
for the optimized bin thresholds, than for the non-optimized case, for which gold is barely
visible. The first image (Figure4.20(a) and (d)) corresponds to liver, the second one to
bone (Figure4.20(b) and (e)) and the third image (Figure4.20(c), (f) and (g)) contains the
gold concentration. All three metastases with 0.3w% gold are clearly identifiable in the
gold image (Figure 4.21(f) and (g)). The metastases with 0.2w% gold are barely visible
in the unfiltered gold image, but they are visible in the filtered gold image (Figure 4.22(f)
and (g)). The liver images (Figure 4.21(a), (d)) and Figure 4.22(a), (d)) do not provide
much information. Hardly any contrast differences in the soft tissue are visible.
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Non-optimized bin thresholds
(a) Liver (b) Bone (c) Gold
Optimized bin thresholds
(d) Liver (e) Bone (f) Gold (g) Gold after bilat-
eral filtering
Figure 4.22: Images corresponding to the concentration of gold, liver and bone of the
eigenvector decomposition of the human voxel phantom with 0.2w% gold.
The optimized unfiltered and filtered gold images will be analyzed in more detail now. The
performance results for the eigenvector decomposition are summarized in Table 4.6 and
4.7. The SNR is high, however the contrast is very low. The bilateral filter improves the
SNR, (effective) CNR and the contrast for all cases. However, taking into consideration
the standard deviation, the metastases with 0.1w% and 0.2w% gold in the unfiltered
image can not be clearly distinguished from the background. In the filtered images all
metastases have an effective CNR greater than 5, i.e. they can be clearly distinguished
from the background.
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Table 4.6: Performance results of the eigenvector decomposition for the optimized gold images of the simple voxel phantom.
unfiltered filtered
SNR CNR CNReff C SNR CNR CNReff C
0.7w% gold 7.39±1.0 2.47±1.03 49.5±20.6 0.279±0.12 10.6±1.0 4.00±0.99 80.1±19.8 0.288±0.071
0.4w% gold 7.95±1.0 1.71±0.89 34.1±17.7 0.181±0.094 15.0±1.0 3.52±0.88 70.3±17.5 0.183±0.046
0.3w% gold 7.62±1.0 1.27±0.88 25.4±17.6 0.138±0.096 14.8±1.0 2.70±0.99 54.1±19.9 0.144±0.053
0.2w% gold 7.87±1.0 0.945±0.80 18.9±16.1 0.0930±0.079 16.1±1.0 1.96±0.96 39.1±19.1 0.0961±0.047
0.1w% gold 8.11±1.0 0.480±0.65 9.60±13.0 0.0469±0.064 18.9±1.0 1.07±0.72 21.3±14.3 0.0496±0.033
Table 4.7: Performance results of the eigenvector decomposition for the optimized gold images of the human voxel phantom.
unfiltered filtered
SNR CNR CNReff C SNR CNR CNReff C
0.3w% gold 7.19±1.0 1.17±0.78 10.6±6.97 0.151±0.10 14.0±1.0 2.82±0.82 24.7±7.47 0.183±0.056
0.2w% gold 6.94±1.0 0.765±0.68 7.05±6.21 0.102±0.090 14.9±1.0 1.90±0.78 16.7±6.96 0.115±0.049
70 CHAPTER 4. RESULTS AND DISCUSSION
As described in equation 3.18, the concentration of gold multiplied by the total density
can be calculated. The total density can be estimated according to ρtotal(x) =
∑3
i=1 w˜i(x).
The numerical values can then be corrected to obtain the weight fraction of gold. The
results are summarized in Table 4.8. The algorithm underestimates the amount of gold
for all simulations and all ROIs by 35 up to 40%. The bilateral filter algorithm reduces
noise up to 57%, however the predicted concentration of gold remains almost unchanged.
Further investigations about the ability of the eigenvector decomposition to estimate the
gold concentration are summarized in the annex. The calculated concentrations there are
in good agreement with the implemented gold concentration.
Table 4.8: Implemented gold concentration and by the eigenvector decomposition algo-
rithm calculated weight fraction of gold multiplied by the total density (uncorrected) and
the corrected weight fraction of gold.
uncorrected corrected
implemented unfiltered filtered unfiltered filtered
0.7w% gold 0.50±0.16 0.49±0.11 0.43±0.16 0.42±0.11
simple 0.4w% gold 0.27±0.12 0.27±0.06 0.25±0.12 0.25±0.06
voxel 0.3w% gold 0.20±0.11 0.19±0.06 0.19±0.11 0.18±0.06
phantom 0.2w% gold 0.14±0.10 0.14±0.05 0.13±0.10 0.13±0.05
0.1w% gold 0.066±0.09 0.066±0.04 0.064±0.09 0.064±0.04
human
voxel 0.3w% gold 0.21±0.14 0.20±0.06 0.20±0.14 0.19±0.06
phantom 0.2w% gold 0.14±0.14 0.13±0.06 0.13±0.14 0.12±0.06
In Figure 4.23 the linear attenuation values in the reconstructed images for each bin and
the attenuation values calculated with XCOM are compared. For liver tissue the values in
the reconstructed images are consistent with the XCOM values. Only the value in the first
bin is too small, which could be due to the rather high noise level in the first bin image.
However, for the metastases with 0.2 and 0.3w% gold the values in the reconstructed
images are clearly smaller than the XCOM values. Especially the value above the K-
edge and in the first and second bin are too small. The deviations are summarized in
Table 4.9. These deviations of the linear attenuation values could be the reason for the
underestimation of the gold concentrations.
Table 4.9: Deviation of the linear attenuation values in the reconstructed images and the
values calculated by XCOM in percent.
Bin 1 Bin 2 Bin 3 Bin 4 Bin 5 Bin 6
Liver tissue -3.22% -0.78% -0.50% -0.14% 0.04% -0.47%
0.2w% gold -3.30% -1.94% -0.66% 0.34% -2.23% -0.55%
0.3w% gold -3.91% -2.25% -0.86% 0.27% -3.23% -1.44%
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(a) Liver tissue
(b) 0.3w% gold (c) 0.2w% gold
Figure 4.23: Comparing the linear attenuation values in the reconstructed images and the
values calculated by XCOM.
The results indicate that a minimum amount of 0.2w% gold is required to provide suf-
ficient contrast in spectral CT imaging. Gonzales et al. used a similar approach. The
implementation of the described algorithm did not provide satisfying results for the here
presented simulations, as the metastases were not visible at all.
The presented eigenvector decomposition is based on principal component analysis. The
main advantage of the PCA is the possibility to reduce the dimensionality of the data,
without losing a significant amount of information.
PCA was previously applied to spectral X-ray images and has yielded promising re-
sults [20]. Anderson et al. [10] used the PCA for spectral CT imaging in mice. Calcium,
iodine- and barium-based contrast agents could be distinguished in the PC images. In
contrast to the here presented approach, the covariance matrix was always estimated with
the measured data. To my knowledge the PCA has not previously been applied to spectral
images with gold-based contrast agents.
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4.1.4.2 K-edge decomposition algorithm
The basic idea of the K-edge decomposition algorithm is to calculate the fractional con-
tributions of the photoelectric effect, Compton scattering and the high-Z material to the
total attenuation. The results of the K-edge decomposition method, as described in sec-
tion 3.1.4.2, depend strongly on the chosen numerical target accuracy of the minimization
problem. The accuracy was set to 10−6 for this evaluations. The linear independence of the
three vectors 1/E3, fKN(E/Ee) and (µ(E)/ρ)gold was verified with Wolfram Mathematica,
enabling a clear separation of the three terms.
Non-optimized bin thresholds
(a) Compton Effect (b) Photo Effect (c) Gold (d) Gold after bilateral
filtering
Optimized bin thresholds
(e) Compton Effect (f) Photo Effect (g) Gold (h) Gold after bilateral
filtering
Figure 4.24: Images of the K-edge decomposition algorithm of the simple voxel phantom
(corresponding images are equally scaled and windowed).
The differences between the optimized and the non-optimized decomposed images (Figure
4.24) are small. In the Compton effect images (Figure 4.24(a) and (e)) the metastases with
0.7w%, 0.4w% and 0.3w% gold are still visible, the metastases with 0.2w% and 0.1w% gold
are not visible. The K-edge decomposition algorithm seems to overestimate the Compton
effect. As described in Equation 3.23 and 3.22 the total density ρtotal and the density of
the low-Z material (here the metastasis) ρlowZ are taken into account in the calculation
of the Compton and photoelectric effect images. If the gold concentration is low, i.e.
ρlowZ(x) ≈ ρtotal(x) and wlowZ ≈ 1, C˜photo(x) and C˜Compton(x) are not affected by gold
(Equation 4.6 and 4.7). But for higher gold concentrations C˜photo(x) and C˜Compton(x)
depend on ρtotal(x), and therefore on gold. The influence on the photoelectric effect is
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minor, as Z3lowZ(x) ≫ ρtotal(x). But the Compton effect is proportional to ρtotal(x) and
therefore depends on gold.
C˜photo(x) ∝
Z3lowZ(x)ρlowZ(x) if ρtotal(x) ≈ ρlowZ(x)Z3lowZ(x)ρtotal(x) if ρtotal(x) > ρlowZ(x) (4.6)
C˜Compton(x) ∝
ρlowZ(x) if ρtotal(x) ≈ ρlowZ(x)ρtotal(x) if ρtotal(x) > ρlowZ(x) (4.7)
This seems to explain the positive contribution of gold in the Compton effect images and
lead to the conclusion that the K-edge decomposition does not work effective for higher
gold concentrations. In the optimized-case photoelectric image (Figure 4.24(f)) gold is
clearly removed and there are “holes” in the image, where as for the non-optimized case
(Figure 4.24(b)) this effect is not visible. The strong noise in the photoelectric images
is partly due to the absence of materials with a high-atomic-number. The probability of
the photo-effect at the used energies is therefore very low leading to high noise. The gold
images (Figure 4.24(c), (d), (g) and (h)) are very noisy. Figure 4.24(d) and (h) show the
gold images after applying the bilateral filter (section 3.1.1.2). The minimal concentration
of gold which is clearly visible in the simple voxel phantom is 0.2w%. For the metastases
with 0.1w% gold, a clear distinction between signal and noise is hardly possible. For 0.3,
0.4 and 0.7w% even the smallest metastases are clearly identifiable.
In the human voxel phantom with 0.3w% gold, all three metastases are clearly recognizable
in the non-optimized and optimized case, but the images show strong noise (Figure 4.25(c),
(d), (g) and (h)), which could be due to the small fractional contribution of gold compared
to the total attenuation leading to strong noise in the raw data set corresponding to gold.
Figure 4.25(d) and (h) show the gold images after applying the bilateral filter (section
3.1.1.2). The photoelectric effect images (Figure 4.25(b) and (f)) mainly show bones
having a higher atomic number than the soft tissue. The Compton and photoelectric
effect images are similar for both simulations. Gold is faintly visible in the Compton
images for these simulations as well.
The results of the K-edge decomposition algorithm for the human voxel phantom with
0.2w% gold are shown in Figure 4.26. Again the photoelectric images (Figure 4.26(b) and
(f)) mainly show bones and the Compton and photoelectric effect images are similar for
both simulations. For the 0.2w% gold, it is harder to distinguish between noise and signal
in the gold images (Figure 4.26(c), (d), (g) and (h)). Figure 4.26(d) and (h) show the
gold images after applying the bilateral filter, all three metastases are identifiable in the
non-optimized and optimized case.
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Non-optimized bin thresholds
(a) Compton Effect (b) Photo Effect (c) Gold (d) Gold after bilat-
eral filtering
Optimized bin thresholds
(e) Compton Effect (f) Photo Effect (g) Gold (h) Gold after bilat-
eral filtering
Figure 4.25: Images of the K-edge decomposition algorithm of the human voxel phantom
with 0.3w% gold (corresponding images are equally scaled and windowed).
The optimized gold images of all three simulations are now analyzed in more detail, the
results are summarized in Table 4.10 and 4.11. Images were filtered with the bilateral
filter algorithm first and were then evaluated with respect to the SNR, (effective) CNR
and the contrast.
All filtered images provide an effective CNR higher than 5, indicating that the ROIs
can be distinguished from the background. The differences between the non-optimized
and optimized bin thresholds are not significant, making it difficult to decide which bin-
thresholds should be preferred.
In comparison to the results of the photon-counting and energy-integrating detector (Table
4.1 and 4.2), the contrast is much higher. In the human voxel phantom with 0.3w% gold
the contrast is 19 times higher and 33 times higher for the 0.2w% gold. The SNR is 81 up
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to 97% smaller than for the photon-counting or energy-integrating detector. The CNRs
are clearly smaller for almost all K-edge decomposition gold images, with the exception of
0.1w% gold in the simple voxel phantom having a 4 times higher CNR and a more than
200 times higher contrast than for the photon-counting and energy-integrating detector.
However, the ROIs with 0.1% gold are barely recognizable in the image (Figure 4.24(c), (d),
(g) and (h)). The results of the K-edge decomposition algorithm also predict a minimal
gold concentration of 0.2w% gold.
Non-optimized bin thresholds
(a) Compton Effect (b) Photo Effect (c) Gold (d) Gold after bilat-
eral filtering
Optimized bin thresholds
(e) Compton Effect (f) Photo Effect (g) Gold (h) Gold after bilat-
eral filtering
Figure 4.26: Images of the K-edge decomposition algorithm of the human voxel phantom
with 0.2w% gold (corresponding images are equally scaled and windowed).
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Table 4.10: Performance results of the K-edge decomposition algorithm for the non-optimized and optimized gold images of the simple
voxel phantom.
non-optimized optimized
bin thresholds bin thresholds
SNR CNR CNReff C SNR CNR CNReff C
0.7w% gold
unfiltered 3.50±1.0 2.98±1.02 59.6±20.3 0.859±0.29 3.54±1.0 3.03±1.02 60.7±20.4 0.859±0.29
filtered 4.97±1.0 4.45±1.00 89.0±20.0 0.848±0.19 5.11±1.0 4.60±0.98 92.0±19.5 0.857±0.18
0.4w% gold
unfiltered 2.63±1.0 2.09±0.97 41.9±19.3 0.786±0.36 2.69±1.0 2.16±0.96 43.2±19.2 0.799±0.36
filtered 4.92±1.0 4.09±1.00 81.7±20.1 0.777±0.19 5.25±1.0 4.39±1.00 87.9±20.1 0.792±0.18
0.3w% gold
unfiltered 2.01±1.0 1.58±0.95 31.5±19.1 0.747±0.45 2.09±1.0 1.55±0.89 31.1±17.9 0.720±0.41
filtered 4.39±1.0 3.49±0.99 69.7±19.8 0.747±0.21 4.68±1.0 3.43±0.98 68.6±19.6 0.722±0.21
0.2w% gold
unfiltered 1.73±1.0 1.15±0.87 22.9±17.4 0.630±0.48 1.77±1.0 1.18±0.86 23.6±17.2 0.621±0.45
filtered 4.43±1.0 2.89±1.00 57.7±20.1 0.632±0.22 3.95±1.0 2.72±0.95 54.3±19.0 0.623±0.22
0.1w% gold
unfiltered 1.11±1.0 0.466±0.73 9.31±14.5 0.366±0.57 1.17±1.0 0.487±0.69 9.75±13.9 0.355±0.50
filtered 2.88±1.0 1.20±0.79 24.0±15.8 0.375±0.25 2.69±1.0 1.19±0.81 23.8±16.1 0.365±0.25
Table 4.11: Performance results of the K-edge decomposition algorithm for the non-optimized and optimized gold images of the human
voxel phantom.
non-optimized optimized
bin thresholds bin thresholds
SNR CNR CNReff C SNR CNR CNReff C
0.3w% gold
unfiltered 1.86±1.0 1.42±0.90 13.0±8.37 0.712±0.46 2.10±1.0 1.52±0.95 13.5±8.63 0.692±0.46
filtered 5.18±1.0 3.86±0.91 35.5±8.53 0.708±0.17 6.64±1.0 4.76±0.89 43.4±8.18 0.697±0.15
0.2w% gold
unfiltered 1.44±1.0 0.945±0.83 8.76±7.89 0.603±0.53 1.59±1.0 1.01±0.88 9.44±8.10 0.573±0.50
filtered 4.17±1.0 2.67±0.88 24.2±8.14 0.596±0.20 5.31±1.0 3.29±1.01 30.5±9.33 0.582±0.19
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The numerical values in the gold images of the K-edge decomposition algorithm contain
the weight fraction of gold multiplied by the total density (in units of mass per volume).
For the simulations the total density is known (Table 3.1) and the numerical values can be
corrected to obtain the weight fraction of gold, however in clinical practice the total density
is not known. The results are summarized in Table 4.12. The K-edge decomposition
algorithm underestimates the concentration of gold by an average of 36% for all ROIs
and both phantoms. The bilateral filter algorithm reduces noise (up to 73% and on
average 57%), however the predicted concentration of gold remains almost unchanged.
The underestimation could be due to the positive contribution of gold in the Compton
effect images.
Table 4.12: Implemented gold concentration and by the K-edge decomposition algorithm
calculated weight fraction of gold multiplied by the total density (uncorrected) and the
corrected weight fraction of gold.
uncorrected corrected
implemented unfiltered filtered unfiltered filtered
0.7w% gold 0.52±0.15 0.51±0.10 0.45±0.15 0.44±0.10
simple 0.4w% gold 0.28±0.10 0.27±0.05 0.26±0.10 0.25±0.05
voxel 0.3w% gold 0.20±0.10 0.20±0.04 0.19±0.10 0.19±0.04
phantom 0.2w% gold 0.14±0.08 0.14±0.03 0.13±0.08 0.13±0.03
0.1w% gold 0.068±0.06 0.069±0.03 0.065±0.06 0.066±0.03
human
voxel 0.3w% gold 0.21±0.11 0.20±0.03 0.20±0.11 0.19±0.03
phantom 0.2w% gold 0.15±0.10 0.14±0.03 0.11±0.10 0.13±0.03
The efficiency of the K-edge decomposition algorithm was already previously demonstrated
in Monte Carlo simulations and real measurements. One of the first K-edge imaging sim-
ulations (Radonis CT-simulation package, Philips Research Hamburg) was applied to a
artherosclerotic coronary vessel phantom. The used gadolinium concentrations in the
coronary artery were 31.76mg/ml (approximately 3.176w%) [97]. Feuerlein et al. [40] also
used a vessel phantom partly filled with a gadolinium-based contrast agent (0.05mol/L of
Magnevist; Bayer-Schering Pharma, Leverkusen, Germany) for their measurements at the
Philips Healthcare spectral CT. The spectral data and the K-edge imaging algorithm en-
abled the distinct detection of atherosclerotic plaques and the gadolinium-based contrast
agent in both cases.
The K-edge decomposition algorithm can be extended using it for more than one contrast
agent at the same time. The measurements and calculations done by Schlomka et al. [100]
provide good results for simultaneous imaging of gadolinium- (30, 60 and 120 ➭mol/ml,
approximately 0.47, 0.94 and 1.89w%) and iodine-based contrast agents (37.5, 75, and
150 ➭mol/ml, approximately 0.95, 1.91 and 3.81w%). The actual and the calculated con-
centrations were in good agreement. The simultaneous detection of gold and iodine in
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an artery phantom was analyzed by Cormode et al. [34]. They furthermore injected mice
with 500mg gold-HDL/kg26 body weight and performed the spectral CT measurements
(Philips Healthcare) 24h after injection. The K-edge decomposition algorithm clearly
identified the gold-HDL in plaques in the aorta, but the final gold concentration in these
plaques was not investigated. Therefore no conclusion can be drawn about the required
gold concentration which needs to accumulate in the target tissue.
Baturin et al. [15] applied the K-edge decomposition algorithm to two simulated phantoms.
A small phantom (diameter 3 cm) containing 1.4 to 3.4mg gold per cm3 (approximately
1.4 to 3.4w%) was used for calibration measurements. The calculated gold concentrations
corresponded well with the known concentrations and gold was identifiable in the decom-
posed images. The second phantom was a chest phantom (33×24 cm2) containing one
point of interest (diameter 2mm) with a water-based iodine-gold-calcium mixture. The
concentration of gold and iodine in the chest phantom was not specified. It is therefore
not possible to relate these calculations to this thesis.
According to the references discussed above, the K-edge decomposition algorithm pro-
vided promising results with respect to the detection of the high-Z contrast agent and
the calculated contrast agent concentrations. But the contrast agent concentrations were
rather high, or in some cases not specified. To my knowledge, the impact of contrast
agent concentration and the bin thresholds on the performance of the algorithm was not
investigated yet. The here presented results demonstrate the strong dependency of the
algorithm on the contrast agent concentration and the bin thresholds.
It should be mentioned that the decomposed raw data sets for the photoelectric effect and
the high-atomic-number material contained negative values. Further investigations were
performed and are outlined in the annex.
4.1.4.3 Least-squares parameter estimation
The least-squares parameter estimation is based on the least-squares fitting method. It is
assumed that the tissue in each pixel is a combination of three basis materials (here: liver,
hard bone mixture and gold). The mass attenuation values of these basis materials were
used to fit the values in each pixel. The density filter was then applied to the material
density images.
The results for all three phantoms are shown in Figure 4.27, 4.28 and 4.29. The least
square parameter estimation also provides better results, with respect to the detection of
gold, for the optimized bin thresholds than for the non-optimized bin thresholds. Espe-
cially in the liver images, and the gold images the density filter decreases the noise level
compared to the images without the density filter.
The liver image (Figure 4.27(c)) should mainly contain the information related to the liver
26HDL means high density lipoprotein, which is specific for macrophages. It was used to identify plaques
in the aorta containing numerous macrophages.
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(representative for soft tissue), but gold is still visible in that image. In the gold image
(Figure 4.27(d)) the metastases with 0.7w% down to 0.3w% gold are recognizable, but the
image has a high noise level. The metastases with 0.2w% gold can be hardly identified
due to the high noise level. In the images with the density filter (Figure 4.27(f) and (g))
all metastases with 0.7w%, 0.4w% and 0.3w% are clearly identifiable. For 0.2w% gold
only the smallest metastasis can not be distinguished from noise, the other metastases are
visible. The metastases with 0.1w% gold are not detectable.
The results of the least-squares parameter estimation for the human voxel phantom with
0.3w% gold are shown in Figure 4.28. The first images (Figure 4.28(a) and (d)) mainly
show the soft tissue (calculated with the energy dependent mass attenuation coefficients
of the liver). The second images (Figure 4.28(b) and (e)) are related to bone and the
third images are related to gold (Figure 4.28(c) and (f)). The optimized images show
less noise than the non-optimized images. In the optimized case the three metastases are
hard to identify due to the high noise level (Figure 4.28(f)), but in the non-optimized case
the metastases are not identifiable at all (Figure 4.28(c)). All three metastases can be
detected easily in the images with the density filter (Figure 4.28(j)).
The algorithm performs also better for the optimized bin thresholds than for the non-
optimized bin thresholds in the human voxel phantom with 0.2w% gold. The first two
images (related to soft tissue and bone) of the least-squares parameter estimation algo-
rithm (Figure 4.29) are similar for the human voxel phantom with 0.2w% and the 0.3w%
gold, since the properties of soft tissue and bones are the same for both simulations. In the
gold image (Figure 4.29(f)), the metastases are hardly identifiable. In the images with the
density filter the three metastases are still hard to distinguish from noise (Figure 4.29(j)).
The performance results for the least-squares parameter estimation are summarized in Ta-
ble 4.13 and 4.14. The bilateral filter improves the SNR, (effective) CNR and the contrast
for almost all cases, the exceptions are the contrast for the 0.3w% and the 0.2w% gold
in the simple voxel phantom. The SNR is on average 2.4 times higher with the bilateral
filter, but with the density filter only 1.5 times higher. The CNR is on average 2.4 times
higher with the bilateral filter and 1.7 times higher with the density filter. The SNR and
the CNR for all metastases is lower than for the K-edge decomposition. The effective CNR
for the ROI with 0.1w% gold is higher than 5 for all cases, but the standard deviation is
very high, the metastasis with 0.1w% gold can therefore not be clearly distinguished from
background. The contrast is very similar for both algorithms. The K-edge decomposition
provides a slightly higher contrast for the 0.2w% and the 0.1w% gold in the simple voxel
phantom and in the human voxel phantom for the unfiltered 0.3w% gold and the 0.2w%
gold. In the other cases the contrast is slightly higher for the least-squares parameter
estimation.
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Non-optimized bin thresholds without density filter
(a) Liver (b) Gold
Optimized bin thresholds without density filter
(c) Liver (d) Gold (e) Gold after bilateral
filtering
Optimized bin thresholds with density filter
(f) Liver (g) Gold
Figure 4.27: Least-squares parameter estimation of the simple voxel phantom (correspond-
ing images are equally scaled and windowed).
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Non-optimized bin thresholds without density filter
(a) Liver (b) Bone (c) Gold
Optimized bin thresholds without density filter
(d) Liver (e) Bone (f) Gold (g) Gold after bi-
lateral filtering
Optimized bin thresholds with density filter
(h) Liver (i) Bone (j) Gold
Figure 4.28: Least-squares parameter estimation of the human voxel phantom with 0.3w%
gold (corresponding images are equally scaled and windowed).
82 CHAPTER 4. RESULTS AND DISCUSSION
Non-optimized bin thresholds without density filter
(a) Liver (b) Bone (c) Gold
Optimized bin thresholds without density filter
(d) Liver (e) Bone (f) Gold (g) Gold after bi-
lateral filtering
Optimized bin thresholds with density filter
(h) Liver (i) Bone (j) Gold
Figure 4.29: Least-squares parameter estimation of the human voxel phantom with 0.2w%
gold (corresponding images are equally scaled and windowed).
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Table 4.13: Performance results of the least-squares parameter estimation for the opti-
mized gold images of the simple voxel phantom.
SNR CNR CNReff C
unfiltered
0.7w% gold 2.62±1.0 2.36±1.00 47.2±20.0 0.889±0.38
0.4w% gold 1.83±1.0 1.54±0.92 30.8±18.5 0.822±0.49
0.3w% gold 1.37±1.0 1.08±0.89 21.6±17.8 0.747±0.61
0.2w% gold 1.26±1.0 0.832±0.82 16.6±16.5 0.606±0.60
0.1w% gold 0.849±1.0 0.307±0.72 6.15±14.4 0.302±0.71
with bilateral filter
0.7w% gold 4.54±1.0 4.19±0.99 83.8±19.8 0.891±0.21
0.4w% gold 4.00±1.0 3.46±0.96 69.2±19.2 0.817±0.23
0.3w% gold 2.98±1.0 2.42±0.97 48.4±19.3 0.746±0.30
0.2w% gold 3.00±1.0 1.20±0.92 39.9±18.4 0.604±0.28
0.1w% gold 2.04±1.0 0.767±0.68 15.3±13.6 0.311±0.27
with density filter
0.7w% gold 3.65±1.0 3.32±0.99 66.4±19.9 0.924±0.28
0.4w% gold 2.76±1.0 2.42±0.94 48.4±18.8 0.890±0.35
0.3w% gold 1.92±1.0 1.57±0.91 31.4±18.3 0.819±0.48
0.2w% gold 1.90±1.0 1.39±0.87 27.8±17.4 0.730±0.46
0.1w% gold 1.05±1.0 0.523±0.72 10.5±14.5 0.456±0.63
Table 4.14: Performance results of the least-squares parameter estimation for the opti-
mized gold images of the human voxel phantom.
SNR CNR CNReff C
unfiltered
0.3w% gold 1.15±1.0 0.853±0.85 7.96±8.02 0.691±.069
0.2w% gold 0.878±1.0 0.524±0.82 4.99±7.71 0.519±0.82
with bilateral filter
0.3w% gold 3.54±1.0 2.62±0.95 24.4±8.95 0.709±0.26
0.2w% gold 2.68±1.0 1.67±0.96 15.8±9.05 0.557±0.32
with density filter
0.3w% gold 2.00±1.0 1.66±0.91 15.2±8.62 0.849±0.47
0.2w% gold 1.26±1.0 0.964±0.87 8.77±8.27 0.740±0.69
The numerical values in the gold images of the least-squares parameter estimation repre-
sent the concentration of gold in the tissue; the results are summarized in Table 4.15. The
algorithm underestimates the concentration of gold on average by 44% for all ROIs and
both phantoms. The bilateral filter leads to a higher noise reduction (on average 59%)
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than the density filter (on average 22%), but the density filter improves the estimated gold
concentration. Further investigations about the ability to estimate the gold concentration
are summarized in the annex. The calculated concentrations there only slightly underes-
timate the gold concentration. It was already outlined in Section 4.1.4.1 (Figure 4.23 and
Table 4.9), that the linear attenuation values in the reconstructed images differ from the
XCOM values. These differences could be the reason for the underestimation of the gold
concentrations.
Table 4.15: Implemented and by the least-squares parameter estimation calculated con-
centrations of gold in w%.
implemented unfiltered with bilateral filter with density filter
0.7w% gold 0.31±0.15 0.31±0.08 0.34±0.11
simple 0.4w% gold 0.18±0.11 0.17±0.05 0.20±0.08
voxel 0.3w% gold 0.14±0.11 0.13±0.05 0.15±0.09
phantom 0.2w% gold 0.12±0.10 0.11±0.04 0.14±0.07
0.1w% gold 0.056±0.07 0.056±0.03 0.059±0.06
human
voxel 0.3w% gold 0.15±0.14 0.13±0.04 0.18±0.11
phantom 0.2w% gold 0.095±0.12 0.088±0.04 0.11±0.10
To my knowledge the least-squares parameter estimation algorithm was hardly applied
to spectral CT till now. Least-squares parameter calculations of CT simulations of a
breast phantom provided good separation and quantification of hydroxyapatite, iodine,
glandular, and adipose tissues [68].
4.1.5 Conclusion
In this section the above presented results will be compared and summarized. For all
simulations the total number of views was equal to 1160 and the number of histories per
view was 109. A liver-spleen scan (scan-length approximately 18.4 cm, yielding 210 ro-
tations) with that number of photons would lead to an effective dose of 13.0mSv, which
is approximately the same as for a real liver-spleen scan. The presented images should
therefore be comparable to clinical CT images.
The obtained gold images of the eigenvector decomposition, the K-edge decomposition
and the least-squares parameter estimation can be filtered with the bilateral filter (section
3.1.1.2) to decrease the high noise level in the gold images (refereed to as K-edge+bifilt,
EV+bifilt and LSPE+bifilt). The reconstructed images of the individual bins have a rather
high noise level. It might therefore be beneficial to filter these images prior to further pro-
cessing. Again the bilateral filter is used to filter the reconstructed images of each bin.
The density images generated by the least-squares parameter estimation can be filtered
with the bilateral filter or the density filter (section 3.1.4.3), refereed to as LSPE+bifilt
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or LSPE+density.
The results of the thus processed images for the simple voxel phantom and the human
voxel phantom are shown in Figure 4.30, Figure 4.31 and Figure 4.32. Distinct differences
of the different algorithms and filters are demonstrated in the close-ups.
All unfiltered images of the simple voxel phantom have a high noise level, which decreased
after the application of the bilateral filter (Figure 4.30(b), (d), (f) and (i)). For the least-
squares parameter estimation the density filter provides better results than the bilateral
filter (Figure 4.30(f) and (g)). Filtering the reconstructed images prior to the least-squares
parameter estimation produces better results than without that filtering (Figure 4.30(h),
(i) and (j)). The biggest metastasis with 0.1w% gold is faintly visible in all subfigures. The
smaller metastases with 0.1w% gold are barely identifiable. The smallest metastases with
0.2w% gold can not be distinguished from noise in all close-ups. The remaining metastases
are detectable in all images.
For the human voxel phantom the different algorithms/filters give similar results (Fig-
ure 4.31 and 4.32) as for the simple voxel phantom. In the human voxel phantom with
0.3w% gold, all three metastases can be clearly identified in the filtered images (Figure
4.31(b), (d), (f), (g), (h), (i) and (j)). Even the smallest metastasis with a size of only
0.35×0.35 cm2, is clearly recognizable. Figure 4.31(j) has the lowest background noise.
The square shape of the metastases is well reproduced by all filtered images.
In the human voxel phantom with 0.2w% gold, the smallest metastasis is faintly visible in
all images, but it is hard to distinguish it from background noise. The other two metas-
tases are clearly identifiable especially in the filtered images (Figure 4.32(b), (d), (f), (g),
(h), (i) and (j)). The least-squares parameter estimation in combination with the bilat-
eral and density filter provides the lowest background noise and the square shape of the
metastases is reproduced best (Figure 4.32(j)).
The above presented results are evaluated with respect to the SNR, the (effective) CNR
and the contrast. For the simple voxel phantom only the biggest metastases for each gold
concentration were selected as ROIs. For the human voxel phantom the SNR, (effective)
CNR and the contrast was calculated for all three metastases individually and then the
mean was calculated. Results are summarized in Tables 4.16, 4.17 and Figure 4.33. The
gold images are very noisy, a higher number of simulated incident photons might overcome
this problem. However, as already described, the effective dose is in the same range as for
a real liver-spleen scan. The simulation results and the evaluation of the SNR, (effective)
CNR and the contrast should provide a reasonable approximation.
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(a) EV (b) EV+bifilt
(c) K-edge (d) K-edge+bifilt
(e) LSPE (f) LSPE+bifilt (g) LSPE+density
(h) bifilt+LSPE (i) bifilt+LSPE+bifilt (j) bifilt+LSPE+density
Figure 4.30: Close-ups of the optimized simple voxel phantom. In order to better illustrate
the differences in the algorithm results, the negative of the images is shown (all K-edge
and LSPE images are equally scaled). LSPE - least-squares parameter estimation, den-
sity - density filter, bifilt - bilateral filter, EV - eigenvector decomposition, + - indicates
successive application of the algorithm/filter
4.1. SPECTRAL CT IMAGING WITH GOLD 87
(a) EV (b) EV+bifilt
(c) K-edge (d) K-edge+bifilt
(e) LSPE (f) LSPE+bifilt (g) LSPE+density
(h) bifilt+LSPE (i) bifilt+LSPE+bifilt (j) bifilt+LSPE+density
Figure 4.31: Noise reduced close-ups of the optimized human voxel phantom with 0.3w%
gold. In order to better illustrate the differences in the algorithm results, the negative of the
images is shown (all K-edge and LSPE images are equally scaled). LSPE - least-squares
parameter estimation, density - density filter, bifilt - bilateral filter, EV - eigenvector
decomposition, + - indicates successive application of the algorithm/filter
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(a) EV (b) EV+bifilt
(c) K-edge (d) K-edge+bifilt
(e) LSPE (f) LSPE+bifilt (g) LSPE+density
(h) bifilt+LSPE (i) bifilt+LSPE+bifilt (j) bifilt+LSPE+density
Figure 4.32: Noise reduced close-ups of the optimized human voxel phantom with 0.2w%
gold. In order to better illustrate the differences in the algorithm results, the negative of the
images is shown (all K-edge and LSPE images are equally scaled). LSPE - least-squares
parameter estimation, density - density filter, bifilt - bilateral filter, EV - eigenvector
decomposition, + - indicates successive application of the algorithm/filter
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For the 0.4w%, 0.3w%, 0.2w% and the 0.1w% gold the SNR is markedly highest for the
eigenvector decomposition in combination with bilateral filtering (EV+bifilt), but the con-
trast is very low. In the simple voxel phantom the SNR for the unfiltered and filtered gold
image is markedly higher than for the other algorithms. Considering only the K-edge
decomposition and the least-squares parameter estimation, the highest SNR is attained
by the K-edge decomposition in combination with the bilateral filter (K-edge+bifilt). The
(effective) CNR and the contrast are also high. The least-squares parameter estimation in
combination with the bilateral and density filter (bifilt+LSPE+density/bifilt) reveal the
highest contrast and the SNR is only about 10% smaller than for the K-edge algorithm in
combination with the bilateral filter. For the calculation of the SNR, the background is
not taken into account. To be able to precisely identify the metastases a high contrast and
low noise is needed. Therefore the (effective) CNR and the contrast are of main interest to
us. The least-squares parameter estimation with all filter combinations provides a higher
contrast than the K-edge or the eigenvector decomposition. The highest contrast for all
metastases is attained with the least-squares parameter estimation in combination with
the bilateral and the density filter (bifilt+LSPE+density). The highest (effective) CNR
is obtained with the least-squares parameter estimation in combination with the bilateral
and the density filter (bifilt+LSPE+density) or the bilateral filter (bifilt+LSPE+bifilt).
As can be seen in Figure 4.30, the biggest metastases with 0.1w% gold is faintly visible in
all images. The effective CNR is higher than 5 for all cases, however, taking into account
the standard deviation of the effective CNR for the biggest metastasis with 0.1w% gold,
a clear distinction between background and ROI is only possible for the filtered eigen-
vector decomposition (EV+bifilt), the filtered K-edge decomposition (K-edge+bifilt) and
the least-squares parameter estimation in combination with the bilateral and the density
filter (bifilt+LSPE+bifilt, bifilt+LSPE+density). Comparing the biggest metastases with
0.2w% gold and with 0.1w% gold reveals a reduction of the (effective) CNR and the SNR
of approximately 50% and also the contrast decreases by more than 10%.
The results for the human voxel phantom (Table 4.17) are very similar to the ones for
the simple voxel phantom. The highest SNR is attained for the filtered gold image of the
eigenvector decomposition. The least-squares parameter estimation in combination with
the bilateral and the density filter (bifilt+LSPE+density) provide the highest (effective)
CNR and the highest contrast for the human voxel phantom with 0.3w% gold. For the
human voxel phantom with 0.2w% gold, the highest contrast and the second highest (ef-
fective) CNR is achieved with the least-squares parameter estimation in combination with
the bilateral and the density filter (bifilt+LSPE+density). The K-edge decomposition in
combination with the bilateral filter (K-edge+bifilt) provides the highest (effective) CNR,
but the contrast is almost 60% smaller than for the least-squares parameter estimation in
combination with the bilateral and the density filter (bifilt+LSPE+density).
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(a) SNR
(b) CNR
(c) contrast
Figure 4.33: Comparing the performance of the different algorithms.
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Table 4.16: Comparing the performance of the different algorithms for the simple voxel phantom.
simple voxel phantom
0.7w% gold 0.4w% gold
SNR CNR CNReff C SNR CNR CNReff C
EV 7.39±1.0 2.47±1.03 49.5±20.6 0.279±0.12 7.95±1.0 1.71±0.89 34.1±17.7 0.181±0.094
EV+bifilt 10.6±1.0 4.00±0.99 80.1±19.8 0.288±0.071 15.0±1.0 3.52±0.88 70.3±17.5 0.183±0.046
K-edge 3.54±1.0 3.03±1.02 60.7±20.4 0.859±0.29 2.69±1.0 2.16±0.96 43.2±19.2 0.799±0.36
K-edge+bifilt 5.11±1.0 4.60±0.98 92.0±19.5 0.857±0.18 5.25±1.0 4.39±1.00 87.9±20.1 0.792±0.18
LSPE 2.62±1.0 2.36±1.0 47.2±20.0 0.889±0.38 1.83±1.0 1.54±0.92 30.8±18.5 0.822±0.49
LSPE+bifilt 4.54±1.0 4.19±0.99 83.8±19.8 0.891±0.21 4.00±1.0 3.46±0.96 69.2±19.2 0.817±0.23
LSPE+density 3.65±1.0 3.32±0.99 66.4±19.9 0.924±0.28 2.76±1.0 2.42±0.94 48.4±18.8 0.890±0.35
bifilt+LSPE 4.44±1.0 4.34±0.99 83.8±19.8 0.977±0.22 3.55±1.0 3.45±0.97 69.2±19.2 0.975±0.27
bifilt+LSPE+bifilt 4.68±1.0 4.61±0.99 92.3±19.8 0.978±0.21 4.35±1.0 4.25±0.97 84.9±19.4 0.974±0.22
bifilt+LSPE+density 4.64±1.0 4.56±0.98 91.3±19.6 0.984±0.21 4.55±1.0 4.48±0.98 89.6±19.6 0.987±0.22
0.3w% gold 0.2w% gold
SNR CNR CNReff C SNR CNR CNReff C
EV 7.62±1.0 1.27±0.88 25.4±17.6 0.138±0.096 7.87±1.0 0.945±0.80 18.9±16.1 0.0930±0.079
EV+bifilt 14.8±1.0 2.70±0.99 54.1±19.9 0.144±0.053 16.1±1.0 1.96±0.96 39.1±19.1 0.0961±0.047
K-edge 2.09±1.0 1.55±0.89 31.1±17.9 0.720±0.41 1.77±1.0 1.18±0.86 23.6±17.2 0.621±0.45
K-edge+bifilt 4.68±1.0 3.43±0.98 68.6±19.6 0.722±0.21 3.95±1.0 2.72±0.95 54.3±19.0 0.623±0.22
LSPE 1.37±1.0 1.08±0.89 21.6±17.8 0.747±0.61 1.26±1.0 0.832±0.82 16.6±16.5 0.606±0.60
LSPE+bifilt 2.98±1.0 2.42±0.97 48.4±19.3 0.746±0.30 3.00±1.0 1.20±0.92 39.9±18.4 0.604±0.28
LSPE+density 1.92±1.0 1.57±0.91 31.4±18.3 0.819±0.48 1.90±1.0 1.39±0.87 27.8±17.4 0.730±0.46
bifilt+LSPE 2.78±1.0 2.68±0.98 48.4±19.3 0.962±0.35 2.57±1.0 2.19±0.94 39.9±18.4 0.847±0.37
bifilt+LSPE+bifilt 3.60±1.0 3.50±0.99 70.0±19.7 0.960±0.27 3.95±1.0 3.39±0.93 67.7±18.6 0.845±0.23
bifilt+LSPE+density 3.66±1.0 3.55±1.00 71.0±20.0 0.974±0.27 3.32±1.0 3.02±0.98 60.4±19.7 0.910±0.30
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0.1w% gold
SNR CNR CNReff C
EV 8.11±1.0 0.480±0.65 9.60±13.0 0.0469±0.064
EV+bifilt 18.9±1.0 1.07±0.72 21.3±14.3 0.0496±0.033
K-edge 1.17±1.0 0.487±0.69 9.75±13.9 0.355±0.50
K-edge+bifilt 2.69±1.0 1.19± 0.81 23.8±16.1 0.365±0.25
LSPE 0.849±1.0 0.307±0.72 6.15±14.4 0.302±0.71
LSPE+bifilt 2.04±1.0 0.767±0.68 15.3±13.6 0.311±0.27
LSPE+density 1.05±1.0 0.523±0.72 10.5±14.5 0.456±0.63
bifilt+LSPE 1.58±1.0 1.13±0.82 15.3±13.6 0.689±0.50
bifilt+LSPE+bifilt 2.07±1.0 1.54±0.90 30.8±17.9 0.686±0.40
bifilt+LSPE+density 1.85±1.0 1.53±0.87 30.6±17.4 0.804±0.46
Table 4.17: Comparing the performance of the different algorithms for the human voxel phantom.
human voxel human voxel
phantom, 0.3w% gold phantom, 0.2w% gold
SNR CNR CNReff C SNR CNR CNReff C
EV 7.19±1.0 1.17±0.78 10.6±6.97 0.151±0.10 6.94±1.0 0.765±0.68 7.05±6.21 0.102±0.090
EV+bifilt 14.0±1.0 2.82±0.82 24.7±7.47 0.183±0.056 14.9±1.0 1.90±0.78 16.7±6.96 0.115±0.049
K-edge 2.10±1.0 1.52±0.95 13.5±8.63 0.692±0.46 1.59±1.0 1.01±0.88 9.44±8.10 0.573±0.50
K-edge+bifilt 6.64±1.0 4.76±0.89 43.4±8.18 0.697±0.15 5.31±1.0 3.29±1.01 30.5±9.33 0.582±0.19
LSPE 1.15±1.0 0.853±0.85 7.96±8.02 0.691±0.69 0.878±1.0 0.524±0.82 4.99±7.71 0.519±0.82
LSPE+bifilt 3.54±1.0 2.62±0.95 24.4±8.95 0.709±0.26 2.68±1.0 1.67±0.96 15.8±9.05 0.557±0.32
LSPE+density 2.00±1.0 1.66±0.91 15.2±8.62 0.849±0.47 1.26±1.0 0.964±0.87 8.77±8.27 0.740±0.69
bifilt+LSPE 2.44±1.0 2.44±1.00 22.3±9.31 0.997±0.42 1.58±1.0 1.58±1.00 15.2±9.35 0.994±0.64
bifilt+LSPE+bifilt 3.56±1.0 3.55±1.00 32.7±9.37 0.995±0.29 2.39±1.0 2.37±1.01 22.5±9.42 0.988±0.43
bifilt+LSPE+density 5.57±1.0 5.56±1.00 55.7±9.36 0.998±0.21 2.89±1.0 2.89±1.00 28.6±9.36 0.998±0.38
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Table 4.18: Implemented and calculated concentrations of gold in w%. The values for
the eigenvector decomposition and the K-edge decomposition are corrected with the total
density.
simple voxel phantom
implemented 0.7w% 0.4w% 0.3w% 0.2w% 0.1w%
EV 0.43±0.16 0.25±0.12 0.19±0.11 0.13±0.10 0.064±0.09
EV+bifilt 0.42±0.11 0.25±0.06 0.18±0.06 0.13±0.05 0.064±0.04
K-edge 0.45±0.15 0.26±0.10 0.19±0.10 0.13±0.08 0.065±0.06
K-edge+bifilt 0.44±0.10 0.25±0.05 0.19±0.04 0.13±0.03 0.066±0.03
LSPE 0.31±0.15 0.18±0.11 0.14±0.11 0.12±0.10 0.056±0.07
LSPE+bifilt 0.31±0.08 0.17±0.05 0.13±0.05 0.11±0.04 0.056±0.03
LSPE+density 0.34±0.11 0.20±0.08 0.15±0.09 0.14±0.07 0.059±0.06
bifilt+LSPE 0.32±0.08 0.19±0.06 0.14±0.06 0.12±0.05 0.058±0.04
bifilt+LSPE+bifilt 0.31±0.08 0.18±0.05 0.14±0.04 0.12±0.03 0.057±0.03
bifilt+LSPE+density 0.33±0.08 0.19±0.05 0.15±0.04 0.13±0.04 0.059±0.03
human voxel phantom
implemented 0.3w% 0.2w%
EV 0.20±0.14 0.13±0.14
EV+bifilt 0.19±0.06 0.12±0.06
K-edge 0.20±0.11 0.11±0.10
K-edge+bifilt 0.19±0.03 0.13±0.03
LSPE 0.15±0.14 0.095±0.12
LSPE+bifilt 0.13±0.04 0.088±0.04
LSPE+density 0.18±0.11 0.11±0.10
bifilt+LSPE 0.13±0.06 0.078±0.05
bifilt+LSPE+bifilt 0.12±0.04 0.072±0.03
bifilt+LSPE+density 0.15±0.03 0.086±0.03
The numerical values in the gold images of the three different algorithms represent the
fractional weight of gold in the tissue. The values are summarized in Table 4.18. All
algorithms underestimate the concentration of gold for all ROIs and both phantoms. The
reason for the underestimation for the K-edge decomposition was already outlined in
4.1.4.2 (Equation 4.6 and 4.7). The reason for the underestimation of the gold concentra-
tion for the eigenvector decomposition and the least-squares parameter estimation could
be the differences between the linear attenuation values in the reconstructed images and
the XCOM values. The eigenvector decomposition and the K-edge decomposition provide
slightly better results than the least-squares parameter estimation. The eigenvector de-
composition and the least-squares parameter estimation are able to calculate the weight
fraction of gold without any prior information. For the K-edge decomposition algorithms
the values need to be corrected with the total density, which is generally not known. The
total density of soft tissue can be approximated by one, but when gold is in the tissue the
total density increases considerably. The error in the total density, which is introduced
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by neglecting the gold concentration, is illustrated in Table 4.19. The numerical values in
the gold images of the K-edge decomposition could be used to correct the total density.
Table 4.19: Error in the total density, when the gold concentration is neglected.
gold concentration ρtotal error
0w% 1.0 0%
0.1w% 1.0183 1.83%
0.2w% 1.0366 3.66%
0.3w% 1.0549 5.49%
0.4w% 1.0732 7.32%
0.7w% 1.1281 12.81%
The applied filter algorithms clearly reduce noise, only the density filter slightly improves
the estimated gold concentration, for the bilateral filter the predicted concentration of
gold remains almost unchanged.
In summary, the best results were achieved by the least-squares parameter estimation in
combination with the bilateral and the density filter (bifilt+LSPE+density).
The computing time and the required input and output of the different algorithms and the
filters is summarized in Table 4.20 and 4.21. The eigenvector decomposition is very fast
and could be used to get a first impression. The performance results of the K-edge decom-
position and the least-squares parameter estimation are very promising. All algorithms
provide the density of gold in the decomposed images. But the K-edge decomposition
has a very long computation time compared to the least-squares parameter estimation.
This fact and the high SNR, (effective) CNR and contrast, which were obtained with the
least-squares parameter estimation in combination with the bilateral and density filter,
make this algorithm with the two filters a very promising candidate for the material-
decomposition in spectral CT imaging.
Table 4.20: Comparison of the relative computing time of the different algorithms
Computing Computing
time time
EV 1 LSPE+density 102
K-edge 1129 bifilt+LSPE 100
K-edge+bifilt 1129 bifilt+LSPE+bifilt 101
LSPE 100 bifilt+LSPE+density 102
LSPE+bifilt 101
It was already outlined in section 3.1.1.3, that the effective CNR (and taking into account
the standard deviation) must be greater than 5 to be able to clearly distinguish the back-
ground and the metastases with gold. This Rose criterion is fulfilled by all algorithms (in
combination with different filter algorithms) if the gold concentration is at least 0.2w%.
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Several factors influence the detectability of gold, e.g. the size of the ROI, the applied
decomposition algorithm and the X-ray spectrum. It could furthermore be beneficial to
use statistical reconstruction algorithms [99].
Table 4.21: Comparison of the different algorithms
Specific
detection
of gold required input output
EV yes energy dependent mass six noise reduced images of the
attenuation coefficients original images and six basis
of gold, liver and bone images, providing information
about the covariance and
the gold concentration
K-edge yes energy dependent mass three images, corresponding
attenuation coefficients to the photoelectric effect,
of gold Compton scattering and the
gold concentration
LSPE yes energy dependent mass three images, corresponding to
attenuation coefficients gold, liver and bone, each image
of gold, liver and bone contains the density of the
corresponding material
bifilt / image noise reduced image
density / material density images and noise reduced material density
standard CT image and mass images
attenuation coefficients of
gold, liver and bone at the
mean energy of the used
X-ray spectrum
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4.2 Dose enhancement effect - Monte Carlo simulations
4.2.1 Simulation results
The dose enhancement simulations provide information about the secondary electron spec-
tra and about the deposited dose. The used voxel phantom imitated a cell culture flask
which can be used for irradiation cell experiments.
Figure 4.34 shows the energy distribution of secondary Compton, photo- and Auger elec-
trons for the 100 kV spectrum and 0.2w% gold in the tissue. The produced Compton
electrons have a low energy below 30 keV. The energy of the produced photo-electrons is
distributed over the whole spectrum. The energy of the Auger electrons shows no contin-
uous distribution.
Figure 4.34: Spectrum of secondary electrons for 100 kV and 0.2w% gold.
In Figure 4.35 the number of produced secondary electrons depending on the X-ray tube
voltage is plotted. The number of Compton electrons is almost the same for all spectra and
for the different concentrations of gold. With increasing X-ray tube voltage the number
of produced Compton electrons slightly decreases. The number of produced photo- and
Auger electrons decreases with increasing X-ray tube voltage, due to the lower interaction
probability. The higher the concentration of gold the more secondary photo- and Auger
electrons are generated.
Table 4.22 displays the percentage of the produced Compton, photo- and Auger electrons
for different gold concentration and different X-ray spectra. The percentage of Compton
electrons increases with increasing X-ray tube voltage, but decreases for increasing concen-
trations of gold. Photo- and Auger electrons show the opposite behavior. The percentage
of produced photo- and Auger electrons decreases with increasing X-ray tube voltage and
increases with increasing concentrations of gold. Only for the 60 kV spectrum the per-
centage of photo-electrons for 0.1 up to 0.3w% gold is smaller than in the metastasis. The
reason for this is the high number of Auger electrons.
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Figure 4.36 shows the number of produced Auger electrons as a function of energy for
different X-ray spectra and 0.1w% gold. First of all, the distribution of Auger electrons
is not continuous. It can be seen that most of the produced Auger electrons have a low
energy and therefore a short penetration range.
Dose increases almost linearly with the gold concentration (Figure 4.37). The highest dose
in tissue is produced by the 60 kV spectrum. As the energy of the spectrum increases, the
dose in tissue decreases. This effect is due to the higher interaction probability at lower
energies, leading to a higher number of secondary electrons. The dose in the liver is higher
than for the metastasis due to the higher density of liver tissue (Figure 4.37).
The dose enhancement factor was calculated according to Eq. 3.40 and is shown in Fig-
ure 4.38. The dose enhancement factor is almost independent of the used spectra. The
concentration of gold is the main factor influencing the dose enhancement. The maximum
dose enhancement factor is 1.95 at 80 kV for 0.1w% gold, 2.89 at 80 kV for 0.2w% gold,
3.84 at 80 kV for 0.3w% gold and 4.98 at 60 kV for 0.4w% gold.
Figure 4.35: Number of secondary Compton, photo- and Auger electrons for different
spectra and different concentrations of gold.
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Table 4.22: Comparison of the number of produced secondary electrons for different con-
centrations of gold and different X-ray spectra. The number of secondary electrons in the
metastasis was set to 100%.
gold concentration 60 kV 80 kV 100 kV 120 kV 140 kV
Compton electrons
Metastasis 59.4% 66.8% 72.2% 75.1% 77.5%
0.1w% 57.0% 58.4% 64.1% 67.2% 69.7%
0.2w% 48.7% 52.0% 57.6% 60.9% 63.5%
0.3w% 43.0% 46.7% 52.5% 55.6% 58.2%
0.4w% 35.7% 42.6% 47.9% 51.1% 53.7%
photo-electrons
Metastasis 36.0% 29.4% 24.6% 22.0% 19.8%
0.1w% 31.6% 30.3% 25.9% 23.5% 21.5%
0.2w% 32.7% 31.0% 27.0% 24.7% 22.8%
0.3w% 33.0% 31.6% 27.9% 25.7% 23.9%
0.4w% 36.2% 32.0% 28.6% 26.6% 24.9%
Auger electrons
Metastasis 4.6% 3.8% 3.2% 2.9% 2.7%
0.1w% 11.4% 11.3% 10.0% 9.3% 8.8%
0.2w% 18.6% 17.0% 15.4% 14.4% 13.7%
0.3w% 24.0% 21.7% 19.8% 18.7% 17.9%
0.4w% 28.1% 25.4% 23.5% 22.3% 21.4%
Figure 4.36: Number of Auger electrons for different X-ray spectra and 0.1w% gold.
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Figure 4.37: Calculated dose in different tissues and for different spectra.
Figure 4.38: Dose enhancement factor for different X-ray spectra and different concentra-
tions of gold.
4.2.2 Conclusion
The simulations indicate that the dose enhancement factor depends mainly on the concen-
tration of gold. The X-ray tube voltage has a minor influence. Low X-ray tube voltages
seem to lead to a higher dose enhancement effect. As shown in Figure 4.35, the total
number of Compton electrons is much higher than the produced photo- and Auger elec-
trons and is almost the same for all simulations. But the percentage of Compton electrons
(Table 4.22) decreases with increasing gold concentration. On the contrary, the percentage
of photo- and Auger electrons increases with increasing gold concentration, leading to the
conclusion that photo- and Auger electrons induce the dose enhancement effect.
Owing to the fact that most Auger electrons have a very low energy (Figure 4.36), i.e. a
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short penetration range, they can get absorbed within the gold-nanoparticles. Lechtman
et al. [69] obtained a non-linear correlation between the dose enhancement factor and the
gold-nanoparticle radius-cubed, by cause of the self-absorption of Auger electrons. This
self-absorption cannot be analyzed with the presented simulations, as a homogeneous dis-
tribution of gold was simulated instead of individual gold-nanoparticles. In consequence,
the EGSnrc simulations might overestimate the dose enhancement factor.
In the imaging section, the minimum concentration of gold required to provide sufficient
contrast in spectral CT imaging, is predicted to be 0.2w% for the used 120 kV X-ray
spectrum. The dose enhancement simulations for this X-ray spectrum yield a dose en-
hancement factor of 2.77 for 0.2w% gold. This dose enhancement effect should not be
neglected when using gold-nanoparticles for medical X-ray imaging. Gold-nanoparticles
should be functionalized to ensure specific targeting of metastases or other tissues.
The different dose enhancement factors from the literature (Table 2.1) and the here calcu-
lated dose enhancement factors are rather difficult to compare, due to the different spectra
and the different gold concentrations. The dose enhancement factors by Cho et al. [30]
(DEF=2.114 up to 5.601), McMahon et al. [77] (DEF=1.7), Martinez-Rovira et al. [75]
(DEF=1.304 up to 1.597) and Lechtman et al. [69] are smaller than the values predicted
here. The obtained dose enhancement factor with the novel multicompartment phantom
radiochromic radiation dosimeter by Alqathami et al. [5] was 1.77 for a 100 kV spectrum.
This result is close to the here presented simulations.
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4.3 Internalization of gold-nanoparticles into cells - biolog-
ical experiments
In the first part of the thesis the concentration of gold required for medical CT imaging
was estimated with Monte-Carlo simulations. In the following part biological experiments
will be performed to determine the actual concentration of gold which can be specifically
conjugated to cells. For the specific targeting of cancer cells the monoclonal antibody
cmHsp70.1 was used. This antibody binds to Hsp70, which is only present on the cell
membrane of tumor cells.
The main aim of the cell culture experiments was to determine the amount of gold which
is internalized by the cells or attached to the cell membrane. On the basis of these
results, the question, whether the amount of gold-nanoparticles is sufficient for spectral CT
imaging, can be addressed. To be able to specifically target malignant tissues, the tumor
specific monoclonal antibody cmHsp70.1 was conjugated to gold-nanoparticles, referred to
as gold-cmHsp70.1; as a reference, gold-nanoparticles were coated with BSA, referred to
as gold-BSA.
4.3.1 Optimization of antibody concentration for gold-antibody conju-
gation
To determine the required cmHsp70.1 concentration to stabilize the gold-nanoparticles (15
and 50 nm) a titration series was performed. If the cmHsp70.1 concentration is too low,
the gold-solution turns blue, otherwise no color change is visible. The first tube for which
no color change is visible, determines the minimum required cmHsp70.1 concentration to
stabilize the gold-nanoparticles.
Figure 4.39: Titration series for the gold-nanoparticles with a diameter of 50 nm: The
numbers above the tube designate the antibody concentration in ➭g/ml.
For the tube with 7 ➭g/ml antibody, no color change in the solution is visible; the required
minimum concentration of cmHsp70.1 is therefore 7 ➭g/ml (Figure 4.39). For the conju-
gation of the 50 nm gold-nanoparticles and the antibody, the antibody concentration was
scaled up to 8 ➭g/ml in order to ensure a sufficient antibody concentration.
For the 15 nm gold-nanoparticles, the minimum concentration of cmHsp70.1 is 8 ➭g/ml.
The conjugation is done with a concentration of 9 ➭g/ml.
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4.3.2 Conjugation of gold-nanoparticles and antibody
To verify the conjugation of the cmHsp70.1 antibody and the gold-nanoparticles, a dot blot
with the 50 nm gold-nanoparticles was performed. After the conjugation of cmHsp70.1 and
gold-nanoparticles, different BSA amounts (final concentrations in the solution: 0.25%,
0.5%, 1%) were added. In this way, remaining free surface areas on the gold-nanoparticles
were covered with BSA.
(a) Hsp70 with
gold-cmHsp70.1
and 0.25%BSA
(b) Hsp70 with
gold-cmHsp70.1
and 0.5%BSA
(c) Hsp70 with
gold-cmHsp70.1
and 1%BSA
(d) Hsc70 with
gold-cmHsp70.1
and 0.25%BSA
(e) Hsc70 with
gold-cmHsp70.1
and 0.5%BSA
(f) Hsc70 with
gold-cmHsp70.1
and 1%BSA
Figure 4.40: Dot blot with 50 nm gold-nanoparticles and the cmHsp70.1 antibody.
The red spots in Figure 4.40 are due to the red color of the gold-nanoparticles. As
shown in Figure 4.40(a), (b) and (c) the gold-cmHsp70.1 bound to the Hsp70 protein on
the membrane, but not to the similar Hsc70 protein (Figure 4.40(d), (e) and (f)). The
different amounts of BSA do not seem to have a big impact on the conjugation. For the
following experiments, 1% BSA was used. The results of this dot blot indicate that the
gold-nanoparticles were successfully conjugated to the cmHsp70.1 antibody.
4.3.3 Verification of gold-antibody conjugation with UV-visible spec-
troscopy
UV-visible spectroscopic measurements were performed to verify the conjugation of gold-
nanoparticles (50 nm) and antibody, respectively BSA. To do this the wavelength and
intensity of the absorption of UV-visible radiation was measured for the gold-solution,
gold-BSA and gold-cmHsp70.1. The differences in wavelength and intensity between the
three substances indicate the presence of different proteins on the surface of the gold-
nanoparticles [83].
The results are shown in Figure 4.41. UV-visible spectra of the gold-solution showed
peak absorbance at 530 nm. The peak absorbance for gold-BSA was at 533 nm and for
gold-cmHsp70.1 at 534 nm, indicating the presence of proteins on the surface of the gold-
nanoparticles. The maxima were also calculated with a forth order polynomial fit, which
revealed a peak absorbance at 530.12 nm for the gold-solution, 533.12 nm for gold-BSA
and 533.94 nm for gold-cmHsp70.1. The gold-cmHsp70.1 spectra was slightly shifted to
the right compared with gold-BSA. This slight shift of the absorbance spectra indicates
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the presence of different proteins on gold-BSA and gold-cmHsp70.1. These results and the
results of the dot blot lead to the conclusion, that the cmHsp70.1 antibody was success-
fully conjugated to the gold-nanoparticles.
Figure 4.41: UV-visible spectra of gold-solution (blue line), gold-BSA (red line) and gold-
cmHsp70.1 (green line). The gold-nanoparticles had a diameter of 50 nm.
4.3.4 Determination of the amount of gold per cell with ICP-OES
The amount of gold (15 and 50 nm) internalized into the cell or attached to the cell
membrane was measured with inductively coupled plasma optical emission spectrometry
(ICP-OES). In order to ensure the ICP-OES measurements the gold-solution (without any
cells) was measured first. The obtained measurements of the gold-solution were in good
agreement with the gold amount named by BBI Solutions [1]. The internalized amount of
gold-cmHsp70.1 and gold-BSA is summarized in Table 4.23 and Figure 4.42. The 15 and
50 nm gold-BSA show a higher uptake at all time points than the gold-cmHsp70.1. The
antibody does therefore not lead to a higher amount of the gold-nanoparticles per cell.
The reason for that is not obvious, the number of binding sites at the cell membrane for
BSA might be higher than those for cmHsp70.1. Smaller gold-nanoparticles conjugated
to cmHsp70.1 improve the uptake of gold-nanoparticles. Incubating the cells with gold-
cmHsp70.1, respectively gold-BSA for 12 hours yields the highest uptake. The underlying
cause for the low number of gold-nanoparticles per cell in the samples is uncertain. The
experiments were repeated but the results were similar.
As already mentioned in section 3.3.2, the conjugation of antibodies and gold-nanoparticles
is based on electrostatic interactions. As Kumar et al. [67] pointed out this method has sev-
eral drawbacks. First of all, the conjugated antibodies have a random orientation, but the
correct orientation is essential for appropriate targeting. Secondly, due to the noncovalent
binding of the antibodies to the gold-nanoparticles other biological molecules can replace
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the conjugated antibodies. Furthermore, a rather high concentration of antibodies is re-
quired. One important issue influencing the interaction between gold-nanoparticles and
the cells is the protein layer around the gold-nanoparticles. Uncoated gold-nanoparticles
interact with serum proteins27 leading to an adhesion of serum proteins (i.e. a variety
of different proteins) to the nanoparticle surface. Gold-nanoparticles coated with serum
proteins can bind to a number of different receptors, whereas gold-nanoparticles coated
with one specific protein can only bind to the corresponding receptor (i.e. limited number
of protein specific receptors) [28]. These factors might explain the low amounts of gold in
each cell.
Table 4.23: Cellular uptake of gold-BSA and gold-cmHsp70.1, after 6, 12 and 24h of
incubation (in gold-nanoparticles per cell).
incubation time 6h 12h 24h
gold-nanoparticles 50 nm
gold-cmHsp70.1 48±4.8 66±6.5 61±0.6
gold-BSA 66±19.4 90±7.4 65±8.1
gold-nanoparticles 15 nm
gold-cmHsp70.1 4.4×103±670 7.7×103±690 29×103±7940
gold-BSA 5.3×103±280 21×103±2300 70×103±5840
(a) Cellular uptake of 50 nm gold-nanoparticles (b) Cellular uptake of 15 nm gold-nanoparticles
Figure 4.42: Cellular uptake of gold-BSA and gold-cmHsp70.1, after 6, 12 and 24h of
incubation.
Experiments done by several groups have observed a much higher uptake of gold-nano-
particles per cell (Table 4.24). The cellular uptake of uncoated gold-nanoparticles (i.e.
27Serum proteins are albumin, α1-globuline, α2-globuline, β-globuline and γ-globuline.
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nanoparticles get coated with serum protein after being added to the cell culture medi-
um/into blood) was higher than the uptake of gold-nanoparticles coated with other pro-
teins (e.g. antibodies, bovine serum albumin, epidermal growth factor).
Table 4.24: Summary of ICP-OES gold amount measurements in the literature.
uptake
Nanoparticle characterization Cell type [NP/cell]
1. 14 nm, uncoated [26] Hela 3000
2. 50 nm, uncoated [26] Hela 6160
3. 74 nm, uncoated [26] Hela 2988
4. 50 nm, uncoated [27] MCF-7 ≈750028
5. 50 nm, coated with BSA [27] MCF-7 ≈410028
6. 50 nm, uncoated [27] MDA-MB-468 ≈275028
7. 50 nm, coated with BSA [27] MDA-MB-468 ≈170028
8. 30 nm, conjugated to anti-EGFR A431 39000
antibody [93]
9. 15 nm, PEGylated and conjugated BT474 430000
to trastuzumab [50]
10. 30 nm, PEGylated [70] PC-3 22700
4.3.5 Investigation of the spatial distribution of gold-nanoparticles in
the cell with TEM
The purpose of the transmission electron microscopy (TEM) investigations was to deter-
mine the location of the gold-nanoparticles (50 nm) in the cell and to get a direct optical
verification of the gold-nanoparticle uptake. For the preparation of the TEM samples the
cells were incubated with gold-cmHsp70.1, respectively gold-BSA. The cells were then de-
tached from the cell culture vessel and were centrifuged. The obtained cell pellets were red
(Figure 4.43). This result already indicates that gold-BSA, respectively gold-cmHsp70.1
were internalized into the cell or at least attached to the cell membrane.
Figure 4.43: Cell pellets of 4T1 cells without gold (left) and after incubation with 50 nm
gold-cmHsp70.1 (right).
28Data was read off Table Supplement Figure S4 and Supplement Figure S6 [27].
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The further preparation steps of the cell pellets for the TEM analysis were performed by
the Institute of Pathology at the Helmholtz Zentrum Munich (Prof. Dr. A. Walch and
Dr. M. Aichler). The resulting TEM images are shown in Figure 4.44. The images show
only part of the cell, approximately 2.9× 2.9 ➭m. The uptake and localization of gold-
cmHsp70.1 (second row) and gold-BSA (first row) is compared for different incubation
times. In the three gold-BSA TEM images only a few gold-nanoparticles are visible (yellow
arrows in Figure 4.44(a), (b) and (c)). The gold-nanoparticles from the gold-cmHsp70.1
could not be detected at all (Figure 4.44(d), (e) and (f)).
Ultra-thin slices of the cells with a thickness of approximately 60 nm are needed for the
TEM examinations. Assuming a cell diameter of 13 ➭m, the volume of the ultra-thin
slice is then only about 0.7% of the total cell volume and in Figure 4.44 only 0.04% of
the total cell volume is shown. Due to the small number of nanoparticles per cell (as
calculated with the ICP-OES measurements) the probability to detect gold-nanoparticles
in the ultra-thin slices is very low, e.g. for the maximum of 90 nanoparticles per cell,
only 0.63 nanoparticles per ultra-thin slice or 0.039 nanoparticles in each subfigure are
expected. Furthermore the complex sample preparation for the TEM could furthermore
lead to a washout of the gold-nanoparticles.
(a) Gold-BSA, incubation time:
2h
(b) Gold-BSA, incubation time:
4h
(c) Gold-BSA, incubation time:
6h
(d) Gold-cmHsp70.1, incuba-
tion time: 2h
(e) Gold-cmHsp70.1, incuba-
tion time: 4h
(f) Gold-cmHsp70.1, incuba-
tion time: 6h
Figure 4.44: TEM images of 4T1 cells after the incubation with 50 nm gold-cmHsp70.1 or
50 nm gold-BSA (Magnification 10000×, length of the scale bar: 500 nm).
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4.3.6 Conclusion
Summarizing the results of the biological experiments yields the following outcome. A
titration series with different antibody concentrations has shown that the addition of
cmHsp70.1 to the gold solution stabilizes the gold-nanoparticles by replacing the cit-
rate layer around the gold-nanoparticles. The conjugation of cmHsp70.1 was then ver-
ified with a dot blot using gold-nanoparticles, which are conjugated to the primary anti-
body cmHsp70.1. Furthermore the differences in the UV-visible spectra of gold-solution,
gold-cmHsp70.1 and gold-BSA indicate that the conjugation of gold-nanoparticles and
cmHsp70.1 respectively BSA was successful. Last but not least, the ICP-OES measure-
ments showing differences in the cellular uptake of gold-cmHsp70.1 and gold-BSA lead
to the conclusion that gold-nanoparticles were successfully conjugated to the cmHsp70.1
antibody.
Table 4.25: Estimated amount of gold per cell based on gold uptake experiments from
literature and own experiments.
cell diameter
d=26 ➭m d=13 ➭m
calculated fractional fractional
Nanoparticle characterization mass of gold weight of weight of
and Reference per cell [pg] gold [w%] gold [w%]
references
1 14 nm, stabilized by citric acid [26] 0.0832 0.0009 0.0074
2 50 nm, stabilized by citric acid [26] 7.7812 0.0805 0.6636
3 74 nm, stabilized by citric acid [26] 12.239 0.1265 1.0428
4 50 nm, uncoated [27] 9.4739 0.0980 0.8078
5 50 nm, coated with BSA [27] 5.1790 0.0536 0.4418
6 50 nm, uncoated [27] 3.4738 0.0359 0.2959
7 50 nm, coated with BSA [27] 2.1474 0.0222 0.1830
8 30 nm, conjugated to anti-EGFR 10.064 0.1041 0.8581
antibody [93]
9 15 nm, PEGylated and conjugated 14.666 0.1517 1.2505
to trastuzumab [50]
10 30 nm, PEGylated [70] 6.1936 0.0641 0.5284
own results
11 50 nm, gold-BSA 0.1137 0.0012 0.0099
12 50 nm, gold-cmHsp70.1 0.0834 0.0009 0.0074
13 15 nm, gold-BSA 2.3917 0.0240 0.2039
14 15 nm, gold-cmHsp70.1 1.0000 0.0103 0.0853
To address the question whether the concentration of gold-nanoparticles inside the cell
or attached to the cell membrane is sufficient for spectral CT imaging, the density of
the cell was assumed to be 1.02 g/cm3. The cell diameter ranges a lot for different cell
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types. For the used 4T1 cells the cell diameter was approximated by 13 ➭m (Figure 3.7).
For a second alternative evaluation, a cell diameter of 26 ➭m, as proposed by Lechtman et
al. [70], was assumed. Based on the assumption that the cell is a sphere, calculating the cell
volume and mass gives 1150 ➭m3 and 1.1734 ng and 9480 ➭m3 and 9.6696 ng, respectively.
With this estimated cell masses, the density of gold (ρgold =19.3 g/cm
3), the mass of
each nanoparticle (mnanoparticle = 4/3πr
3ρgold) and the number of nanoparticles per cell
(Table 4.24 and 4.23) the fractional weight of gold per cell was calculated (Table 4.25).
The required concentration of gold obtained by the simulations (0.2w% gold) cannot be
attained for the cell diameter of 26 ➭m. Only for the 15 nm PEGylated gold-nanoparticles,
which were conjugated to trastuzumab (Table 4.25 (9.)), the concentration was close to
the required concentration of 0.2w%. For a cell diameter of 13 ➭m almost all measurements
in Table 4.25 would be sufficient for spectral-CT imaging. However, the results obtained
within this thesis (Table 4.25 (11.)-(14.)) yield very small amounts of gold. Only the
15 nm gold-BSA amount (assumed cell diameter 13 ➭m) would be sufficient for spectral-
CT imaging as estimated by simulations in Section 4.1.
The ICP-OES measurements seem to be reliable as the measured amount of the gold-
solution corresponds well with the named amount. The unsatisfactory results of the TEM
images are a result of the small number of nanoparticles per cell. Further research is
required to optimize the conjugation of the antibodies to the gold-nanoparticles.
Chapter 5
Conclusion and Summary
Computed tomography (CT) is an important X-ray-based diagnostic tool in medical imag-
ing, especially for cancer diagnosis and therapy monitoring. A drawback of CT imaging,
however, is the lack of targeted and molecularly specific CT contrast agents. Newly de-
veloped spectral CT devices with an energy-selective and photon-counting detector can
be expected to substantially increase the sensitivity and the specificity of contrast agent
detection. High-atomic-number materials such as gold-nanoparticles are promising new
contrast agents for these systems, which can be detected by exploiting the material-specific
K-edge absorption properties. A restricting factor for the application of gold-nanoparticles
as spectral CT contrast agents in humans is the required in-vivo concentration of gold.
The potential improvement of medical tumor imaging by combining spectral CT and the
properties of gold-nanoparticles was the background and motivation of this thesis. The
major part of this work reports the design and analysis of Monte-Carlo simulations of med-
ical spectral CT imaging with gold as a contrast agent; the purpose of these simulations
were to demonstrate the general feasibility of gold-enhanced spectral CT, to optimize and
evaluate acquisition and post-processing strategies, and to estimate the minimum in-vivo
concentration of gold required for sufficient image contrast in spectral CT. Furthermore the
dose enhancement effect of gold was examined, to estimate potential side effects. For both
tasks Monte Carlo simulations were performed with the software tool EGSnrc, which mod-
els the transition of photons and electrons through matter. Finally, biological experiments
were performed in which gold-nanoparticles were functionalized with a tumor-specific an-
tibody for nanoparticle-based targeted tumor imaging.
To compare and optimize spectral CT acquisition and post-processing strategies as well as
to estimate the minimal tissue concentration of gold-nanoparticles required for gold-specific
spectral CT, Monte Carlo simulations were performed in two voxel phantoms. The first
phantom was a simple cylindrical voxel phantom consisting of simulated liver parenchyma
and five sets of four metastases. The metastases had sizes between 0.35×0.35 cm2 and
1.4×1.4 cm2. For each set of four metastases, different concentrations of gold (0.7w%,
0.4w%, 0.3w%, 0.2w% and 0.1w%) were added to the metastases. The second phantom
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was an anatomic human voxel phantom, where three liver metastases with gold concen-
trations of 0.3w% and 0.2w% were implemented. Spectral CT was simulated with a
120 kV X-ray source and an ideal energy-selective and photon-counting detector. The
energy-resolved projection data was binned to six energy bins with thresholds optimized
with respect to the attenuation properties of gold and biological tissue. The generated
spectral data sets were then processed with different material-decomposition algorithms:
K-edge decomposition (applied to the raw data sets), eigenvector decomposition, and a
least-squares parameter estimation. Furthermore two filters were applied to reduce noise
in the images: a bilateral filter and a density filter. The calculated decomposed images
were evaluated with respect to the signal-to-noise ratio (SNR), the contrast-to-noise ratio
(CNR), and the contrast of the metastases.
To distinguish gold from background and to precisely identify the metastases, a high con-
trast and low noise is needed characterized by the image-quality parameters CNR and
contrast. The eigenvector decomposition provided a high SNR in the gold images, but
the CNR and the contrast were comparably low. The K-edge decomposition and the least
squares parameter estimation provided very good results, which could be further improved
by the additional application of the bilateral filter and the density filter. The K-edge
decomposition yielded higher SNR, but lower CNR and contrast than the least-squares
parameter estimation. The least-squares parameter estimation in combination with the
bilateral and density filter revealed the highest CNR and contrast, while the SNR was
only about 10% smaller than for the K-edge algorithm in combination with the bilateral
filter. The computing time for the K-edge decomposition was by a factor of approxi-
mately 11 longer than for the least-squares parameter estimation, which, summarizing the
results described above, appeared to be the most recommandable post-processing algo-
rithm for gold-specific spectral CT. In the simple voxel phantom, the biggest metastasis
(1.4×1.4 cm2) with 0.1w% gold was weakly detected by all three algorithms, while the
smaller metastases with 0.1w% gold were not or hardly visible. All three algorithms al-
lowed the specific identification of gold, i.e. a clear distinction between gold and bone, in
all three metastases with 0.3w% gold in the human voxel phantom. The smallest metasta-
sis (0.35×0.35 cm2) in the human voxel phantom with 0.2w% was only faintly visible in the
decomposed images, and it was hard to distinguish between noise and the metastasis. The
numerical values in the gold images of the three different algorithms represent the frac-
tional weight of gold in the tissue. All algorithms underestimate the absolute concentration
of gold (up to 56%) in all metastases and both phantoms. The eigenvector decomposition
and the K-edge decomposition provide slightly better results than the least-squares pa-
rameter estimation. Summarized, the accomplished results indicate a lower limit of 0.2w%
on the required gold enrichment in malignant tissue for the specific identification of gold
in spectral CT imaging.
The dose enhancement effect in the vicinity of gold-nanoparticles is a consequence of the
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higher mass attenuation coefficient of gold compared to biological tissues. This effect leads
to an increased absorption followed by secondary electron production when the incoming
photons interact with gold-nanoparticles. On the one hand, it should be carefully con-
sidered as undesirable side effect of gold-based contrast agents; on the other hand, the
dose enhancement effect might also be of interest for the application of gold-nanoparticles
in radiotherapy. The dose enhancement was simulated with EGSnrc, which provided in-
formation about the secondary Compton, photo-electric and Auger electron spectra and
about the deposited dose. The simulations revealed a significant dose enhancement effect
in the considered energy range, which mainly depends on the gold concentration and al-
most not on the used X-ray tube voltage. For the concentration of 0.2w% gold in tissue,
a dose enhancement of 2.77 (ratio of absorbed dose with and without gold) was found.
Thus, for a safe application of gold-nanoparticles in medical imaging, a specific localized
targeting of gold-nanoparticles should be ensured to protect healthy tissue against this
additional dose.
One beneficial characteristic of gold-nanoparticles is the possibility to easily couple them
with biological targeting molecules, which enables targeted nanoparticle-based tumor
imaging. Whether the required gold concentration found above can be specifically targeted
to malignant tissue was investigated with cell culture experiments. The tumor specific
monoclonal antibody cmHsp70.1 was conjugated to gold-nanoparticles (gold-cmHsp70.1)
with a diameter of 50 nm and 15 nm. As a reference gold-nanoparticles were coated only
with (non-targeting) BSA (gold-BSA). Spectroscopy with wavelengths of the ultraviolet
and visible spectrum as well as inductively coupled plasma optical emission spectrom-
etry (ICP-OES) measurements indicated that the conjugation of cmHsp70.1 and gold-
nanoparticles was successful. The gold amount per cell was measured with ICP-OES.
Unfortunately only the unspecific 15 nm gold-BSA showed a sufficient accumulation in
the cells with the required concentration of about 0.2w%. Specific targeting of tumor cells
with gold-cmHsp70.1 did not lead to a sufficiently high accumulation of gold-nanoparticles.
Thus, a further optimization of the conjugation process of gold-nanoparticles and antibody
is required to obtain a considerably higher cellular accumulation of gold.
In conclusion, gold-nanoparticles are promising candidates for medical spectral CT imag-
ing. The Monte Carlo simulations performed for this thesis provide performance compar-
isons of different material-decomposition algorithms and, in particular, an estimation of
the minimum concentration of gold in tissue (0.2w%) required for gold-specific spectral
CT in humans. Cell culture experiments performed for this thesis indicate that a concen-
tration of 0.2w% gold in tissue might be realistically obtained with an optimized antibody
conjugation procedure. Thus, it remains to be examined whether and how the required
gold concentration in malignant tissue in vivo can be achieved in practice. Further re-
search needs to be done concerning the uptake, specific targeting and functionalization,
kinetics of biodistribution and toxic effects of gold-nanoparticles.
Kapitel 6
Zusammenfassung
Die Computertomographie (CT) hat als ro¨ntgenbasiertes bildgebendes Verfahren vor al-
lem fu¨r die Krebsdiagnostik und Therapieu¨berwachung einen hohen medizinischen Stellen-
wert. Allerdings ist bislang keine molekulare Bildgebung mit der Computertomographie
mo¨glich. Neu entwickelte Spektral-CT-Gera¨te mit einem energieselektiven und Photonen
za¨hlenden Detektor ermo¨glichen einen wichtigen Fortschritt in der CT-Bildgebung. Diese
neuen CT-Systeme sollen zu einer Erho¨hung der Sensitivita¨t und der Spezifita¨t bei der
Detektion von Kontrastmitteln fu¨hren. Materialien mit einer hohen Ordnungszahl, wie
z.B. Gold-Nanopartikel, sind vielversprechende neue Kontrastmittel und ko¨nnen mit Hilfe
der materialspezifischen Absorptionseigenschaften an der K-Kante detektiert werden.
Den Hintergrund und die Motivation fu¨r diese Doktorarbeit bildete das Verbesserungspo-
tential in der medizinischen Tumorbildgebung durch die Kombination von Spektral-CT
und den spezifischen Eigenschaften von Gold-Nanopartikeln. Der Hauptteil der Arbeit be-
schreibt die Entwicklung und Analyse von Monte-Carlo-Simulationen der medizinischen
Spektral-CT-Bildgebung mit Gold als Kontrastmittel. Der Zweck der Simulationen be-
stand in der Demonstration der generellen Realisierbarkeit des gold-versta¨rkten Spektral-
CT, der Optimierung und Auswertung von Aufnahme- und Nachbearbeitungsstrategien,
sowie der Abscha¨tzung der minimalen In-vivo-Goldkonzentration, die fu¨r einen ausreichen-
den Bildkontrast im Spektral-CT beno¨tigt wird. Weiterhin wurde der Dosiserho¨hungseffekt
von Gold untersucht, um mo¨gliche Nebenwirkungen besser abscha¨tzen zu ko¨nnen. Fu¨r bei-
de Fragestellungen wurden Monte-Carlo-Simulationen mit der Software-Anwendung EGS-
nrc berechnet; EGSnrc modelliert den Transport von Photonen und Elektronen in Ge-
webe. Im letzten Teil der Arbeit wurden biologische Experimente durchgefu¨hrt, um eine
zielgerichtete Tumorbildgebung mit Nanopartikel zu ermo¨glichen. Die Gold-Nanopartikel
wurden hierzu mit einem tumorspezifischen Antiko¨rper gekoppelt.
Um die Einstellungen des Spektral-CTs und die Nachbearbeitungsstrategien zu verglei-
chen und zu optimieren, sowie die beno¨tigte minimale Goldkonzentration im Geweben zu
bestimmen, wurden Monte-Carlo-Simulationen mit zwei Voxelphantomen durchgefu¨hrt.
Das erste Phantom war ein einfaches zylindrisches Voxelphantom, das aus simuliertem Le-
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bergewebe und fu¨nf Gruppen mit je vier Metastasen besteht. Die Metastasen hatten eine
Gro¨ße zwischen 0,35×0,35 cm2 und 1,4×1,4 cm2. Jede Gruppe von je vier Metastasen ent-
hielt eine unterschiedliche Goldkonzentration (0,7w%, 0,4w%, 0,3w%, 0,2w% und 0,1w%).
Das zweite Phantom war ein anatomisches Human-Voxelphantom bei dem drei Leberme-
tastasen mit einer Goldkonzentration von 0,3w% bzw. 0,2w% implementiert wurden. Das
Spektral-CT wurde mit einer 120-kV-Ro¨ntgenquelle und einem idealen energieselektiven
und photonen-za¨hlenden Detektor implementiert. Die energieaufgelo¨sten Projektionsda-
ten wurden in sechs Energie-Bins aufgeteilt. Die Grenzen der einzelnen Bins wurden unter
Beru¨cksichtigung der Abschwa¨chungseigenschaften von Gold und biologischem Gewebe op-
timiert. Die so generierten spektralen Datensa¨tze wurden dann mit verschiedenen Materi-
alzerlegungsalgorithmen weiterverarbeitet: eine K-Kanten-Zerlegung (angewendet auf die
Rohdaten), eine Eigenvektor-Zerlegung und einer Kleinste-Quadrate-Parameterscha¨tzung.
Zur Rauschreduzierung in den Bildern wurden zusa¨tzlich zwei Filter, ein bilateraler und
ein Dichtefilter angewendet. Die so erzeugten zerlegten Bilder wurden in Bezug auf das
Signal-Rausch-Verha¨ltnis (SNR), das Kontrast-Rausch-Verha¨ltnis (CNR) und den Kon-
trast der Metastasen ausgewertet.
Um Gold vom Hintergrund zu unterscheiden und zur exakten Identifizierung der Metasta-
sen wird ein hoher Kontrast und ein geringes Rauschen beno¨tigt; dies wird durch die Bild-
qualita¨tsparameter CNR und Kontrast charakterisiert. Die Eigenvektor-Zerlegung lieferte
ein hohes SNR in den Goldbildern, allerdings war das CNR und der Kontrast vergleichs-
weise niedrig. Die K-Kanten-Zerlegung und die Kleinste-Quadrate-Parameterscha¨tzung
lieferten sehr gute Ergebnisse, die durch die zusa¨tzliche Anwendung des bilateralen und des
Dichtefilters noch verbessert werden konnten. Die K-Kanten-Zerlegung ergab ein ho¨heres
SNR, aber ein geringeres CNR und geringeren Kontrast als die Kleinste-Quadrate-Para-
meterscha¨tzung. Die Kleinste-Quadrate-Parameterscha¨tzung in Kombination mit dem bi-
lateralen und dem Dichtefilter lieferte das ho¨chste CNR und den ho¨chsten Kontrast, wobei
das SNR nur ca. 10% geringer war, als fu¨r die K-Kanten-Zerlegung in Kombination mit
dem bilateralen Filter. Die Berechnungszeit fu¨r die K-Kanten-Zerlegung ist anna¨hernd
11 mal la¨nger als fu¨r die Kleinste-Quadrate-Parameterscha¨tzung. Zusammenfassend kann
man sagen, dass die Kleinste-Quadrate-Parameterscha¨tzung der empfehlenswerteste Nach-
bearbeitungsalgorithmus fu¨r das Gold-spezifische Spektral-CT ist. Im einfachen Voxel-
phantom wurde die gro¨ßte Metastase (1,4×1,4 cm2) mit 0,1w% Gold von allen drei Algo-
rithmen schwach detektiert, die kleineren Metastasen waren allerdings nicht oder kaum
sichtbar. Alle drei Algorithmen ermo¨glichen die spezifische Identifizierung der drei Meta-
stasen mit 0,3w% Gold im Human-Voxelphantom, d.h. eine klare Unterscheidung zwischen
Gold und Knochen. Die kleinste Metastase (0,35×0,35 cm2) mit 0,2w% Gold im Human-
Voxelphantom war in den zerlegten Goldbildern nur schwach sichtbar; eine eindeutige
Unterscheidung zwischen Rauschen und der Metastase war kaum mo¨glich. Die numeri-
schen Werte in den Goldbildern der drei Zerlegungsalgorithmen geben den Gewichtsanteil
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von Gold im Gewebe an. Alle Algorithmen unterscha¨tzten die absolute Konzentration von
Gold (bis zu 56%) in allen Metastasen und beiden Phantomen. Die Eigenvektor- und die
K-Kanten-Zerlegung lieferten geringfu¨gig bessere Ergebnisse als die Kleinste-Quadrate-
Parameterscha¨tzung. In der Zusammenfassung kann man fu¨r die Spektral-CT-Bildgebung
mit Gold die beno¨tigte minimale Goldkonzentration in malignem Gewebe mit 0,2w% an-
geben.
Die Dosiserho¨hung in der Umgebung von Gold-Nanopartikeln basiert auf dem ho¨heren
Absorptionskoeffizienten von Gold im Vergleich zu biologischem Gewebe. Bei der Wech-
selwirkung von Photonen mit Gold-Nanopartikeln kommt es daher zu einer erho¨hten Ab-
sorption und der Erzeugung von Sekunda¨relektronen. Auf der einen Seite sollte dies als un-
erwu¨nschte Nebenwirkung von auf gold-basierenden Kontrastmitteln sorgfa¨ltig u¨berpru¨ft
werden; auf der anderen Seite kann der Dosiserho¨hungseffekt fu¨r die Anwendung von Gold-
Nanopartikeln in der Strahlentherapie genutzt werden. Die Simulations-Untersuchungen
zur Dosiserho¨hung wurden mit EGSnrc durchgefu¨hrt und lieferten Informationen u¨ber
die Sekunda¨relektronenspektren von Compton-, Photo- und Auger-Elektronen und die
deponierte Dosis. Die Simulationen zeigen einen deutlichen Dosiserho¨hungseffekt im be-
trachteten Energiebereich, wobei die Dosiserho¨hung hauptsa¨chlich von der Goldmenge
im Gewebe abha¨ngt und kaum von der Ro¨ntgenro¨hren-spannung. Fu¨r eine Goldkonzen-
tration von 0,2w% ergibt sich eine Dosiserho¨hung von 2,77 (Verha¨ltnis von absorbierter
Dosis mit und ohne Gold). Fu¨r eine sichere Anwendung von Gold-Nanopartikeln in der
medizinischen Bildgebung sollte daher eine ra¨umlich spezifische Anreicherung der Gold-
Nanopartikel sichergestellt werden, um gesundes Gewebe vor der zusa¨tzlichen Strahlenbe-
lastung zu schu¨tzen.
Eine nu¨tzliche Eigenschaft von Gold-Nanopartikeln ist die Mo¨glichkeit, sie an biologi-
sche Moleku¨le zu koppeln, um so eine zielgerichtete Tumorbildgebung zu ermo¨glichen.
Ob die oben bestimmte beno¨tigte Goldkonzentration spezifisch und zielgerichtet in ma-
lignem Gewebe erreicht werden kann, wurde mit Zellkulturexperimenten untersucht. Der
tumorspezifische Antiko¨rper cmHsp70.1 wurde an Gold-Nanopartikel mit einem Durch-
messer von 50 nm und 15 nm gekoppelt. Als Referenz wurden Gold-Nanopartikel mit BSA
(unspezifisch) beschichtet. Spektroskopische Messungen mit Wellenla¨ngen im ultraviolet-
ten und sichtbaren Spektrum, sowie die optische Emissionsspektrometrie mit induktiv
gekoppeltem Plasma (ICP-OES) deuteten darauf hin, dass die Kopplung von cmHsp70.1
und Gold-Nanopartikeln erfolgreich war. Die Goldmenge pro Zelle wurde mit ICP-OES
bestimmt. Leider ergab sich nur fu¨r die unspezifischen 15 nm Gold-Nanopartikel eine aus-
reichende Anreicherung in den Zellen von rund 0,2w%. Der spezifische und zielgerichtete
Gold-cmHsp70.1-Komplex fu¨hrte nicht zu einer ausreichend hohen Anreicherung von Gold-
Nanopartikeln. Eine weitere Optimierung des Kopplungsprozesses von Gold-Nanopartikeln
und Antiko¨rper ist daher erforderlich, um eine deutlich ho¨here Anreicherung von Gold in
den Zellen zu erreichen.
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Abschließend kann festgehalten werden, dass Gold-Nanopartikel vielversprechende neue
Spek-tral-CT-Kontrastmittel sind. Die im Rahmen dieser Arbeit durchgefu¨hrten Monte-
Carlo-Simulationen liefern einen Vergleich von unterschiedlichen Materialzerlegungsalgo-
rithmen und insbesondere eine Abscha¨tzung der minimal beno¨tigten Goldkonzentration
im Gewebe (0,2w%) fu¨r die Spektral-CT-Bildgebung im Menschen. Zellkulturexperimente,
die fu¨r diese Arbeit durchgefu¨hrt wurden, lassen vermuten, dass eine Konzentration von
0,2w% Gold im Gewebe mit einer optimierten Antiko¨rperkopplung realistisch ist. Es bleibt
daher noch zu zeigen, wie und ob die beno¨tigte Goldmenge in malignem Gewebe in-vivo
in der Praxis erreicht werden kann. Weiterfu¨hrende Forschung hinsichtlich der Aufnahme,
spezifischen Bindung, Biokinetik und der Toxizita¨t von Gold-Nanopartikeln ist allerdings
no¨tig.
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Annex
A. Algorithms
Eigenvector decomposition
IDL algorithm used for the eigenvector decomposition (section 3.1.4.1).
Listing 6.1: IDL Source Code: Eigenvector decomposition algorithm
pro eigendecomp , file , dim ,FOD , speichern=sp
;Eigenvector decomposition
;file - reconstructed CT images
;dim -dimension of images [xsize x ysize x #bins]
time1 = systime (/ seconds)
rdata=fltarr(dim)
for i=1, dim[2] do begin
if (i lt 10) then filename=file+string(i,format=’(i1)’)+’.img’ ✩
else filename=file+string(i,format=’(i2)’)+’.img’
img=read_binary(filename , data_type=4, data_dim =[dim[0],dim [1]])
endfor
f=fltarr ([dim [2] ,3])
;Bins [25 -47 -60 -75 -81 -86 -120] optimized
f[* ,0]=[13.070 ,5.9140 ,3.4790 ,2.3650 ,8.2920 ,5.5590] ;Gold
f[* ,1]=[0.6125 ,0.3479 ,0.2623 ,0.2232 ,0.2100 ,0.1865] ;HardBoneMixture
f[* ,2]=[0.2698 ,0.2162 ,0.1957 ,0.1844 ,0.1800 ,0.1709] ;Liver
;Bins [25 -34 -51 -80 -91 -110 -120] non -optimized
;f[* ,0]=[25.470 ,10.490 ,3.9630 ,7.8490 ,5.3600 ,3.7850] ;Gold
;f[* ,1]=[1.1110 ,0.5149 ,0.2792 ,0.2063 ,0.1847 ,0.1700] ;HardBoneMixture
;f[* ,2]=[0.3638 ,0.2507 ,0.2001 ,0.1787 ,0.1701 ,0.1630] ;Liver
pixel=long(dim [0])* dim[1]
rdata=reform(rdata ,[pixel ,dim [2]])
;calculation of the correlation matrix
U=dblarr ([dim[2],dim [2]])
pixel=long(dim [0])* dim[1]
cow=replicate (0.,[3, pixel])
for i=0,581 do cow[*,i]=[0.00322 ,0. ,1.0716]
for i=582 ,50771 do cow[*,i]=[0. ,1.782 ,0.]
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for i=50771 ,130562 do cow[*,i]=[0. ,0. ,1.06]
cow=correlate(cow ,/ covariance)
U=transpose(f)##cow##f
U=(U+transpose(U))/2.
;Eigenvalue decomposition , to calculate a set of basic functions
EW=Eigenql(float(U),EIGENVECTORS=EV ,/ double)
;projecting the attenutation curves onto the orthogonal basic functions
;calculate dot product
Z=replicate (0.,[pixel ,dim [2]]) ;noise -suppressed attenuation curves
B=fltarr ([pixel ,6])
for i=0,pixel -1 do begin
B[i,*]=EV##rdata[i,*]
Z[i,*]= transpose(EV[* ,0:2])## EV[* ,0:2]## rdata[i,*]
endfor
Z=reform(Z,dim)
B=reform(B,[dim[0],dim [1] ,6])
rdata=reform(rdata ,dim)
time2 =systime (/ seconds)
print ,’Eigendecomp calculation took ’,time2 -time1 ,’ seconds ’
end
K-edge decomposition
IDL algorithm used to calculate the decomposed images corresponding to the photoelec-
tric effect, Compton scattering and gold (section 3.1.4.2).
Listing 6.2: IDL Source Code: K-edge decomposition algorithm
;IMAGING SPECTRAL CT
;;using the decomposition of the attenuation , in photo -effect , compton
;scattering and constrast agent (with K-edge)
;based on "K-edge imaging in x-ray computed tomography using multi -bin
;photon counting detectors", E. Roessl and R. Proksa
;Phys. Med. Biol. 52 (2007) 4679 -4696
pro Kedge , file ,fileneu ,dim ,meth
;file - name of input files with raw data
;fileneu - name of output files
;dim - [xsize x ysize x bins]
;meth - which method should be used
; ML - maximum likelihood approac
; LS - least squares method
; NB - with constraints
; Re - applied to reconstructed images
common variKedge , I0 ,C, d ;global variables
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time1 = systime (/ seconds)
rdata=fltarr(dim) ;array for sinogramm data
Photo=fltarr(dim(0),dim (1)) ;array for photo effect
Compton=fltarr(dim(0),dim (1)) ;array for compton effect
Gold=fltarr(dim(0),dim (1)) ;array for gold
;mean energies
E=[39.9 ,54.1 ,66.5 ,77.5 ,83.0 ,97.1] ;optimized
;E=[30.9 ,43.4 ,63.2 ,84.8 ,98.5 ,113.0];non -optimized
;Mass attenuation of gold
fAu =[13.070 ,5.9140 ,3.4790 ,2.3650 ,8.2920 ,5.5590];optimized
;fAu =[25.470 ,10.490 ,3.9630 ,7.8490 ,5.3600 ,3.7850];non -optimized
hilf =1./E^3
;Klein Nishina cross section
en=E/511.
fKN =(1+en)/en ^2*((2*(1+ en )/(1+2* en)-alog (1+2*en)/en)) ✩
+alog (1+2* en)/(2* en) -(1+3*en )/(1+2* en)^2
Ct=([[ hilf],[fKN],[fAu ]])
C=transpose(Ct)
case meth of
’Re’: begin
for i=1,dim[2] do begin
filename=file+string(i,format=’(i1)’)+’.img’
rdata[*,*,i-1]= read_binary(filename , data_type =4, ✩
data_dim =[dim(0),dim (1)])
endfor
fileneu=fileneu+’img’
end
else: begin
I0=fltarr(dim [2])
for i=1,dim[2] do begin
filename=file+string(i,format=’(i1)’)+’.fdat’
rdata[*,*,i-1]= read_binary(filename , data_type =4, ✩
data_dim =[dim(0),dim (1)])
I0[i-1]= max(rdata[*,*,i-1])
endfor
fileneu=fileneu+’fdat’
end
endcase
case meth of
’ML’: begin
for j=0,dim[1]-1 do begin
for i=0,dim[0]-1 do begin
A=[1.d,1.d,1.d] ;first estimate
;Define the starting directional vectors
Xi=transpose ([[1.0d,0.0d,0.0d],[0.0d,1.0d,0.0d], ✩
[0.0d,0.0d,1.d]])
d=reform(rdata[i,j,*])
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Powell ,A,Xi ,0.000001 ,Fmin ,’MLfunc ’,ITMAX =10000
Photo[i,j]=A[0]
Compton[i,j]=A[1]
Gold[i,j]=A[2]
endfor
print ,j
endfor
end
’LS’: begin
for i=0,dim[0]-1 do begin ;loop over detector elements
for j=0,dim[1]-1 do begin ;loop over projections
d=reform(alog(I0/rdata[i,j,*]))
A=LA_Linear_equation(Ct##C,Ct##d)
Photo[i,j]=A[0]
Compton[i,j]=A[1]
Gold[i,j]=A[2]
endfor
print , i
endfor
end
’NB’: begin
for i=0,dim[0]-1 do begin ;loop over detector elements
for j=0,dim[1]-1 do begin ;loop over projections
d=reform(alog(I0/rdata[i,j ,*]))
;minimization with constraint A>=0
A=[1.d,1.d,1.d] ;first estimate
Abnd =[[0 ,0 ,0] ,[1.0e30 ,1.0e30 ,1.0 e30]]
;lower and upper bounds for A
Gbnd =[[0 ,0 ,0 ,0] ,[1.0e30 ,1.0e30 ,1.0e30 ,0]]
;lower and upper bounds of the contraints
constrained_min ,A,Abnd ,Gbnd ,3,’NBfunc ’,inform , ✩
epstop =1.0e-6
Photo[i,j]=A[0]
Compton[i,j]=A[1]
Gold[i,j]=A[2]
endfor
print , i
endfor
end
’Re’: begin
for i=0,dim[0]-1 do begin ;loop over x-axis
for j=0,dim[1]-1 do begin ;loop over y-axis
d=reform(rdata[i,j,*])
x=LA_Linear_equation(Ct##C,Ct##d)
Photo[i,j]=x[0]
Compton[i,j]=x[1]
Gold[i,j]=x[2]
endfor
print , i
endfor
end
else: print ,’method not defined ’
endcase
130
openw , 3, ’photo.’+fileneu
writeu , 3, float(Photo)
close ,3
openw , 3, ’compt.’+fileneu
writeu , 3, float(Compton)
close ,3
openw , 3, ’gold.’+fileneu
writeu , 3, float(Gold)
close ,3
time2 =systime (/ seconds)
print ,’Kedge calculation took ’,time2 -time1 ,’ seconds ’
end
function MLfunc , A
;maximum likelihood approach
common variKedge
lambda=I0*exp(-C##A)
return ,total(lambda -d*alog(lambda ))
end
function NBfunc , A
;with constraints
common variKedge
g=dblarr (4)
g[0]=A[0]
g[1]=A[1]
g[2]=A[2]
g[3]= total ((C##A-d)^2)
return ,g
end
Least squares parameter estimation
IDL algorithm for the least squares parameter estimation used to calculate the density
images of gold, liver and bone (section 3.1.4.3).
Listing 6.3: IDL Source Code: Least squares parameter estimation algorithm
pro LSMin , file , dim ,FOD , speichern=sp
;Least squares minimization for reconstructed spectral CT images
;Le 2010 Least squares parameter estimation methods for material
;decomposition with energy discriminating detectors
common vari , rdata , i,j ;global variables
time1 = systime (/ seconds)
;read in data
rdata=fltarr(dim)
for i=1, dim[2] do begin
if (i lt 10) then filename=file+string(i,format=’(i1)’)+’.img’ ✩
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else filename=file+string(i,format=’(i2)’)+’.img’
rdata[*,*,i-1]= read_binary(filename , data_type =4, ✩
data_dim =[dim[0],dim [1]])
endfor
imgneu=fltarr ([dim[0],dim [1] ,3])
for i=0,dim[0]-1 do begin
for j=0,dim[1]-1 do begin
A=[1.d,1.d,1.d] ;first estimate
Abnd =[[0 ,0 ,0] ,[1.0e30 ,1.0e30 ,1.0 e30]]
;lower and upper bounds for A
Gbnd =[[0 ,0 ,0 ,0] ,[1.0e30 ,1.0e30 ,1.0e30 ,0]]
;lower and upper bounds for constraints
constrained_min ,A,Abnd ,Gbnd ,3,’lsfunc ’,inform ,epstop =1.0e-6
imgneu[i,j,*]=A
endfor
endfor
print , min(imgneu [*,*,0]),max(imgneu [*,*,0])
if keyword_set(sp) then begin
openw ,3,file+’LSmin.gold.img’
writeu ,3,img[*,*,0]
close ,3
openw ,3,file+’LSmin.bone.img’
writeu ,3,img[*,*,1]
close ,3
openw ,3,file+’LSmin.ST.img’
writeu ,3,img[*,*,2]
close ,3
endif
time2 =systime (/ seconds)
print ,’LSmin calculation took ’,time2 -time1 ,’ seconds ’
end
function lsfunc , A ;function for optimization
common vari
f=fltarr ([6 ,3])
;Bins [25 -47 -60 -75 -81 -86 -120] optimized bins
f[* ,0]=[13.070 ,5.9140 ,3.4790 ,2.3650 ,8.2920 ,5.5590] ;fGold
f[* ,1]=[0.6125 ,0.3479 ,0.2623 ,0.2232 ,0.2100 ,0.1865] ;fHardBoneMixture
f[* ,2]=[0.2698 ,0.2162 ,0.1957 ,0.1844 ,0.1800 ,0.1709] ;fLiver
;Bins [25 -34 -47 -60 -80 -100 -120] non -optimized bins
;f[* ,0]=[21.100 ,10.740 ,5.2860 ,3.3370 ,7.0390 ,4.4810] ;fAu
;f[* ,1]=[0.9313 ,0.5245 ,0.3256 ,0.2573 ,0.1994 ,0.1766] ;fHardBoneMixture
;f[* ,2]=[0.3302 ,0.2526 ,0.2112 ,0.1944 ,0.1762 ,0.1664] ;fLiver
g=dblarr (4)
g[0]=A[0]
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g[1]=A[1]
g[2]=A[2]
g[3]= total ((rdata[i,j,*]-A##f)^2)
return ,g
end
Density filter
IDL algorithm for the density filter (section 3.1.4.3).
Listing 6.4: IDL Source Code: Density filter algorithm
pro density ,file1 ,file2 ,dim ,speichern=sp
;Based on Kalender 1988 An Algorithm for noise suppression in dual
;energy CT material density images
;file - name of input file
;dim - dimension of image in file [xsize x ysize]
liver=read_binary(file1+’liver.img’,data_type=4,data_dim=dim)
gold=read_binary(file1+’gold.img’,data_type =4,data_dim=dim)
bone=read_binary(file1+’bone.img’,data_type =4,data_dim=dim)
img=img=read_binary(file2 ,data_type=4,data_dim=dim)
;mass attenuation coefficient at 64.5keV , mean energy of used spectrum
fliver =0.1983
fgold =3.761
fbone =0.2722
liverneu=liver
goldneu=gold
boneneu=bone
k=3 ;size of mask
eta =0.05
for i=k,dim[0]-1-k do begin
for j=k,dim[1]-1-k do begin
;calculate high pass filtered version
dliver=liver[i,j]-median(liver[i-k:i+k,j-k:j+k])
dgold=gold[i,j]-median(gold[i-k:i+k,j-k:j+k])
dbone=bone[i,j]-median(bone[i-k:i+k,j-k:j+k])
dmu=img[i,j]-median(img[i-k:i+k,j-k:j+k])
eps=min([1.,abs(dmu/eta)])
if ((bone[i,j] LE 1.e-8) AND (dliver*dgold LT 0.)) then begin
C=( fliver*dliver -fgold*dgold )/2.
liverneu[i,j]=liver[i,j]-(1.-eps ^2)*C/fliver
goldneu[i,j]=gold[i,j]+(1.- eps ^2)*C/fgold
endif else begin
if (( liver[i,j] LE 1.e-8) AND (dbone*dgold LT 0.)) then begin
C=( fbone*dbone -fgold*dgold )/2.
boneneu[i,j]=bone[i,j]-(1.-eps ^2)*C/fbone
goldneu[i,j]=gold[i,j]+(1.- eps ^2)*C/fgold
endif else begin
if ((gold[i,j] LE 1.e-8) AND (dliver*dbone LT 0.)) then begin
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C=( fliver*dliver -fbone*dbone )/2.
liverneu[i,j]=liver[i,j]-(1.-eps ^2)*C/fliver
boneneu[i,j]=bone[i,j]+(1.- eps ^2)*C/fbone
endif
endelse
endelse
endfor
endfor
ind=where(goldneu LT 0.)
goldneu[ind ]=0.
ind=where(liverneu LT 0.)
liverneu[ind ]=0.
ind=where(boneneu LT 0.)
boneneu[ind ]=0.
if keyword_set(sp) then begin
openw ,3,file1+’gold.noiseneu.img’
writeu ,3,goldneu
close ,3
openw ,3,file1+’liver.noiseneu.img’
writeu ,3,liverneu
close ,3
openw ,3,file1+’bone.noiseneu.img’
writeu ,3,boneneu
close ,3
endif
end
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B. Eigenvector decomposition - Basis images
The eigenvector decomposition also provides the possibility to calculate basis images
B(x) = V Tµ(E, x). The first basis image contains the information due to the maxi-
mal variance, the second basis image the information due to the second highest variance
and so on. The basis images are not material specific. The basis images for the optimized
bin-thresholds are shown in Figure 6.1.
simple voxel phantom
(a) #1 basis im-
age
(b) #2 basis im-
age
(c) #3 basis im-
age
(d) #4 basis im-
age
(e) #5 basis im-
age
(f) #6 basis im-
age
human voxel phantom with 0.3w% gold
(g) #1 basis im-
age
(h) #2 basis im-
age
(i) #3 basis image (j) #4 basis image (k) #5 basis im-
age
(l) #6 basis image
human voxel phantom with 0.2w% gold
(m) #1 basis im-
age
(n) #2 basis im-
age
(o) #3 basis im-
age
(p) #4 basis im-
age
(q) #5 basis im-
age
(r) #6 basis im-
age
Figure 6.1: Basis images of the eigenvector decomposition.
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The first basis image (Figure 6.1(a), (g) and (m)) is similar to a CT image of a conventional
CT detector (i.e. without energy resolution). The noise level is rather low in that image.
The basis images are not material specific, however due to the approximation of the
covariance matrix, the second basis images (Figure 6.1(b), (h) and (n)) provide information
about bone and the third basis (Figure 6.1(c), (i) and (o)) images about gold. For the
human voxel phantom the remaining last three basis images (Figure 6.1(j)-(l) and (p)-(r))
hardly provide any information and can therefore be considered as noise. In the last three
basis images (Figure 6.1(d)-(f)) of the simple voxel phantom gold is still slightly visible.
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C. Further considerations about the K-edge decomposition
The presented results in this section were obtained only for the optimized gold images.
As described in section 3.1.4.2 a maximum likelihood approach is used to determine the
unknown coefficients Ak. It is also possible to use the least squares method instead.
Equation 3.25b can be reformulated as a linear equation system
CA = d, C ∈ RK×3, d ∈ RK and A ∈ R3 (6.1)
with C = [1/E3, fKN (E/Ee), fhighZ(E)], d = ln(I0/I(A)) andA = [Aphoto, ACompton, AhighZ].
The error function is given by
CA− d = r r ∈ RK (6.2)
The sum of the squares of the residuals r needs to be minimized and can be formulated
as a linear equation system
CTCA = CTd (6.3)
This linear equation system can be solved for A. For the least squares method it is assumed
that errors are normally distributed. The results with the least squares method are shown
in Figure 6.2 (results are only shown for the optimized bin thresholds).
As already mentioned in section 4.1.4.2 the results of the maximum likelihood approach
for AhighZ and Aphoto are negative for some raw data values. To prevent this equation
6.2 can be minimized under the constraint Ak ≥ 0. The resulting decomposed images are
presented in Figure 6.3.
The K-edge decomposition approach can also be applied to the reconstructed images of
all bins. Each pixel in the reconstructed images contains the linear attenuation coefficient
µ(E), which can be calculated according to Equation 3.21.
µ(E, x) = C˜photo(x)
1
E3
+ C˜Compton(x)fKN
(
E
Ee
)
+ w˜highZ(x)
(
µ(E)
ρ
)
highZ
Transforming this equation into a linear equation system yields
CA = g C ∈ RK×3, g ∈ RK and A ∈ R3 (6.4)
with C = [1/E3, fKN (E/Ee), fhighZ(E)] and gi = µi (i = 1, ...,K). We can now solve
this problem with the least squares fitting method, leading to the linear equation system
CTCA = CT g. The results are demonstrated in Figure 6.4. The maximum likelihood ap-
proach with the assumption of independent Poisson random variables cannot be applied
to the images since the linear attenuation coefficients do not form a discrete distribution.
The evaluation of the SNR, CNR and the contrast is summarized in Table 6.1 and 6.2.
The comparison of the implemented and calculated concentration of gold is shown in Ta-
ble 6.3. The highest SNR is achieved when the K-edge decomposition is applied to the
reconstructed images, the SNR is significiantly higher than for the maximum-likelihood
approach in section 4.1.4.2. The SNR for the K-edge decomposition with a least squares ap-
proach is comparable to the K-edge decomposition with a maximum-likelihood approach.
The smallest SNR is achieved by the K-edge decomposition approach with constraints.
The CNR and the contrast of all three K-edge decomposition approaches are smaller than
for the K-edge decomposition with the maximum-likelihood approach, however the results
are not significant.
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simple voxel phantom
(a) Compton Effect (b) Photo Effect (c) Gold (d) Gold after bilat-
eral filtering
human voxel phantom with 0.3w% gold
(e) Compton Effect (f) Photo Effect (g) Gold (h) Gold after bilat-
eral filtering
human voxel phantom with 0.2w% gold
(i) Compton Effect (j) Photo Effect (k) Gold (l) Gold after bilat-
eral filtering
Figure 6.2: Results of the K-edge decomposition algorithm with a least squares approach
(corresponding images of the human voxel phantom are equally scaled and windowed).
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simple voxel phantom
(a) Compton Effect (b) Photo Effect (c) Gold (d) Gold after bilat-
eral filtering
human voxel phantom with 0.3w% gold
(e) Compton Effect (f) Photo Effect (g) Gold (h) Gold after bilat-
eral filtering
human voxel phantom with 0.2w% gold
(i) Compton Effect (j) Photo Effect (k) Gold (l) Gold after bilat-
eral filtering
Figure 6.3: Results of the K-edge decomposition algorithm with constraints (corresponding
images of the human voxel phantom are equally scaled and windowed).
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simple voxel phantom
(a) Compton Effect (b) Photo Effect (c) Gold (d) Gold after bi-
lateral filtering
human voxel phantom with 0.3w% gold
(e) Compton Effect (f) Photo Effect (g) Gold (h) Gold after bilat-
eral filtering
human voxel phantom with 0.2w% gold
(i) Compton Effect (j) Photo Effect (k) Gold (l) Gold after bilat-
eral filtering
Figure 6.4: Results of the K-edge decomposition algorithm applied to the reconstructed
images (corresponding images of the human voxel phantom are equally scaled and win-
dowed).
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Table 6.1: Performance results of the K-edge decomposition algorithm for the different approaches for the simple voxel phantom.
least squares applied to the
approach with constraints reconstructed images
SNR CNR C SNR CNR C SNR CNR C
0.7w% gold
unfiltered 3.21±1.0 2.61±1.02 0.810±0.32 2.70±1.0 2.21±0.97 0.780±0.35 7.43±1.0 2.51±1.03 0.284±0.12
filtered 5.26±1.0 4.47±0.99 0.810±0.18 4.53±1.0 3.85±0.98 0.782±0.20 8.29±1.0 4.44±0.97 0.466±0.10
0.4w% gold
unfiltered 2.37±1.0 1.75±0.91 0.712±0.37 2.19±1.0 1.51±0.87 0.648±0.37 7.98±1.0 1.74±0.89 0.184±0.094
filtered 4.96±1.0 3.79±0.97 0.708±0.18 4.88±1.0 3.33±0.92 0.644±0.18 10.1±1.0 3.87±0.87 0.326±0.073
0.3w% gold
unfiltered 1.82±1.0 1.22±0.84 0.627±0.43 1.65±1.0 0.99±0.80 0.530±0.43 7.61±1.0 1.29±0.88 0.141±0.096
filtered 3.98±1.0 2.73±0.94 0.634±0.22 3.44±1.0 2.15±0.96 0.539±0.24 9.52±1.0 2.98±0.99 0.269±0.090
0.2w% gold
unfiltered 1.53±1.0 0.884±0.80 0.521±0.47 1.36±1.0 0.775±0.80 0.491±0.51 7.97±1.0 0.978±0.81 0.0952±0.080
filtered 3.52±1.0 1.96±0.91 0.521±0.24 3.11±1.0 1.74±0.91 0.494±0.26 10.1±1.0 2.14±0.94 0.185±0.082
0.1w% gold
unfiltered 1.16±1.0 0.390±0.68 0.283±0.49 1.19±1.0 0.376±0.64 0.265±0.45 8.06±1.0 0.478±0.64 0.0471±0.063
filtered 2.99±1.0 0.922±0.71 0.291±0.22 3.69±1.0 1.01±0.64 0.278±0.18 10.2±1.0 1.11±0.73 0.0991±0.065
Table 6.2: Performance results of the K-edge decomposition algorithm for the different approaches for the human voxel phantom.
least squares applied to the
approach with constraints reconstructed images
SNR CNR C SNR CNR C SNR CNR C
0.3w% gold
unfiltered 1.87±1.0 1.15±0.86 0.589±0.44 1.96±1.0 1.11±0.80 0.540±0.39 7.25±1.0 1.19±0.78 0.152±0.097
filtered 5.80±1.0 3.43±0.81 0.591±0.14 6.22±1.0 3.04±0.68 0.537±0.12 12.2±1.0 3.62±0.83 0.316±0.073
0.2w% gold
unfiltered 1.53±1.0 0.727±0.74 0.438±0.45 1.70±1.0 0.724±0.70 0.390±0.37 6.89±1.0 0.771±0.67 0.102±0.088
filtered 4.58±1.0 2.16±0.88 0.441±0.18 5.04±1.0 2.15±0.76 0.397±0.14 9.22±1.0 2.41±0.85 0.250±0.090
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Table 6.3: Implemented gold concentration and calculated weight fraction of gold multi-
plied by the total density for the K-edge decomposition for the different approaches. The
bilateral filter is used to filter the decomposed gold images, refereed to as bifilt.
simple voxel phantom
implemented 0.7w% 0.4w% 0.3w% 0.2w% 0.1w%
least squares approach 0.48±0.15 0.27±0.11 0.19±0.10 0.14±0.09 0.08±0.07
least squares approach+bifilt 0.47±0.09 0.26±0.05 0.19±0.05 0.13±0.04 0.08±0.03
with constraints 0.30±0.11 0.16±0.07 0.11±0.06 0.07±0.05 0.04±0.04
with constraints+bifilt 0.29±0.06 0.15±0.03 0.10±0.03 0.07±0.02 0.04±0.01
reconstructed images 0.48±0.15 0.27±0.11 0.19±0.11 0.13±0.10 0.06±0.09
reconstructed images+bifilt 0.47±0.09 0.26±0.05 0.18±0.05 0.13±0.04 0.04±0.03
human voxel phantom
implemented 0.3w% 0.2w%
least squares approach 0.21±0.12 0.16±0.11
least squares approach+bifilt 0.20±0.04 0.15±0.03
with constraints 0.13±0.07 0.11±0.07
with constraints+bifilt 0.12±0.02 0.11±0.02
reconstructed images 0.20±0.13 0.14±0.13
reconstructed images+bifilt 0.19±0.04 0.12±0.04
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D. Further considerations about the eigenvector decompo-
sition and the least squares parameter estimation
As already described in section 4.1.4.1 and 4.1.4.3 the estimated gold concentration in
the gold images is too low. In order to investigate the performance of the algorithms the
exact linear attenuation coefficients in each energy bin (optimized bin thresholds) for hard
bone mixture, liver tissue, 0.7w%, 0.4w%, 0.3w%, 0.2w% and 0.1w% gold (values in Table
3.2 multiplied by the density defined in Table 3.1) were used as input for the eigenvector
decomposition and the least squares parameter estimation.
For the eigenvector decomposition the covariance matrix Cov(ρtotal(x)w(x)) was estimated
with
n1︷ ︸︸ ︷ n2︷ ︸︸ ︷ n3︷ ︸︸ ︷ (6.5)
= Cov
 0.0032 0.0 0.0· · · 0.0 · · · · · · 1.782 · · · · · · 0.0 · · ·
1.0716 0.0 1.06
 (6.6)
=
 2.31× 10−6 −6.37× 10−4 3.87× 10−4−6.37× 10−4 0.71 −0.42
3.87× 10−4 −0.42 0.25
 = Cov(ρtotal(x)w(x)) (6.7)
The number of pixels containing gold, bone and liver tissue are equal and n1 = n2 = n3 =
12500.
For the first evaluation no noise was added and for the second evaluation noise was added
to the input data. The setup of the input data is shown in Figure 6.5. The noise level was
chosen such that the SNR in the input data is comparable to the SNR in the simulation
results.
Figure 6.5: Setup of the input data for the analysis of the eigenvector decomposition and
the least squares parameter estimation.
The results of the eigenvector decomposition and the least squares parameter estimation
are shown in Figure 6.6.
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eigenvector decomposition
(a) Liver (b) Bone (c) Gold
least squares parameter estimation without density filter
(d) Liver (e) Bone (f) Gold
least squares parameter estimation with density filter
(g) Liver after den-
sity filtering
(h) Bone after den-
sity filtering
(i) Gold after density
filtering
Figure 6.6: Results of the eigenvector decomposition and the least squares parameter
estimation of the input data with noise.
144
The implemented and calculated gold concentrations are summarized in Table 6.4. For
the input data without noise the calculated concentrations exactly match the implemented
concentrations. The eigenvector decomposition estimates the gold concentration almost
exactly even for the input data with noise. The least squares parameter estimation un-
derestimates the gold concentration for the input data with noise. However the difference
between the calculated and the implemented concentrations is smaller than for the simu-
lations.
Table 6.4: Implemented and calculated concentrations of gold in w%.
implemented 0.7w% 0.4w% 0.3w% 0.2w% 0.1w%
input data without noise
EV 0.70±0.00 0.40±0.00 0.30±0.00 0.20±0.00 0.10±0.00
LSPE 0.70±0.00 0.40±0.00 0.30±0.00 0.20±0.00 0.10±0.00
input data with noise
EV 0.69±0.23 0.40±0.14 0.30±0.12 0.20±0.11 0.10±0.10
LSPE 0.62±0.23 0.35±0.15 0.26±0.13 0.17±0.10 0.08±0.08
LSPE+density 0.67±0.19 0.39±0.12 0.29±0.09 0.19±0.08 0.09±0.06
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E. Materials
Substances and chemicals
❼ Gold Colloid: 50 nm, BBI Solutions (Cardiff, UK)
❼ Gold Colloid: 15 nm, BBI Solutions (Cardiff, UK)
❼ 4T1 cells, ATCC➤ Number: CRL-2539TM
❼ monoclonal antibody cmHsp70.1 (concentration 2.4 ➭g/➭l), Multimmune GmbH (Munich, Germany)
❼ EM Goat anti-Mouse IgG: 30 nm (protein concentration 11.4 ➭g/ml), BBI Solutions (Cardiff, UK)
❼ Hsp70 protein, SignalChem (Richmond, Canada)
❼ Hsc70 protein, Enzo Life Science (Loerrach, Germany)
❼ RPMI 1640 Medium, Gibco (Carlsbad, USA)
❼ Foetal calf serum (FCS), PAA (Pasching, Austria)
❼ L-Glutamine, PAN (Aidenbach, Germany)
❼ Penicillin/Streptomycin, Gibco (Carlsbad, USA)
❼ Sodium/Natrium-Pyruvate, PAN (Aidenbach, Germany)
❼ Phosphate buffered saline (PBS), Lonza (Cologne, Germany)
❼ Trypsin-EDTA 0.25%, Gibco (Carlsbad, USA)
❼ Albumin Fraction V, IgG and protease free (BSA), Carl Roth (Karlsruhe, Germany)
❼ Dimethyl sulfoxide (DMSO), Sigma Aldrich (St. Louis, USA)
❼ Trypan blue stain, Cambrex Bio Science (Walkerville, USA)
❼ May-Gruenwald’s solution, Carl Roth (Karlsruhe, Germany)
❼ 2.5% Glutaraldehyde in 0.1M soidum cacodylate, Buffer pH 7.4, Electron Microscopy Sciences (Hat-
field, USA)
❼ Sodium hydroxide (NaOH)
❼ Hydrogen chloride (HCl)
❼ Methanol
❼ Sodium chloride (NaCl)
❼ Millipore water
Consumables
❼ Cryo.s tubes, Greiner Bio-One (Frickenhausen, Germany)
❼ 1.5ml micro-centrifuge tubes, Eppendorf (Hamburg, Germany)
❼ Cell culture flasks, BD Falcon (California, USA)
❼ 6 well plates, Greiner Bio-One (Frickenhausen, Germany)
❼ Pipetting tips, Eppendorf (Hamburg, Germany)
❼ Counting chamber Fast Read 102, Immune Systems Ltd.
❼ Serological pipettes, Greiner Bio-One (Frickenhausen, Germany)
❼ Tubes, BD Falcon (California, USA)
❼ pH-indicator strips, pH 6.5-10.0, Merck (Darmstadt, Germany)
❼ Filter, Minisart, 0.2 ➭m, Sartorius AG (Go¨ttingen, Germany)
❼ Western Blot Membrane, Hybond PVDF, GE lifescience
❼ Syringe, B. Braun Melsungen AG (Melsungen, Germany)
❼ Microscope slides standard, Carl Roth (Karlsruhe, Germany)
❼ Petri dishes, Carl Roth (Karlsruhe, Germany)
❼ Beem Embedding capsules, Electron Microscopy Sciences (Hatfield, USA)
❼ Silica glass tubes
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Instruments
❼ Laminar flow hood, Schulz-Lufttechnik GmbH (Sprockho¨vel, Germany)
❼ Hettich Universal 32R Centrifuge (Tuttlingen, Germany)
❼ Heraeus Incubator, Thermo Scientific (Waltham, USA)
❼ Axioplan2 imaging Microscope, Zeiss (Jena, Germany)
❼ Axiocam HRc, Zeiss (Jena, Germany)
❼ Cary 1 UV-Vis spectrometer, Varian (Palo Alto, USA)
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